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This dissertation applies a risk communication theoretical framework, the Risk 
Information Seeking and Processing Model (RISP), to address a health communication 
challenge that aims to promote informed decision making about clinical trial 
enrollment. A review of theoretical development and empirical evidence suggests 
several pathways to refine the model, which guides subsequent analyses. To compare 
the general patterns of information seeking among prospective healthy volunteers and 
cancer patients and their caregivers, Chapter 3 tests how risk perceptions, affective 
responses, and normative beliefs motivate routine and non-routine information 
seeking. Specifically focused on prospective healthy volunteers, Chapter 4 examines 
the applicability of the central part of the RISP model to account for more active 
information seeking and higher-level information processing. Linking the RISP model 
to the Theory of Planned Behavior, Chapter 5 investigates how cognitive processing 
styles, affective responses, and normative beliefs influence cancer patients’ general 
attitudes and intentions to enroll in a future trial. Through a comparative analysis 
using multiple-sample structural equation modeling, the final substantive chapter 
demonstrates that even though cognitive processing styles and normative beliefs 
mainly shape prospective healthy volunteers’ decisions about clinical trial enrollment, 
emotional factors have a greater impact on cancer patients and their caregivers. Since 
the most fundamental mechanism that the RISP model proposes, a cognitive need to 
 achieve information sufficiency, fails to influence information seeking and processing 
throughout the different chapters, the final chapter proposes an adjusted version of the 
model that allows for a change in contextualization across research settings. Findings 
from this dissertation also offer evidence-based recommendations to improve patient 
accrual for clinical trials. 
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CHAPTER 1 
INTRODUCTION 
Health communication scholars have long argued for theory-based research 
that offers practical implications for health interventions and public campaigns. To 
solve communication problems related to a variety of health issues, a number of 
theoretical frameworks have been proposed to depict the process in which people 
access and absorb health-related information to guide their behaviors. Some of them 
focus on psychological mechanisms that motivate health-related information seeking 
and retention (Afifi & Weiner, 2004; Brashers, Goldsmith, & Hsieh, 2002; Rimal & 
Real, 2003), while others adopt a more sense-making approach, taking into account 
the background and context of health information acquisition (Johnson, 1997). These 
theories primarily explain how the interplay of uncertainty, expectancy, and efficacy 
could motivate or hinder one’s information seeking; few of them, however, connect 
communication behaviors with subsequent health decision making related to attitude 
formation and behavior change. In other words, communication researchers often 
expect that greater exposure to health information will ameliorate individuals’ 
decision making process. As Brashers (2001) pointed out, however, greater exposure 
to health information could at times distress individuals who suffer from chronic 
illnesses. 
In viewing these theories, even though they mostly adopt a socio-psychological 
perspective when examining information seeking, few evidently describe the cognitive 
and evaluative processes that push individuals from having a tepid interest in health-
related information to sensing an uncertainty or discrepancy that needs to be resolved 
in order to deal with an important health issue. Nonetheless, this latter state, the 
awareness of an uncertainty or discrepancy, often constitutes the starting point for 
many of these existing theories (Brashers, 2001). Further, even though some of these 
 2 
 
theories acknowledge the impact of emotion on rational decision making (Afifi & 
Weiner, 2004), they rarely grant enough attention to emotions’ activating effects that 
could directly motivate information seeking and processing activities. In comparison, 
risk communication theories such as the “affect heuristics” framework (Slovic, 
Finucane, Peters, & MacGregor, 2005) and the “risk as feelings” hypotheses 
(Loewenstein, Weber, Hsee, & Welch, 2001) have highlighted the importance of 
emotions when we study social phenomena that involve risk judgment and reactions to 
an uncertain situation. Since risk and uncertainty are routinely part of the vocabulary 
used to describe health communication challenges, it is essential to investigate how 
emotions, directly or indirectly through the influence on analytical reasoning, could 
impact individuals’ health-related information management.  
Examining these theoretical frameworks together, another important, yet often 
ignored, aspect is the socio-cultural environment in which information seeking 
activities occur. Johnson’s (1997) model and Brashers’ (2001) theories of uncertainty 
management both hint at the impact of relational concerns in shaping individuals’ 
beliefs about information seeking. However, neither of them offers specific 
propositions that allow this impact to be assessed empirically. Similarly, within its 
scope condition of active cognitive engagement in an interpersonal context, Afifi and 
Weiner’s (2004) theory of motivated information management (TMIM) accounts for 
influence of the information provider. However, compared to their detailed illustration 
of how information seekers evaluate information related to outcome and efficacy, it is 
less clear how the feedback from information providers affect information seekers’ 
ultimate decisions. In addition, normative influences from other important people in 
one’s social network, including those who are not key information providers, is not 
reflected. 
As a communication researcher who stands astride the fields of health 
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communication and risk communication, I often pay attention to theoretical models 
that overlap in their basic dynamics because, fundamentally, they are put forward to 
account for similar phenomena. When researchers migrate across these disciplines, a 
more comprehensive conceptual framework might offer a more thorough and cohesive 
portrayal of critical issues that impede effective communications of health and risk 
topics. The present series of studies attempt to assess one such theoretical model, the 
Risk Information Seeking & Processing (RISP) model (Griffin, Dunwoody, & 
Neuwirth, 1999). Based on the Heuristic-Systematic Model (HSM, Eagly & Chaiken, 
1993) and the Theory of Planned Behavior (TPB, Ajzen, 1988), the RISP model 
originates from risk communication research, but over the last decade, it has guided 
research across various disciplines such as risk, health, and environmental 
communication. Empirical evidence from these studies, for the most part, has provided 
support for its key propositions. Chapter 2 provides a review of this research.  
The remainder of the dissertation focuses on testing and extending the RISP 
model to the context of clinical trial enrollment decisions. Presenting a unique 
research context for this investigation are communication issues related to clinical trial 
enrollment. Since risk and uncertainty are inevitable parts of any discussion related to 
clinical trial participation. I believed that the RISP model would be an appropriate 
framework. This conjecture, however, is tested through subsequent analyses. To make 
this investigation even more interesting, I collected data from two samples for the 
purpose of comparative analysis. Information gathered through a random digit dial 
telephone survey of the U.S. adult population, accompanied by a telephone survey of 
members of the Leukemia & Lymphoma Society (LLS), allows me to draw evidence-
based recommendations to improve the dissemination of information related to clinical 
trial enrollment. Applying the RISP model to study informed decision making related 
to clinical trial enrollment, I intend to offer my insight from a communication 
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perspective to solve a problem that has perplexed medical researchers – the low 
enrollment rate for clinical trial studies. Therefore, theoretical pursuit and practical 
need complement each other in forming this research endeavor. 
Research Context 
Low patient accrual in clinical trials poses a serious concern for the 
advancement of medical science in the United States. As the National Cancer Institute 
(2006) states on its clinical trial information portal, less than five percent of adults 
diagnosed with cancer each year get treated through enrollment in a clinical trial. With 
broader enrollment, the effort to find newer and better ways to treat and prevent cancer 
might be swifter. To address low enrollment, hundreds of studies have sought to 
identify and overcome barriers to enrollment, and there are several excellent reviews 
of this literature (Abraham, Young, & Solomon, 2006; Mills et al., 2006). Although 
emerging from several disciplines, some consistent findings are present: 
Among patient-related barriers to enrollment include a lack of awareness and 
knowledge about clinical trials (Baquet, Commiskey, Mullins, Mishra, 2006; Giuliano 
et al., 2000; Harris, Gorelick, Samuels, Bempong, 1996); patient attitudes toward 
clinical trials, including fear of randomization and fear of side-effects (Madsen, Holm, 
& Riis, 2007; Sharp et al., 2006); logistical problems, including travel to study 
locations or access to childcare (Avis, Smith, Link, Hortobagyi, & Rivera, 2006); and 
trust or distrust of physicians and trial researchers (Grady et al., 2006; Jenkins & 
Fallowfield, 2000; Mills et al., 2006). Alternatively, patient incentives have included 
perceived personal benefits (Wright et al., 2004), scientific merit of the study (Wright, 
Crooks, Ellis, Mings, & Whelan, 2002) and feelings of altruism (Peel, Parry, Douglas, 
& Lawton, 2006). 
Physician barriers influencing enrollment have included physicians’ 
knowledge, attitudes, and motivations to enroll patients in clinical trials (Castel, 
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Negrier, & Boissel, 2006; Comis, Miller, Aldige, Krebs, Stoval, 2003; Fallowfield, 
Ratcliffe, & Souhami, 1997; Mannel et al., 2003; Somkin et al., 2005). Research has 
also found that the manner by which physicians communicate with their patients about 
clinical trials plays a key role (Albrecht, Blanchard, Ruckdeschel, Coovert, & 
Strongbow, 1999; Albrecht et al., 2003; Grant, Cissna, & Rosenfeld, 2000; Jenkins, 
Fallowfield, Souhami, Sawtell, 1999). Studies have also specifically targeted 
communication related to explaining randomization and obtaining informed consent 
(Fallowfield et al., 1998; Hutchison & Campbell, 2002; Kodish et al., 2004; Stryker, 
Wray, Emmons, Winer, & Demetri, 2006). Finally, institutional barriers to enrollment 
have also been identified, including a lack of availability of clinical trials for certain 
patients, or the disqualification of other patients (Comis et al., 2003). 
Communication Perspective 
Despite the centrality of communication to many of these challenges, 
communication research is largely absent from this literature, which suggests the 
importance and necessity for the current series of studies. Given the theoretical 
outlook of this research project, findings from these studies will, in return, contribute 
to the development of communication theories on a broader scale.  
Among several theoretical frameworks that focus on motivations for 
communication behavior, the RISP model is unique in that it examines within-
audience variance in risk-related information seeking and processing accounted for by 
a number of important psychological and social mechanisms. For instance, concepts 
reflected in the RISP model include causal attribution, self-efficacy, subjective norm, 
judgmental confidence, and general attitudes towards different information channels. 
The RISP model also evaluates the impact of individual characteristics such as 
education, political philosophy, current knowledge about a particular issue, and 
information gathering capacity. Informed by the main propositions of the RISP model, 
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the series of studies presented here not only examine its overall applicability to this 
health communication issue but also extend the model in several important ways. 
First, the RISP model includes an affective component, termed as affective 
responses, which allows for a comparison between the impact of negative and positive 
emotions that might be associated with perceived risk. Several studies reported here 
contained a comparison of possible negative and positive emotions related to clinical 
trial enrollment and their relative impact on individuals’ communication behavior. 
Second, recent development based on the RISP model (Kahlor, 2007, for instance) has 
argued for a revisit to its theoretical foundation to explore the linkage between the 
RISP model and the TPB. This proposition also guided a number of studies reported 
here. Third, based on new findings accumulated in recent years (for instance, Huurne, 
Griffin, & Gutteling, forthcoming; Griffin et al., 2008; Kaholr et al., 2006), the 
alignment of key cognitive and affective components of the RISP model is reassessed 
with structural equation modeling. Lastly, the RISP model was initially developed to 
examine motivations behind seeking and processing behaviors related to the mass 
media. Since most of the communications of clinical trial enrollment usually occur at 
the interpersonal level, or through new media formats such as health website, applying 
the RISP model to these scenarios could also attest to its ecological validity. 
Outline of Chapters 
Immediately following this introduction, the second chapter provides an 
overview of the RISP model and its development over the past decade. This chapter 
mainly highlights its applicability to a medical decision making context, specifically 
related to the current research project. Based on a synopsis of past findings, it then 
calls attention to the possibility of revising the model to better depict key factors that 
work together to motivate higher-level information seeking and processing. The 
chapter notes that existing research has mainly tested different parts of the RISP model 
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step-by-step but has insufficiently examined the model in its entirety. More 
importantly, the RISP model was constructed to serve as a theoretical linkage between 
individuals’ mental calculation of and response to a potential risk, their submission to 
social influences, and their intention to engage in information seeking and processing 
behavior. Inspired by Kahlor’s (2007) proposition of an augmented RISP model, the 
second chapter argues that the RISP model should go beyond the communication 
behaviors to explore what comes after information seeking and processing. Several 
important features of the model justify this extension. First, within the RISP model, 
key motives that shape attitudinal positions, as proposed by the HSM, such as 
defensive motivation and impression management, could be tested together with other 
individual and social factors that influence risk-related behaviors. Second, the tie 
between the RISP model and the TPB was not only posited in Griffin et al.’s seminal 
piece (1999), but was also shown to be a robust linkage across a variety of research 
settings. Therefore, the chapter concludes by introducing the specific objectives of 
subsequent chapters in order to achieve this overarching goal. 
In an effort to understand what motivates people to attend to information about 
clinical trial enrollment, the third chapter sets up ground work for subsequent chapters 
by depicting how healthy respondents and LLS respondents differ in their information 
seeking behaviors. Specifically, routine information seeking through the traditional 
mass media and non-routine information seeking through online sources were 
categorized separately. Informed by the augmented RISP model, general attitudes 
toward the behavior were assessed along with other RISP components. By testing 
interaction terms, group membership is found to moderate key relationships between 
routine and non-routine information seeking and negative emotions, risk judgment, as 
well as normative beliefs. Other variables examined in this chapter include positive 
emotions associated with clinical trial participation, general awareness, and the 
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tendency to rely on independent decisions. 
Following this general comparison of information seeking behaviors across the 
two samples, the fourth chapter specifically focuses on the national sample because 
one goal of improving communications about clinical trial enrollment is to enhance 
awareness and understanding among the general public. Structural equation modeling 
is used to test the central part of the RISP model. This analysis highlights the role of 
optimism, as a type of affective response, in motivating information seeking and 
processing. Key results indicate that besides exerting an indirect influence on 
information seeking through motivating a cognitive need for more information, 
optimism also directly influences information seeking and processing. Similarly, 
informational subjective norms, as another key component of the RISP model, also 
have more direct influence on information seeking and processing. These results speak 
to the applicability of the RISP model to this health decision making context. In 
addition, major findings from this chapter warrant readjustment of the model and 
inform the accrual of healthy volunteers for clinical trial research. 
Shifting gear back to cancer patients, the fifth chapter mainly tests the 
proposition that the RISP model could serve as an antecedent to the TPB. Specifically, 
the outcome variables of the RISP model, systematic and heuristic processing, are 
examined together with cancer patients’ belief-based attitudes and behavioral 
intentions related to clinical trial enrollment. To explore other individual and social 
factors that might influence cancer patients’ attitudes toward clinical trial enrollment, 
other RISP components are also included in subsequent analyses. Key results indicate 
that risk judgment and affective responses, especially optimistic feelings, have the 
most consistent relationships with cancer patients’ attitudes and behavioral intentions 
related to clinical trial enrollment. Trust in doctors also significantly related to the 
positive attitudes toward clinical trials. These findings suggest that the RISP model 
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might have more constrained applicability as compared to the TPB in explaining 
cancer patients’ motivations for clinical trial enrollment. However, certain components 
of the RISP model might be interesting additions to the TPB as they contribute to the 
formation of belief-based attitudes toward clinical trials. 
As a comparative investigation, the sixth chapter presents findings from 
multiple-sample structural equation modeling analysis. To effectively link 
communication behaviors with actual decisions related to participation, data from the 
two samples are compared to reveal potential differences among healthy respondents 
and LLS members. Main results indicate that information processing strategies have 
less influence on attitudes and behavioral intentions among LLS respondents, as 
compared to the national sample. On the contrary, affective responses, especially 
optimistic feelings, play a bigger role in influencing attitudes and behavioral intentions 
among cancer patients and their caregivers. Surprisingly, normative beliefs have 
stronger total effects on healthy respondents’ behavioral intentions related to clinical 
trial participation. The relationship between belief-based attitudes and behavioral 
intentions is also stronger in the national sample, as compared to the LLS sample. 
These results suggest that communication efforts focused on improving clinical trial 
enrollment should attempt to balance among providing information, using emotional 
appeals, and stressing social norms in order to achieve attitudinal and behavioral 
change in more effective ways. 
Based on results from these studies, the final chapter discusses ethical and 
practical implications of the overall project, while at the same time it reevaluates my 
initial interest and passion to get involved in this research effort. Risk and health 
communication research is often positioned at a unique middle point. That is, we walk 
between scientist and experts who strive to produce and create new knowledge and 
members of the general public who are involved, willingly or unwillingly, in the 
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shaping of policy and the socio-cultural environment of our society. Therefore, the 
mission of the current project, albeit perhaps representing an ideal understanding of 
my duty as a communication researcher, is not to generate new ideas or more effective 
toolkits to recruit more healthy volunteers or cancer patients into clinical trial research. 
Quite the opposite, the ultimate goal is to detect what might urge more people to pay 
attention to information about clinical trial enrollment and equip themselves with basic 
knowledge and resources to deal with this issue. Once basic awareness is improved 
among the general public, it is more likely for ordinary citizens to engage in 
meaningful discussions with their primary care physicians or other medical experts 
about clinical trial opportunities that might benefit themselves or those who are 
important to them. Improved public knowledge and awareness about clinical trial 
research will ultimately benefit medical research as well. After all, it is more likely for 
medical researchers to obtain robust and meaningful results if those who participate in 
clinical studies come from a qualified pool of subjects who are well-informed and well 
prepared, rather than a group of professional “guinea pigs” who exchange their body 
and mind as medical commodities. 
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CHAPTER 2 
APPLYING THE RISP MODEL TO STUDY MEDICAL DECISION MAKING  
RELATED TO CLINICAL TRIAL ENROLLMENT 
The Risk Information Seeking and Processing (RISP) model, since its original 
proposition, has generated a dozen or so empirical analyses that produced a vast 
amount of evidence in support of the key relationships shown in the model (Figure 
2.1). Initial analyses examined different parts of the model separately, while recent 
studies tend to evaluate the model in its entirety across different research contexts. To 
serve as a theoretical overview, this chapter first introduces key components of the 
RISP model as well as the relationships it posits. Then, based on a review of its 
development over the last decade, it concludes with suggestions of several potential 
pathways to enhance the model, which subsequently guide the following chapters. 
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Theoretical Overview 
According to Griffin et al. (1999), the RISP model offers a framework to 
depict what key factors might predispose individuals to seek and process relevant risk-
related information in a more systematic or thoughtful manner. Consistent with the 
assumption of its theoretical foundation, the Heuristic-Systematic Model (HSM) 
(Eagly & Chaiken, 1993), the RISP model views information processing as an 
antecedent to attitude formation and behavior change. There has been empirical 
evidence showing that a deeper, more systematic way of information processing is 
positively related to stronger and more stable behavior-based beliefs related to 
environmental hazards (Griffin, Neuwirth, Giese, & Dunwoody, 2002). Recent 
development of the RISP model also includes an integration of additional key 
concepts from the TPB, investigating the utility of an augmented RISP model (Kahlor, 
2007) to explain individuals’ intention for information seeking about environmental 
risk. The current research project, as part of this continuous effort, returns this 
exploration to the domain of health communication, where the RISP model was first 
introduced. 
Based on dual-processing theories, the RISP model suggests that active 
seeking and systematic processing of risk-related information are primarily motivated 
by one’s psychological need for information sufficiency. This idea is largely adopted 
from the HSM’s sufficiency principle, which suggests that “people will exert whatever 
effort is required to attain a ‘sufficient’ degree of confidence that they have 
satisfactorily accomplished their processing goals” (Eagly & Chaiken, p. 330). The 
motivating effect of the desire for information sufficiency (termed as information 
insufficiency hereafter) is moderated by individuals’ capacity to gather relevant 
information and their assessment of the information source. According to Trumbo 
(2002), this framework is appropriate for communication studies because it forms 
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effective links between the questions of where people get information about a 
particular topic and how they deal with this information. Given the overarching goal 
of this research project, the empirical analyses presented here focus less on whether 
patients are capable of engaging in higher-level information processing because the 
ability to decode health information through a meaningful informed consent process 
warrants another discussion of its own. Rather, these studies are mainly interested in 
the part of the RISP model that addresses the issue of motivation.  
Similar to other dual-processing theories, Eagly and Chaiken defined heuristic 
processing as “a limited mode of information processing that requires less cognitive 
effort and fewer cognitive resources” (p. 327). Systematic processing, in comparison, 
is a “relatively analytic and comprehensive treatment of judgment-relevant 
information” (Chen & Chaiken, 1999, p. 74). These two concepts resemble the 
“central route” and “peripheral route” as proposed in the Elaboration Likelihood 
Model (Petty & Cacioppo, 1986). However, as Chaiken and Stangor (1987) pointed 
out, HSM asserts that “persuasion is often mediated by simple decision rules that 
associate certain persuasion cues with message validity”, whereas ELM specifies 
motives that produce attitude change without generating active issue-relevant thinking 
(p. 593). Consistent with HSM’s assumptions, the RISP model’s focus on how 
information is integrated to affect beliefs and attitudes renders it applicable not only to 
persuasion settings but also to other situations in which people “gain new information 
about attitude objects or ruminate about information they already possess” (Eagly & 
Chaiken, p. 257). 
Even though systematic processing is considered less superficial, a heuristic 
strategy has the mental and economic advantage of requiring a minimum of cognitive 
effort (Chaiken, 1980). Therefore, people tend to engage in heuristic processing unless 
motivated to adopt the more effortful strategy. Heuristic and systematic processing 
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could also occur at the same time (Dijksterhuis, Bos, Nordgren & Van Baaren, 2006). 
However, Chaiken (1980) pointed out that the heuristic strategy may be less reliable 
when used to judge message validity because an overreliance on simple decision rules 
may lead recipients to accept conclusions they might otherwise reject had they 
invested the time and cognitive resources to discover and scrutinize different 
arguments (p. 753). This notion seems particularly relevant to the present case of 
study. As compared to following routine regimen, the decision to participate in a 
clinical trial often requires more detailed risk and benefit assessment and more 
personal involvement in terms of decision making.  
As Beauchamp and Childress (1994) mentioned, the informed consent to 
participate in a clinical trial should represent nothing less than an “autonomous 
authorization” by an individual. Therefore, even though the popular “informed 
judgment model” requires doctors to transfer the necessary expertise to their patients 
so that he or she could make an informed judgment (Charles, Gafni, & Whelan, 1999; 
Wright et al., 2004), it might be insufficient. That is to say, if no systematic evaluation 
of the information follows the knowledge transfer, it is unlikely that an individual will 
be able to reach a decision that works the best for him or her. Therefore, as health 
communication researchers, we need to take on this difficult task of promoting a more 
systematic way to process health information and greater involvement on the patient 
end. 
The RISP model adopts HSM’s proposition of a sufficiency principle that is 
primarily based on judgmental confidence. This judgmental confidence, according to 
Eagly and Chaiken, particularly relates to the assessment of message validity, which 
they described as an accuracy motivation. Two additional motivations are also likely 
to trigger systematic processing. Specifically, defense motivation is based on one’s 
desire to form and hold beliefs that are consistent with his or her material interests and 
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fundamental values. Impression motivation refers to one’s desire to express attitudes 
that help them meet their immediate social goals, such as getting along with others 
(Chen & Chaiken, 1999). Chaiken, Liberman, and Eagly (1989) propose that both 
defense motivation and impression motivation could lead to either heuristic or 
systematic processing, depending on the social contexts in which they function. For 
instance, when defense-motivated individuals receive information from an authority 
figure that is in line with their position, they may adopt heuristics such as the belief 
that expertise and specialized knowledge are always trustworthy. However, when the 
same defense-motivated individuals receive a similar message from a less-valued 
source, they may engage in further deliberation to reinforce their own belief. 
Similarly, even though following a simple decision rule such as “go with the 
consensus” sounds heuristic in nature, the desire to identify the consensus and reach 
conformity might generate greater information seeking and more effortful processing. 
The RISP model alludes to these motivations through concepts such as relevant 
channel beliefs and informational subjective norms. Specifically, even though the 
conceptualization and measurement strategy associated with relevant channel beliefs 
are still under refinement, overall, this component describes whether or not individuals 
believe that a particular information channel could provide useful information, while 
at the same, be accessible and trustworthy. These notions mainly reflect the findings 
that people’s habitual information processing strategies are influenced by their 
perceived images of the media (Kosicki & McLeod, 1990). Informed by Chaffee’s 
(1986) cost-benefit analysis approach to explain information channel selection, Griffin 
et al. (2005) offered a more detailed account for this component, focusing on the 
perception that a particular information channel will contain information that is most 
relevant to individuals’ processing task. Specifically related to the current research 
context, when there is some sort of power differentiation between information seekers 
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and information providers, such as between patients and physicians, it could be 
expected that relational factors such as trustworthiness might be more influential as 
compared to accessibility and usability. When facing an authority figure, defense 
motivation and impression management might be activated to drive individuals into 
more active seeking and processing of relevant information.  
Informational subjective norms, a concept adopted from the TPB, reflect these 
alternative motivations even more closely. The RISP model has traditionally depicted 
this component as individuals’ inclination to respond to social pressures or 
expectations that they should acquire sufficient information to deal with the risky 
situation. The reasoning is that people under greater normative influence from those 
who are important to them will be more likely to engage in information seeking and 
processing activities, and possibly, be more actively involved in the decision making 
process. This component of the RISP model takes into account potential influence 
from the surroundings in which communication behaviors occur. Thus, different from 
other similar theoretical models that are purely based on people’s internal calculations, 
the RISP model has leeway to assess the impact of socio-cultural factors on people’s 
motivations. Recent development has identified both direct and indirect influence from 
this variable on information seeking and processing, which will be discussed in greater 
detail later. 
Besides informational subjective norms, other antecedents to information 
insufficiency include individuals’ cognitive evaluations of and affective responses to a 
particular risk issue. Griffin et al. (1999) proposed that given the negative valence of 
risk perception, affective responses associated with it are most likely negative in 
nature. However, in their subsequent theorization, they recognized that positive 
responses such as hope could also constitute emotions engendered from a risk 
situation (Griffin et al., 2008). Social psychologists have long argued that both hope 
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and anxiety could originate from an appraisal that is based on an uncertain outcome 
(Ortony & Clore, 1981), whereas empirical evidence has shown emotions 
characterized by an uncertain appraisal to promote systematic processing (Tieden & 
Linden, 2001). Since uncertainty is an indisputable part of risk perception, it is 
reasonable to assume that emotions of a positive valence could also play a role in the 
RISP model.  
In regards to the cognitive evaluation of risk, formally termed as perceived 
hazard characteristics in the RISP model, this component involves several distinct 
dimensions. Up until now, Griffin, Neuwirth, Dunwoody and Giese (2004) offered the 
most comprehensive description for this construct. Besides the broadly used measures 
of risk judgment based on subjective perception of the probability and severity of 
personal harm, two more relevant variables were included: personal control and 
institutional trust. Personal control deals with people’s belief that they could do 
something to protect themselves or others. In contrast, institutional trust depicts one’s 
willingness to rely on experts or authorities for protection (Siegret, Cvetkovich, & 
Roth, 2000). Later, informed by attribution theory (McGuire, 1974) and data 
indicating that different attribution styles shape risk perception in different ways 
(Kahlor et al., 2002), causal attribution was integrated into the RISP model as part of 
the perceived hazard characteristics component (Griffin et al., 2008). Viewing various 
RISP components together, in line with the current research context, individuals’ 
general trust for physicians and medical researchers seem to fit better into the model 
as a measure for relevant channel beliefs. Given the complexity of potential risks 
involved in the clinical trial process, a generic assessment of risk perception might suit 
the current study well.  
Lastly, at the deep background of the RISP model, demographic variables, past 
experience, political philosophy, and other sociocultural factors also contribute to 
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within-audience variations in terms of information need and information acquisition 
styles. Past research has found that women, minorities, those who are younger, and 
those who have had previous experience generally report slightly more informational 
insufficiency. Education level has also been associated with current knowledge and 
informational gathering capacity. Overall, however, these variables have accounted for 
a rather minimal amount of variance in the dependent variables.  
Theoretical Development 
Following the key propositions presented in their seminal work, Griffin and his 
collaborators have tested the RISP model in a variety of research contexts. Findings 
from these studies largely support the relationships depicted in the RISP model, while 
at the same time, suggest important ways to refine the model.  
As the first published empirical piece since the model was introduced, Griffin 
et al. (2002) drew linkages between the HSM and the TPB, both of which serve as 
theoretical foundations for the RISP model. Using data from a panel design study 
conducted in the Great Lakes region, both health risks related to fish consumption and 
drinking water quality, as well as environmental risks related to the ecosystem of the 
Great Lakes, were examined. Key findings from this study suggest consistent positive 
relationships between systematic processing of risk information and TPB measures 
such as evaluation strength, attitude strength, and the number of strongly held 
behavioral beliefs associated with environmental hazards. These relationships were 
also robust because they remained significant under multiple statistical controls. This 
study is meaningful to the current research project in that it provides initial evidence 
for the proposed connections between information processing strategies and 
subsequent attitude formation. In other words, results from this study illustrate Griffin 
et al.’s (1999) proposition that key components of the RISP model could serve as 
antecedents to preventive behaviors. 
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Centering on the key assumption behind the RISP model regarding information 
insufficiency, Kahlor, Dunwoody, Griffin, Neuwirth, and Giese (2003) explored a 
novel measure of information processing in a survey setting by sending actual 
information to participants and then inquiring how they attended to it. Health risks 
related to the consumption of PCB-contaminated fish in the Great Lakes formed the 
research context for this study. Results from this study indicated that as the gap 
between current knowledge and information sufficiency threshold increased, 
systematic processing of the relevant information also increased. These findings 
confirmed the value of studying audiences’ information need, which could inform 
message design for risk communication. In the meantime, this study also provided an 
alternative measurement strategy for key dependent variables of the RISP model such 
as information processing. 
In order to further explore what contributes to the sense of information 
insufficiency, Griffin, Neuwirth, Dunwoody, and Giese (2004) adopted a more socio-
psychological approach to examine the relative impact of affective responses (worry), 
hazard characteristics (risk judgment, personal control and institutional trust), and 
informational subjective norms on information insufficiency. Based on the knowledge 
gap hypothesis, education was also analyzed together with current knowledge, the 
baseline measure for information insufficiency. This study formalized measures for 
key components of the RISP model. Key findings indicated that worry and perceived 
normative pressure could raise one’s information thresholds above what they currently 
knew. However, among the different dimensions of hazard characteristics, only 
perceived severity was significantly related to information insufficiency, through the 
intervening variable of worry. Since data collection for this study was carefully 
constructed to ensure generalizability, the contribution of demographic and other 
individual characteristics also deserves attention. In particular, minority respondents 
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reported greater worry associated with the potential risk, as well as sensing more 
normative pressure to stay on top of risk information. Concurrently, another study 
focused on the immediate predictors of information seeking and processing in two 
research contexts involving environmental risks (Griffin, Powell et al., 2004). Except 
for perceived information gathering capacity, both information insufficiency and 
relevant channel beliefs were related to information seeking and processing in the 
hypothesized directions. 
The larger research project based on the Great Lakes ecosystem offered data 
for the four studies discussed above. Moving on to a new domain, Griffin et al. (2005) 
tested the applicability of the RISP model to communication issues related to energy. 
Key measures for this study were consistent with previous analyses, even though 
relevant channel beliefs were mainly assessed based on the usefulness of different 
channels in providing energy-related information. Energy use is not directly a risk 
issue, but the communication of energy involves the use of technical terms and has 
broad societal impact. Therefore, this study attested to the potential of the RISP model 
in guiding communication studies beyond those directly related to risk. More 
importantly, this study also reflected an initial effort in analyzing informational 
subjective norms as a direct, rather than indirect predictor of information seeking and 
processing. Key results from this study indicated positive relationships between the 
RISP model’s dependent variables and their key predictors: informational subjective 
norms, information insufficiency, capacity and channel beliefs. 
Similar to the energy issue, risks that do not pose direct harm to individuals’ 
well-being but threaten the larger environment present a unique context to evaluate the 
RISP model. Focusing on risk information related to the environment solely, Kahlor, 
Dunwoody, Griffin, and Neuwirth (2006) used a section of the RISP model to examine 
whether it could be applied to this new form of risk, formally termed as impersonal 
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risk. Findings from this study were consistent with Griffin et al. (2005), disclosing a 
more complex role that informational subjective norms might play in influencing 
information seeking and processing when individuals face impersonal risks. 
Specifically, Kahlor et al. argued that the strong direct relationships between 
informational subjective norms and information seeking and processing might be a 
function of impersonal risk because social pressure might seem more salient when 
direct threat was absent. In the meantime, the link between informational subjective 
norms and information insufficiency might also indicate a transformation of social 
norms into personal norms, a new interpretation for a consistent finding based on the 
RISP model. This study was significant in that it extended the scope condition in 
which the RISP model functions to impersonal risks. Considering the current research 
project, since clinical trial opportunities might not represent direct risks to healthy 
adults in the national sample, the RISP model could be further examined in this 
domain. 
Following the direction of exploring impersonal risk, Kahlor (2007) proposed 
an augmented version of the RISP model to examine environmental risk information 
seeking. In this study, TPB measures such as attitude toward the behavior, perceived 
behavioral control, and behavioral intent, were incorporated into the RISP structure 
because of their general robustness in predicting behavior. Based on results from 
structural equation modeling, the proposed model accounted for 72% of the variance 
in behavioral intention, with all the main hypotheses supported except for those 
involving perceived behavioral control. This study was unique in that it distinguished 
intentions for information seeking from actual seeking behavior and offered further 
evidence for the direct relationship between informational subjective norms and 
information seeking intentions. With its focus on information seeking as the main 
dependent variable, this model also informs the current research project because it laid 
 22 
 
out alternative means to test the connections between the RISP model and the TPB, 
different from those employed by Griffin et al. (2002). A caveat here, however, is that 
the strong impact of informational subjective norms might again be a function of the 
research context that involves impersonal risks. It would be meaningful to compare 
whether this component would function in similar manners when both impersonal and 
personal risks are present. The current research project, with comparable data sets 
from two different populations, might explore this possibility. 
Even though different emotions could function as part of the RISP model to 
motivate information seeking and higher-level information processing, up until Kahlor 
(2007), only one specific emotion had been tested - worry. In order to explore other 
possibilities, Griffin et al. (2008) examined the role of anger in a context of flooding 
risk management in watershed urban regions. Specifically, this study focused on the 
amount of anger that watershed residents felt toward watershed managing agencies. 
Along with this new addition to the affective responses component, this study also 
investigated the potential role of causal attributions in shaping people’s overall risk 
perception. This study tested the RISP model in its entirety and contributed to theory 
development in several important aspects. Based on attribution theory (Nisbett, 
Borgida, Crandall, & Reed, 1976) and appraisal theory (Lazarus, 2006), this analysis 
confirmed that causal attribution and angry feelings could function together with other 
RISP components in motivating information seeking and processing. In addition, the 
direct influence of informational subjective norms on key dependent variables 
emerged once again. However, channel beliefs remained weaker and somewhat 
inconsistent predictors of seeking and processing. Griffin et al. concluded that when 
risks become public issues and not just private concerns, such as those associated with 
a lack of effective management for flooding risks, the RISP model could help to 
describe the public’s risk communication activities. On a conceptual front end, this 
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analysis also shows that the RISP model is a work in progress. New dimensions of 
various components, as well as their measurement strategies, await researchers to 
continue to explore. The current research project, largely motivated by these 
possibilities, will test the inclusion of other emotions and, perhaps, a revision of the 
overall model. 
Research that aims at testing alternative formulation of the RISP model have 
already started. Following the proposition of the augmented RISP model, Kahlor and 
Rosenthal (2009) studied whether antecedents of information seeking about global 
warming, as portrayed in the RISP model, could also predict actual knowledge about 
this topic. This study generated mixed results, showing education, prior seeking effort, 
and the number of news media sources as most strongly related to actual knowledge. 
Only instrumental attitudes (related to utility) toward information seeking, however, 
was positively related to knowledge, whereas attitudes based on experiential 
evaluations of the behavior were negatively related to knowledge. In contrast, key 
components of the RISP model such as worry, subjective norms, personal relevance, 
and perceived behavioral control, were not significantly related to knowledge. Kahlor 
and Rosenthal offered various explanations for the lack of findings in their study. 
Overall, they suggested that measures for key variables of the RISP model still need 
improvement. However, their study showed that past information seeking effort did 
correlate positively to current knowledge, which supported the underlying notion of 
the RISP model that communication behaviors such as information seeking and 
processing could enhance individuals’ awareness and comprehension of risk 
information. Kahlor and Rosenthal also contributed to theory development in that they 
offered a more detailed account for attitudes as a predicting variable for information 
seeking. In fact, they continued to argue that attitudes could serve as a more generic 
measure in replacement of relevant channel beliefs, one of the weakest components of 
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the RISP model.  
The most recent analysis of the RISP model involves a comparison of two 
independent samples in the United States and the Netherlands on the issue of industrial 
safety related to the storage and transportation of hazardous substances. In this study, 
Huurne et al. (forthcoming) tested alternative measures for information insufficiency 
with multiple Likert-type items. They also tested direct paths from informational 
subjective norms and affective responses to information seeking, and directly 
associated current knowledge with perceived information gathering capacity. Overall, 
their results supported the RISP model’s main propositions. In particular, they found 
that negative emotional reactions were among the strongest predictors of individuals’ 
information seeking behavior. The two samples mainly differed in that informational 
subjective norms seemed to have a more direct impact on information seeking in the 
US sample, whereas in the Dutch sample, this variable was indirectly related to 
information seeking through information insufficiency. In terms of theoretical 
contribution, their findings justified the proposed modifications to the original RISP 
model. These authors also encouraged subsequent research to explore whether the 
model should be similarly modified when employed to study information processing. 
Backed by evidence from these recent studies, it seems vital to adapt the RISP model 
to represent these new modifications. If the current research project generates 
additional evidence in support of these revisions within a context of health 
communication and health decision making, we should give reformulation of the RISP 
model its due attention. 
Future Directions 
Initial empirical tests based on the RISP model formed a theory-driven 
progression with a clear overarching goal to advance knowledge in this area. Griffin 
and his collaborators first tested both sides of the model in separate studies, based on 
 25 
 
which the whole model was examined in at least four different research contexts. Even 
though the RISP model was under some criticism for its lack of parsimony, the 
comprehensiveness of the model allows it to account for many of the key mechanisms 
that risk communication research has identified to influence communication behaviors 
over the years. Recent analyses using structural equation modeling, when supported by 
an adequate sample size, also show evidence that the model fit well to data gathered 
from different practical domains. Examining the empirical studies reviewed above 
systematically, the next stage of development for the RISP model could focus on the 
areas described in the following paragraphs. 
First, there should be additional tests of the model in its entirety because 
different parts of the model have already demonstrated their capacity in portraying 
individuals’ varied motivations for risk information seeking and processing, as 
depicted in the RISP model. Kahlor (2007) offered practical recommendations for data 
analysis in this regard, especially when it comes to subjecting certain exogenous 
variables (such as current knowledge) as controls when evaluating the relative impact 
of others (for instance, information sufficiency). Alternatively, to avoid ceiling effects, 
Huurne et al. (forthcoming) tested a different measurement strategy for information 
insufficiency, which seems more straightforward for a path analyses approach. When 
resources and logistics allow, future research should probably consider including both 
to measure this fundamental mechanism of the RISP model - information insufficiency 
- so that its influence on the dependent variables do not get washed away due to 
measurement errors. In addition, it has always been a compromise to capture this 
subtle mental calculation process through self-report questionnaires. Future studies 
should consider including experimental elements in the research design to evaluate 
this cognitive need for information more precisely. 
Testing the model in its entirety will also allow the relative impact of different 
 26 
 
predicting variables to be assessed in the presence of each other, which might present 
findings that are different from earlier studies. For instance, in several initial studies, 
based on results from multiple regression analyses, perceived information gathering 
capacity seemed to have a rather significant impact on information seeking and 
processing (Griffin, Powell et al., 2004; Kahlor et al., 2003, for instance). In later 
analyses, especially those using structural equation modeling, this variable seemed 
less influential as compared to other RISP components (Kahlor, 2007; Huurne et al., 
forthcoming, for instance). Therefore, at this stage of development for the RISP 
model, it is essential to test multiple hypotheses at once based on covariance structures 
while taking into account potential measurement errors.  
Second, when limiting the scope to analyze only those studies that focus on 
key relationships proposed within the RISP model, this review also identified some 
interesting patterns (Table 2.1). First of all, perceived hazard characteristics were 
proposed to be a multi-dimensional construct that likely includes risk judgment 
(probability * severity), perceived behavioral control, institutional trust, and causal 
attribution. Some of these constructs, however, have consistently shown rather limited 
impact on the dependent variables. In cases where statistical significance was 
achieved, the relationships were mostly based on indirect effects that are difficult to 
interpret with clear conclusions. For instance, Griffin et al. (2008) found that anger 
towards watershed managing agencies was significantly related to information 
insufficiency, information seeking, and systematic processing. Various aspects of 
perceived hazard characteristics, given their significant relationships with anger, 
therefore, were indirectly related to these dependent variables. As a newly added 
dimension to perceived hazard characteristics, however, only two out of the five 
causal attributions were significantly related to anger. In another study that 
specifically focused on antecedents to information insufficiency, only the estimates of 
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probability and severity related to the potential risk had significant relationships with 
worry and information insufficiency, while institutional trust and personal control had 
marginal relationships with worry, and no significant relationships (direct or indirect) 
with information insufficiency (Griffin, Neuwirth et al., 2004). Concluding from these 
observations, even though risk perception is indeed a multiplex concept that calls for 
comprehensive measures, to assess its impact on communication behaviors such as 
information seeking and processing, it might be more feasible to keep it simple and 
easy for operationalization. 
 
Table 2.1 
Overview of results from past analyses of the RISP Model 
 
Key Predictors Information 
Insufficiency 
Information 
Seeking 
Systematic 
Processing 
Heuristic 
Processing 
Perceived Hazard 
Characteristics 
    
Probability b   a 
Severity b    
Personal control     
Institutional Trust     
Affective Responses     
Worry b f    
Anger g g e g  
egative emotions h h   
Subjective Norms b c e f g h d e f g h d e g d e g 
Current Knowledge b e f g h  c e f g h c e c d e 
Sufficiency -- c d e f g h  a c d e g c d e g 
Channel Beliefs     
Media distort    g 
Validity cues  c c e g  
Usefulness  d d d f 
Perceived Information 
Gathering Capacity 
 c d g h c g a c g 
Notes: 
a. Kahlor et al. (2003) 
b. Griffin, Neuwirth et al. (2004) 
c. Griffin, Powell et al. (2004) 
d. Griffin et al. (2005) 
e. Kahlor et al. (2006) 
f. Kahlor (2007) 
g. Griffin et al. (2008) 
h. Huurne et al. (forthcoming) 
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Among the studies that assessed worry, anger, or a latent construct 
representing different negative emotions such as anxiety and discomfort, consistent 
findings have supported their motivational effects, directly or indirectly through 
information insufficiency, on information seeking and systematic processing. 
Conceding the fact that different specific emotions might differ in the type of action 
tendencies they engage (Lerner & Keltner, 2001), most negative emotions, when 
associated with a risk situation, are likely to heighten a cognitive need for more 
information, albeit for differing goals or reasons (Raghunathan & Pham, 1999). 
Therefore, within the context of the RISP model, since affective responses are 
examined along with risk perception and information insufficiency, as a mediating 
variable between the two, it might be more cost-effective to explore emotions based 
on the general valence they represent. Realistically, it is almost impossible to capture 
the delicate difference in functionality among different specific emotions through 
survey data. Tracing back to the original propositions of the RISP model, however, it 
might be valuable to compare the relative impact of positive and negative emotions. 
Generally speaking, negative emotions usually come in tandem with any circumstance 
that involves risk. However, in situations where the outcome is unclear and 
uncertainty is high, it might be meaningful to take into consideration the effect of 
positive emotions, such as hope, that might occur due to one’s ambiguous anticipation 
for future results. 
Serving as key motives for information seeking and processing, information 
insufficiency has functioned consistently throughout these studies. Informational 
subjective norms, in similar ways, have performed well in hypotheses testing. More 
importantly, as mentioned earlier, when informational subjective norms are examined 
as a direct motive for seeking and processing, rather than through information 
insufficiency, the proportion of variance explained by this component deserves further 
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recognition. Future analyses could also investigate the relative direct and indirect 
effects that informational subjective norms exert on key dependent variables, in an 
attempt to justify a repositioning of this component in the model. As an organic 
linkage between the RISP model and the TPB, this variable is expected to not only 
influence communication behaviors but also have some impact on subsequent 
attitudinal positions and behavioral intentions. 
In contrast, relevant channel beliefs have always been a weaker predicting 
variable, which leaves a lot of room for improvement in the conceptualization and 
measurement of this component. A closer examination of the different strategies 
employed so far, however, indicates that validity cues (whether a specific channel 
offers believable and consistent information) seems slightly better than the other 
measures for this component. However, research context is expected to determine 
whether this measurement strategy is appropriate. That is, validity cues would be a 
sensible measure only when people are already engaged in some sort of information 
acquisition activities through certain channels. If no such channel is available or 
accessible, more generic measures for channel beliefs might be necessary. In fact, 
Kahlor (2007) went as far as to argue that general attitudes toward the targeted 
behavior could capture the meanings underlying relevant channels beliefs in a 
replacement of this concept. That is, rather than assessing individuals’ beliefs about 
the quality and ability of specific information channel to supply them with needed 
information, information seeking, in its most basic form, is not necessarily bound to a 
particular information channel or information source. Thus, general attitudes might 
have greater utility when evaluated together with other cognition-based motivations 
for information seeking and processing. When the RISP model is expanded to study 
communication activities outside of the mass media environment, this strategy could 
offer a testable alternative for future studies, especially when the RISP model is linked 
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together with the TPB.  
Third, empirical tests of the RISP model started from a context that involves 
both health risks and ecological risks, then moved on to include issues with broader 
societal impact such as watershed management, energy, and workplace safety. Kahlor 
et al.’s (2006) theorization about impersonal risks introduced new domains in which 
the RISP model could be applied to tackle novel challenges. In particular, as Kahlor et 
al. (2006) discussed, personal relevancy at times determines people’s participation in 
communication activities and decision making related to risk issues. When the goal of 
communication is to promote a behavior that does not directly affect personal safety 
and well-being, however, the RISP model might also be useful to identify more 
profound value and belief system that people might hold. For instance, in both Kahlor 
et al. (2006) and Kahlor (2007), normative beliefs were found to have significant 
direct effects on seeking and processing, as well as indirect effects through 
information insufficiency. These authors suggested that the contexts of these two 
studies, having to do with environmental risks that could endanger the greater 
ecosystem, probably granted this component its unique impact. Taking this conjecture 
one step ahead, what if the type of risk being examined is even further removed from 
personal well-being? Would normative beliefs continue to play such an important 
role? In other words, even though environmental risks are impersonal in nature, they 
could still influence one’s overall well-being. In contrast, what if the potential risk has 
more to do with other people and does not have any consequence upon oneself? 
Would these relationships still hold? On a flip side, if the only benefit from engaging 
in a behavior comes from altruism-based contentment, would the motives described in 
the RISP model still lead to information seeking and processing? 
These questions, while waiting to be tested empirically, also raise other related 
issues. The RISP model, as well as several other information seeking models, albeit 
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taking an audience-based approach, often describe the general public as a whole. 
However, to design effective communication messages, it is of crucial importance to 
examine specific audience groups, as one of the many publics, to create targeted 
information campaigns. More importantly, it is insufficient to categorize these 
audience groups merely based on their demographic characteristics. If the targeted 
audience group has some form of common experience or history that is not shared by 
the larger general public, it is likely that communication researchers and practitioners 
would need to consider the unique features of this group to better suit their need. The 
current research project, supported by two datasets from a national sample and a 
patient sample, will offer some insight in this regard. Likewise, the scope of the 
current research project also presents an opportunity to assess the utility of the RISP 
model both in an interpersonal setting of doctor-patient communication, as well as in a 
context where mediated communication occurs, through both traditional media and 
new media such as the internet. 
Lastly, recent theoretical extensions have effectively linked the RISP model 
back to its theoretical roots and identified new possibilities to enhance the model. On 
one hand, these extensions reflect other motives for systematic processing as discussed 
by the HSM. On the other, new ways to conceptualize RISP components as 
antecedents to the TPB have been proposed and tested. Additional efforts to look at 
how communication activities might translate into actual behaviors will complement 
the continuous development of the RISP model. In relation to risk and health 
communication research on a broader scale, a better understanding of this process is 
likely to benefit communication scholars and practitioners over time. 
Conclusion 
As Griffin and his collaborators acknowledged, the RISP model is still a work 
in progress. An increasing amount of evidence has shown that a cognitive need for 
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more information is not necessarily the only, or even the most important, factor to 
motivate risk information seeking and processing. Emotions, normative beliefs, and 
general attitudes might exert stronger influences on seeking and processing in certain 
settings. In other words, research context plays an important role in delineating how 
various parts of the model work together to shape communication behaviors. Even 
though the RISP model was constructed based on social psychology theories, to solve 
practical problems with broad societal impact, communication scholars have managed 
to study various complex psychological processes in field settings. This project, 
informed by past and ongoing research based on the RISP model, will strive to 
respond to the issues reflected above. Testing the applicability and extension of the 
RISP model in this context of health decision making related to clinical trial 
enrollment also offers a range of possibilities for comparative investigations. 
Method Overview 
Survey Research 
The current project was supported by a research grant from the Leukemia & 
Lymphoma Society (LLS). Before data collection, Institutional Review Board (IRB) 
approval for social and behavioral studies involving human participants was sought 
and granted. A copy of the IRB application form is attached in Appendix 1.  
For comparison purposes, two telephone surveys were conducted that repeated 
the same questions when applicable to the sampled population. Since clinical trial 
participation, in general, is more relevant to the LLS sample, how their responses are 
similar to or different from the national sample might offer useful information to 
improve communication about clinical trial enrollment. In total, 1,000 interviews were 
completed. Reproductions of the questionnaires appear in Appendix 2A and 2B. 
Using a random digit dial (RDD) sample of the general population purchased 
from a professional sampling firm, Cornell University’s Survey Research Institute 
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completed 500 interviews for the national sample. Data collection began on September 
27, 2007 and was completed on October 31, 2007. The response rate was 24% and the 
cooperation rate was 54%, using American Association of Public Opinion Research 
(AAPOR) calculation standards. 
Another 500 interviews were completed for the LLS sample. Respondents 
were initially contacted by LLS, expressed an interest in the survey, and were 
interviewed in a follow-up phone call. Data collection began on October 5, 2007 and 
was completed on October 28, 2007. For the LLS sample, the response rate was 67% 
and the cooperation rate was 99%. 
Comparing the demographics of the national sample with those of the LLS 
sample, respondents in the LLS sample appeared to be older, with higher education. 
The LLS sample also included more female respondents and more white respondents. 
The household income for the LLS sample was also slightly higher than that for the 
national sample.  
Of the 491 LLS respondents who categorized themselves, 83.7% were self-
identified as patients with cancer diagnosis, 11.6% as caregivers of someone with 
cancer, and 4.7% as both. Testing for potential differences in responses from these 
three groups, cancer patients were more likely to express positive attitudes about 
clinical trials than caregivers. Cancer patients also reported greater trust in their 
doctors and cared more about their doctors’ opinions. Caregivers, on the other hand, 
were less likely to have previously enrolled in a clinical trial. Those who identified 
themselves as both cancer patients and caregivers reported slightly more optimism as 
compared to caregivers, as well as greater attention paid to clinical trial information 
from medical experts. However, these three groups did not differ significantly in their 
responses to most key variables of the RISP model. Since cancer patients were the 
majority group, the LLS sample was treated as a whole in subsequent chapters as 
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representing a patient sample, except for in Chapter 4, where only cancer patients were 
included in the analysis. 
In general, LLS respondents were more likely to have heard about clinical trial 
opportunities and enrolled in a clinical trial (about 39% had participated in a clinical 
trial before the survey). Among key RISP variables, there was significant difference 
between the national and LLS respondents in terms of knowledge and information 
sufficiency. LLS respondents were more likely to believe they already know a lot and 
have sufficient information about enrolling in clinical trials. Respondents from both 
samples reported similar levels of perceived information gathering capacity. Overall, 
LLS respondents trusted their doctors more and held more positive beliefs about 
clinical trial enrollment than respondents in the national sample. They also perceived 
less risk in clinical trial participation in general, and viewed any degree of potential 
risk as worth the effort. In contrast, LLS respondents reported greater optimism and 
anxiety than national respondents when thinking about clinical trial enrollment. LLS 
respondents generally reported paying more attention to information about clinical 
trial enrollment. 
Up until now, few theory-based studies have examined clinical trial enrollment 
as a unique communication problem, whereas research from other disciplines have 
identified a lack of effective communication as posing barriers for patients to make 
informed health decisions and for medical researchers to advance scientific 
knowledge. To bridge this gap, guided by the RISP model, this project will integrate 
health communication and risk communication theories to address these issues: 
• To describe the actual information seeking behaviors among healthy 
respondents, in comparison to those among cancer patients and their caregivers. This 
comparison will primarily focus on whether cancer patients and their caregivers, as a 
specific audience group, engage in routine and non-routine information seeking for 
 35 
 
similar reasons as respondents in the national sample (Chapter 3). 
• To explore whether positive emotions could function as part of the affective 
responses component in the RISP model. This investigation will expand to include a 
comparative analysis of both negative emotions and positive emotions as they co-exist 
as motives for risk information seeking and processing and, possibly, as motives for 
behavioral intentions related to clinical trial enrollment (Chapters 3, 5, & 6). 
• To assess structural models with direct paths from informational subjective 
norms to information seeking and processing and those with information insufficiency 
as a mediating variable. Model fit indices will offer some insight as to whether 
informational subjective norms work better serving as a primary indicator for seeking 
and processing along with information insufficiency (Chapters 4 & 6).  
• To investigate the impact of outcome variables of the RISP model, systematic 
processing and heuristic processing, on cancer patients’ attitudes and behavioral 
intentions related to clinical trial enrollment. Findings from this analysis will offer 
evidence-based recommendations to improve health campaigns that aim to facilitate 
informed decision making among cancer patients (Chapter 5). 
• To test a new measurement strategy for relevant channel beliefs. Since most 
communications about clinical trials happen between doctors and patients, general 
trust in doctors seems a reasonable way to measure whether respondents believe that 
they are provided with unbiased and useful information (Chapters 4 & 5).  
• To compare data from the two samples when RISP components are treated as 
antecedents to the TPB. The goal of this analysis is to generate more conclusive 
findings, based on multiple-sample structural equation modeling, about what factors 
might drive respondents in these two samples to enroll in a future trial. Results from 
this comparative investigation will bear important practical implications (Chapter 6). 
The following chapters reflect these attempts. 
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CHAPTER 3 
INFORMATION SEEKING RELATED TO CLINICAL TRIAL ENROLLMENT1 
Information seeking has been a central topic in communication research as it 
provides organic linkages between message senders’ intentions and receivers’ needs. 
In recent years, communication scholars have proposed a variety of theoretical models 
to document the antecedents and outcomes of information seeking in different research 
contexts, especially those such as health communication that target audiences’ attitude 
formation and behavior changes (Afifi & Weiner, 2004; Case, 2002; Griffin et al., 
1999; Johnson, 1997). In the meantime, the audience-oriented approach, as part of the 
health communication research tradition, determines that an increasing amount of 
scholarly works is attending to how members of the public incorporate mediated 
health messages in their personal health decisions (Johnson & Meishcke, 1992; 
Niederdeppe, Frosch, & Hornik, 2008). Recent theoretical development, in particular, 
has argued for a distinction between active, purposeful information seeking and 
casual, incidental exposure to information.  
In particular, communication researchers have acknowledged that in an 
information-saturated media environment, health information is broadly available, 
even if not always strategically planned or readily accessible (Brashers et al., 2002; 
Niederdeppe et al., 2007; Romantan, Hornik, Price, Cappella, & Viswanath, 2008). 
According to these authors, health communication has entered a consumer paradigm 
in which individuals could pick and choose among various information channels to 
acquire the most relevant and useful information to assist with their health-related 
decision making (Cassileth, Zupkis, Sutton-Smith, & March, 1980; Fallowfield, Ford, 
& Lewis, 1995; Sharf & Street, 1997). For instance, past research has found that even 
                                                 
1 A version of this chapter has been accepted for presentation to the Mass Communication & Society 
Division of the Association for Education in Journalism and Mass Communication Annual Convention 
in Boston, MA, August 2009. 
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though purposive information seeking behavior occurs less frequently and involves 
fewer sources than other routine patterns of information acquisition, termed as 
information scanning, targeted information seeking exerts greater influence on health-
related decisions (Niederdeppe et al., 2007).  
Specifically related to clinical trial enrollment, even though doctor-patient 
communication plays an important mediating role in influencing patients’ decisions 
about participation (Albrecht et al., 2003), research suggests that a large percentage of 
potentially eligible patients are not offered trials during interactions with their doctors 
(Albrecht et al., 2008). Other researchers have described physicians’ lack of 
communication about clinical trial opportunities as “the greatest source of lost 
opportunities” (Siminoff & Thomas, 2008, p. 2614). If we consider potential trial 
participants as consumers of health information, then we should also consider that 
those patients’ information needs and information seeking behaviors might influence 
the nature of communication that takes place with their doctors. As Leydon et al. 
(2008) pointed out, even though all patients want basic information on diagnosis and 
treatment, their attitudes and strategies for coping with illnesses can constrain their 
wish for information and their efforts to obtain it.  
Recent research has identified that the media continue to function as a 
powerful information source and motivator for prospective clinical trial participants. 
For instance, a recent study found that while media coverage about clinical trials 
spurred prospective participants to contact their physicians for further discussion, it 
did not inflate unrealistic hope or cause misunderstanding among these individuals 
(Pentz et al., 2002). Therefore, it seems important to further examine individuals’ 
seeking of information related to clinical trial enrollment, especially given evidence 
showing that many patients begin to make decisions about entering a trial prior to any 
formal discussion with their doctors or other clinical investigators (Gordon & 
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Daugherty, 2001). More importantly, similar to other health-related issues, we should 
focus this investigation on factors that might motivate individuals to go beyond what 
is offered in the traditional media to explore what is available through alternative 
channels. For example, recent research has identified that the internet could serve as 
an effective means to acquire health information, especially when the goal of 
information seeking is to obtain greater knowledge (James et al., 2007; Lemire, Paré, 
Sicotte, & Harvey, 2008). At the same time, most clinical trial search tools on the 
internet require that users be fairly knowledgeable about their medical condition and 
sophisticated in their web navigation skills (Atkinson et al., 2008). That is to say, 
greater motivation seems a contingency behind these non-routine information seeking 
activities. 
To investigate the individual and social factors that work together to motivate 
information seeking about clinical trial enrollment, this chapter employs a derivative 
of the Risk Information Seeking & Processing (RISP) model (Griffin, Dunwoody, & 
Neuwirth, 1999), the Augmented Risk Information Seeking (ARIS) model (Kahlor, 
2007). In this analysis, clinical trial enrollment is viewed as a unique case study for 
risk because potential risks involved in the trial procedure (e.g., fear of randomization, 
side-effects) pose barriers for many prospective participants (Avis et al., 2006; Jones 
et al., 2006; Linden et al., 2007; Stryker et al., 2006). The comparisons between data 
from the national sample and the LLS sample will help to draw evidence-based 
recommendations on how to improve the communications of clinical trial enrollment. 
Augmented Risk Information Seeking Model 
Based on empirical evidence that has accumulated over the past decade, 
Kahlor (2007) proposed the ARIS model and tested it in the context of risk 
information seeking related to global warming (Figure 3.1).  
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Similar to the RISP model, the ARIS model suggests that the motives for 
seeking judgmental confidence are based on validity and the motives for holding and 
maintaining socially acceptable attitudes drive information seeking behaviors, as 
posited by the HSM. In addition, the ARIS model incorporated an additional TPB 
concept, belief-based attitudes, which along with subjective norms and perceived 
behavioral control already constitute the RISP model. According to Kahlor, this 
integration would “enable researchers from different disciplines to recognize they are 
pursuing similar phenomena” (p. 419). Since this chapter primarily focuses on 
information seeking, I will apply the ARIS model to test its applicability to a health-
related communication issue. In addition to the relationships that the ARIS model 
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depicts, since the present analysis does not submit to the same technical constraint for 
latent-variable models (Kahlor, 2007), I will also examine the influence of individual 
characteristics at the background of the original RISP model. Specifically related to 
clinical trial enrollment, key components of the ARIS model include: 
Information insufficiency. Based on HSM’s assumption of validity-seeking 
motives, this concept describes how the need to achieve information sufficiency could 
influence the extent to which individuals seek out risk information in both routine and 
non-routine channels. 
Perceived hazard characteristics. Consistent with the original RISP model, 
cognitive evaluations of a potential risk, defined through a multidimensional construct 
that includes risk judgment, institutional trust, personal control, and causal attribution, 
could contribute to one’s sense of information insufficiency and indirectly influence 
information seeking.  
Affective responses. Recent development of the RISP model has identified 
indirect and direct relationships between affective responses and information seeking 
(Griffin et al., 2008; Kahlor, 2007). However, very few studies have compared the 
relative impacts of negative and positive emotions. With the exception of optimistic 
feelings, most existing literature has only identified negative emotions, such as fear, 
worry, and anxiety, as having an impact on individuals’ decisions to participate in a 
clinical trial (Madsen et al., 2002; Meropol et al., 2007; Schain, 1994). These negative 
and positive emotions are expected to influence information seeking in similar ways, 
but for different reasons. Specifically, even though negative emotions are likely to 
highlight a need for greater attention to specific risk information (Bless & Schwarz, 
1999), positive emotions could also enhance individuals’ interest in potentially 
negative information (Aspinwall & Brunhart, 1996; Trope & Neter, 1994).  
Informational subjective norms. Besides seeking validity and information 
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sufficiency to achieve judgmental confidence, the desire to defend one’s existing 
opinions and the desire to form socially acceptable attitudes could also motivate 
greater attention to information (Chaiken et al., 1989; Eagly & Chaiken, 1993). The 
ARIS model incorporates these alternative motives through the informational 
subjective norms component, which suggests that individuals’ information seeking 
may be motivated by their willingness to fulfill others’ expectations about their 
information level. Recent studies have presented evidence in support of this 
proposition (Griffin et al., 2008; Kahlor, 2007; Kahlor et al., 2006).  
Behavioral control (perceived information gathering capacity). In addition to 
motivation, capacity also plays an important role in dual-process theories such as the 
HSM. Integrating with TPB’s behavioral control concept, the ARIS model suggests 
that individuals’ perceived information gathering capacity (self-efficacy and 
controllability of the behavior) is likely to influence information seeking.  
Attitude toward the behavior (seeking). The ARIS model adapted the relevant 
channel beliefs component of the original RISP model to include attitudes toward the 
behavior. As Kahlor (2007) argues, this reconceptualization represents a paradigmatic 
shift away from specific channels to a more holistic and general manner (also reflected 
in Case, 2002).  
Behavioral intent (seeking). Consistent with the TPB, this concept describes 
individuals’ general intention to seek information. 
Behavior (seeking). Griffin et al. (1999) suggests that besides habitual 
information gathering, the sufficiency principle can also motivate non-routine seeking 
of information, which involves “active attempts to gather relevant risk information 
that go beyond routine sources” (p. S238). No empirical work to date has 
distinguished these two types of information seeking within this theoretical 
framework; this analysis, therefore, represents a first attempt to evaluate this 
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proposition in the formulation of the ARIS model. 
Research Questions and Hypotheses 
The main objective of this chapter is to examine whether the ARIS model 
explains motivations for the seeking of information about clinical trial enrollment 
through routine and non-routine channels in two comparable samples. Even though no 
previous research has compared the model components’ relative influences on routine 
and non-routine information seeking, based on existing evidence (Griffin et al., 2008; 
Kahlor, 2007; Kahlor et al., 2006), several hypotheses were proposed: 
 
Table 3.1 
Hypothesized relationships between routine/non-routine information seeking and 
components of the Augmented Risk Information Seeking and Processing Model 
 
 Routine  
Information Seeking 
on-routine  
Information Seeking 
Information insufficiency H1a (+) H1b (+) 
Risk Judgment H2a (+) H2b (+) 
Affective responses H3a (+) H3b (+) 
Informational subjective norms H4a (+) H4b (+) 
Behavioral control H5a (+) H5b (+) 
Attitudes toward the behavior H6a (+) H6b (+) 
Behavioral intent H7a (+) H7b (+) 
This chapter also examines the relationships between the dependent variables 
and individual characteristics including demographic variables: 
RQ1: Do individual characteristics influence routine/non-routine information 
seeking? 
To compare information seeking behaviors among healthy respondents and 
members of a patient advocacy group, the next research question is:  
RQ2: Does group membership moderate the relationships between ARIS 
variables and the dependent variables, routine and non-routine information seeking? 
Method 
Data  
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To examine specific hypotheses, data from the national sample and the LLS 
sample were first pooled together to describe general information seeking patterns 
among the respondents. In order to investigate differences between these two samples, 
interaction terms involving group membership and other key variables were 
constructed. Since 82.2% of the respondents in the LLS sample were cancer patients, 
with an additional 4.6% of them being both cancer patients and caregivers, this group 
was treated as a patient sample. 
Measurement 
Measures for key variables were adopted from past analyses based on the RISP 
model (Griffin et al., 2008; Griffin et al., 2002). Specific measures are shown in 
Appendix 2A and 2B. 
Information insufficiency. On scales from zero to 100, information 
insufficiency was measured with two variables that asked respondents to assess how 
much they knew about clinical trial enrollment (M = 38.49, SD = 32.33) and how 
much they needed to know (M = 83.41, SD = 21.50) to fully understand this issue 
(information sufficiency threshold). Consistent with past analyses based on the RISP 
model (Griffin et al., 2008; Griffin et al., 2004), this analysis did not use the calculated 
difference in absolute values between these two items to create an “information 
insufficiency” measure but controlled for current knowledge first in the regression 
models. As Kahlor (2007) advised in her analysis, this technique helps avoid potential 
reliability issues and the influence of ceiling effects. 
Perceived hazard characteristics: Risk judgment. Given the degree of 
complexity in the potential risks involved in clinical trials, this analysis used the most 
generic, and arguably, most frequently used measure, risk judgment, to assess this 
component (Gregory & Mendelsohn, 1993; Slovic, 1992). On scales from zero to 100, 
risk judgment was measured based on respondents’ perceived susceptibility to (M = 
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49.15, SD = 25.65) and severity of (M = 51.43, SD = 26.77) of the potential harm 
involved in clinical trials. The risk judgment scale (susceptibility by severity) based on 
raw scores was skewed (skewness = 1.17, kurtosis = 1.18), so square root 
transformation was conducted to create a new scale for further analysis (M = 48.01, 
SD = 24.54, skewness = -.13, kurtosis = -.25). 
Affective responses. Respondents were asked to indicate on 10-point scales 
how optimistic, afraid, worried, and anxious they felt when thinking about enrolling in 
a clinical trial. These three items were condensed them to create a negative affect scale 
(M = 16.47, SD = 8.36, α = .91). The summed scale was not significantly correlated 
with optimistic feelings (M = 5.93, SD = 2.60). 
Informational subjective norms. Two items were used to measure whether 
respondents sensed normative influence from their doctors, friends, family and other 
people who are important to them (r = .21, p < .001, α = .34).2 These two items were 
summed to create a norm scale (M = 7.67, SD = 1.38).  
Behavioral control (perceived information gathering capacity). To assess this 
construct, respondents’ perceived ability to locate relevant information, as well as their 
perceived efficacy to comprehend this information (r = .24, p < .001, α = .38) were 
assessed.3 These two items were then summed to create a behavioral control scale (M 
= 6.67, SD = 1.70). 
Belief-based attitudes. Respondents indicated their level of agreement with 
five statements ranging from financial concerns to altruistic reasons related to clinical 
trials. These statements were adapted from past studies that have identified them as 
among the most salient beliefs associated with clinical trial enrollment (Comis et al., 
                                                 
2 Items 40 & 41 in the questionnaire 
3 Items 23 & 24 in the questionnaire 
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2003; Schain, 1994). Belief-based attitudes were then linked to their corresponding 
evaluations and condensed them into a single scale, with higher scores indicating more 
positive attitudes toward clinical trial participation (M = 72.54, SD = 18.49, α = .78). 
Behavioral intent (seeking). Intent for information seeking was assessed with 
two previously tested items (r = .37, p < .001, α = .54, condensed scale: M = 7.38, SD 
= 1.90).4  
Behavior (seeking). With cross-sectional survey data, this analysis could not 
precisely assess actual behavior. However, since it is important to distinguish this 
concept from behavioral intent, respondents’ self-reported attention paid to 
information about clinical trial enrollment was used as a proxy measure for past 
behavior. In particular, four items inquired about the amount of attention that 
respondents have paid to routine channels (newspapers and radio or television, r = .84, 
p < .001, α = .91, M = 7.59, SD = 5.23) and non-routine channels (websites and 
internet support groups, r = .73, p < .001, α = .84, M = 10.46, SD = 5.35). 
For the pooled sample, this chapter examined demographic variables including 
age (M = 51.93, SD = 14.29, ranging from 18 to 90), gender (54.8% female), race 
(87.7% White), education from 1 = eighth grade or less to 7 = post-graduate training 
(M = 5.25, SD = 1.58), with the largest group being those with post-graduate training, 
and household income from less than $10,000 to $150,000 or more (M = $56,700, SD 
= $22, 820). Other individual characteristics included: (a) awareness of clinical trial 
opportunities measured from 0 = never heard about opportunities to 4 = heard a great 
deal (M = 2.00, SD = 1.30); (b) prior experience with clinical trials (23.5% have 
enrolled before); (c) visits to doctors in the past 12 months (M = 24.83, SD = 43.66, 
ranging from zero visit to daily visits); and (d) likelihood to enroll even if unsupported 
                                                 
4 Items 15 & 17 in the questionnaire 
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by their doctors measured from 1 = strongly disagree to 5 = strongly agree (M = 3.04, 
SD = 1.16). 
Analysis 
This analysis used hierarchical ordinary least squares (OLS) regression to test 
key hypotheses and examine research questions. Hierarchical OLS allowed these 
variables to be entered in a series of blocks with the results at each step indicating the 
relative influence of the variables on the dependent variable while controlling for 
variables entered in previous steps (Cohen, Cohen, West, & Aiken, 2003). Variables in 
each block were entered together. Since the condensed sample size was fairly large, 
this analysis used list-wise deletion to retain only cases with no missing data for key 
variables. 
To test hypotheses, control variables were entered in the first block, followed 
by ARIS components in subsequent blocks. To answer research questions centered on 
potential differences between the national sample and LLS sample’s information 
seeking behaviors, I tested interactions between the dichotomous variable of group 
(National = 0, LLS = 1) and key ARIS variables. 
Results 
Hypotheses were proposed based on theoretical propositions and empirical 
evidence showing positive relationships between various ARIS components and 
information seeking. Results from this analysis, however, provided limited support for 
these hypotheses (Table 3.2).  
The first hypothesis stated that information insufficiency would be positively 
related to routine and non-routine information seeking. Results from neither regression 
model supported H1. Information insufficiency did not significantly relate to either 
type of information seeking.  
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Table 3.2 
OLS regression analysis for routine and non-routine information seeking 
(Standardized regression coefficients (betas) except where indicated) 
 
 Routine Seeking on-routine Seeking 
Sample -.03 -.18*** 
Individual characteristics   
Age -.05 -.05 
White -.12*** -.07 
Male .02 -.03 
Income -.10* -.03 
Education -.03 -.02 
Awareness .03 .13** 
Prior experience -.00 -.03 
Visits to a doctor -.03 -.03 
Ever diagnosed with illness -.08 -.09* 
Would enroll despite doctor .08* .09* 
ARIS components   
Current knowledge .04 .05 
Risk Judgment              .11** .02 
Optimistic Feelings .17*** .09* 
Negative Affects .05 .08* 
Sufficiency threshold -.04 -.01 
Informational Subjective Norms .15*** .12*** 
Information Gathering Capacity -.03 -.02 
Attitudes toward the behavior .04 .10* 
Seeking intent .13** .15*** 
Multiple R .39*** .46*** 
Adjusted   R2 .13 .19 
ANOVA F20,737 = 6.43 F20,731 = 9.61 
*Significance regression coefficients are in bold: *p ≤ .05; **p ≤ .01; ***p ≤ .001.  
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H2 predicted that risk judgment would be positively related to routine and non-
routine information seeking. Results indicated that risk judgment was significantly 
related to routine information seeking (β = .11, p < .01), supporting H2a, which 
indicated that those who perceived greater risk in clinical trials were also more likely 
to pay attention to relevant information through routine channels. However, H2b was 
not supported. The relationship between risk judgment and non-routine information 
seeking was not significant. 
H3 suggested that both positive and negative emotions would be positively 
related to routine and non-routine information seeking. Results from this chapter 
suggested partial support for this hypothesis. Specifically, positive affect (feeling 
optimistic when thinking about clinical trial enrollment) significantly related to both 
routine (β = .11, p < .01) and non-routine information seeking (β = .09, p < .05). 
Negative affects (fear, worry, anxiety) were significantly related to non-routine 
information seeking but not to routine information seeking.  
H4 indicated that informational subjective norms would be positively related to 
both routine and non-routine information seeking. Results from this analysis provided 
strong support for this hypothesis. Respondents who cared about the opinions of their 
doctors, family members and friends also were more likely to engage in both forms of 
information seeking. 
H5 stated that behavioral control (perceived information gathering capacity) 
would be positively related to routine and non-routine information seeking. This 
hypothesis did not receive any support in the data.  
H6 suggested that positive attitudes toward clinical trials would be positively 
related to routine and non-routine information seeking. Statistical findings indicated 
no significant relationship between positive attitudes and routine information seeking 
and a marginal significant relationship between positive attitudes and non-routine 
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information seeking (β = .10, p < .05). Positive attitudes toward clinical trial 
participation seemed to drive the respondents to seek information actively through 
non-routine channels but not necessarily motivate them to pay more attention to this 
information in the traditional media. 
The last hypothesis focused on the relationship between general intent for 
information seeking and specific information seeking behaviors. Data from both 
regression models provided support for H7: Those who reported stronger intention to 
seek information about clinical trials also seemed to have paid more attention to 
relevant information through both routine and non-routine channels. 
With regard to the first research question, the results found that among the 
demographic variables and individual characteristics, white respondents were less 
likely to engage in routine information seeking as compared to minority respondents 
(β = -.12, p = .001). Respondents with higher income were also less likely to seek 
information through routine channels (β = -.10, p < .05). However, none of the 
demographic variables was significantly related to non-routine information seeking. 
Both awareness (β = .13, p < .01) and illness diagnosis (β = -.09, p < .05) were 
significantly related to non-routine information seeking, but neither related to routine 
information seeking. In contrast, those who reported that they would enroll in clinical 
trials even without their doctors’ support were more likely to engage in both types of 
information seeking. 
To answer the second research question, further analysis tested interactions 
between the sample and key ARIS variables. Group membership seemed to moderate 
the relationships between non-routine information seeking and three ARIS variables: 
risk judgment, negative affect, and informational subjective norms. Specifically, when 
data from the two samples were examined together, the effects of risk judgment on 
non-routine information seeking in both samples seemed to have canceled each other 
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out, which generated non-significant results in the regression model. The significant 
interaction (sample * risk judgment, β = .12, p = .01), however, suggested a different 
story. To gain a better understanding of the relationships between these variables, 
hierarchical regression model parameter estimates were used to graph non-routine 
information seeking by risk judgment and sample membership (Figure 3.2). There was 
a positive relationship between risk judgment and non-routine information seeking 
among LLS respondents and a seemingly equally strong negative relationship between 
risk judgment and non-routine information seeking in the national sample. 
 
 
Figure 3.2  
Model predicted relationship between non-routine information seeking and 
information subjective norms by sample (n = 751) 
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In contrast, the positive relationship between negative affects and non-routine 
information seeking in the whole sample seemed driven mainly by responses from the 
LLS sample (sample * negative affects, β = .15, p = .001). As shown in Figure 3.3, the 
model predicted non-routine information seeking to increase with greater negative 
emotions among cancer patients and their caregivers, but the relationship between 
non-routine information seeking and negative emotions was rather flat in the national 
sample.  
Figure 3.3  
Model predicted relationship between non-routine information seeking and 
negative affects by sample (n = 751) 
As for subjective norms, both relationships were in the positive direction 
(Figure 3.4), even though the relationship was stronger among the LLS respondents, 
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with a marginally significant interaction (sample * subjective norms, β = .10, p < .05).  
Figure 3.4 
Model predicted relationship between non-routine information seeking and risk 
judgment by sample (n = 751) 
Discussion 
This chapter provides some evidence in support of the ARIS model and its 
predecessor, the RISP model. When comparing responses from a national sample of 
mainly healthy participants and a sample of cancer patients and their caregivers, some 
interesting differences between these two samples emerged with regard to the relative 
impact of various ARIS components on routine and non-routine information seeking. 
Informing theory development, these results highlight the importance of distinguishing 
purposive, targeted information seeking through non-routine channels from the more 
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casual, generic form of exposure to information through routine channels. These 
findings also suggest important practical implications in relation to designing health 
communication campaigns that aim at enhancing awareness and understanding of 
clinical trial enrollment among the general public. 
Viewing these results as a whole, cognitive evaluation of and affective 
responses to potential risks involved in clinical trials seem to motivate both routine 
and non-routine information seeking. In particular, respondents who reported feeling 
more optimistic when thinking about clinical trial enrollment in both samples also 
reported greater information seeking in general. However, negative emotions 
associated with clinical trials mainly motivated non-routine information seeking, 
which potentially requires more time and effort. These findings support the reasoning 
that even though positive and negative emotions might function in similar ways in 
motivating information seeking, different psychological mechanism might be at work. 
Sample membership also moderated the relationship between negative affects and 
non-routine information seeking, as well as the relationship between risk judgment 
and non-routine information seeking. That is, cancer patients and their caregivers who 
sensed greater risk and associated more negative emotions with clinical trial 
enrollment were also more likely to spend time searching for information about 
clinical trials online through health websites and internet support groups. Therefore, 
even though optimistic feelings might increase curiosity and interest in general 
information related to clinical trials among these respondents, risk judgment and 
negative feelings seem to play more significant roles in driving them to active 
information seeking, especially among those for whom this issue bears greater 
relevancy. 
Subjective norms and intentions for information seeking also performed 
consistently in their effects on routine and non-routine information seeking. These 
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results provide support for the relationships outlined in both the TPB and ARIS model. 
Respondents who acknowledged greater social influences from their doctors and other 
important people in their personal network such as family and friends were also more 
likely to pay attention to information about clinical trial enrollment through both 
routine and non-routine sources. However, the impact of social norms was slightly 
stronger among the LLS respondents, for whom the decision to participate in a clinical 
trial might represent a practical issue in their interactions with these important people 
in their social network. The positive relationships between behavioral intent and past 
behavior seem to have supported the decision to operationalize these constructs in this 
manner. 
Surprisingly, information insufficiency and behavioral control failed to show 
any significant relationship with the dependent variables. In light of these results, it 
seems that the need for validity-based information sufficiency may not serve as the 
primary motivator for information seeking in this research context. As Griffin et al. 
(2008) pointed out, it is possible that affective responses and informational subjective 
norms could at times work independently of information insufficiency, a cognitively 
based motivator. Results from this analysis seem to reflect this notion. The 
information seeking activities included in this chapter involved getting information 
from traditional media or the internet. In this day and age, none of these activities is 
likely to require an effort that is much beyond the information gathering capacity of 
the respondents, who had an average education level in the range of post-graduate 
training. Therefore, the amount of variation in behavioral control (and education, for 
that matter) did not account for the differences in information seeking activities. To 
better assess behavioral control in this context, future research might need to 
emphasize more an individual’s ability to comprehend and integrate information that 
is uniquely related to the specific issue, such as medical information related to the 
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clinical trial procedure. 
Similarly, even though respondents with more positive attitudes toward clinical 
trials were more likely to seek information through non-routine channels, this positive 
relationship was only marginally significant. The behavioral beliefs included in the 
questionnaire were directly related to clinical trial enrollment, rather than the seeking 
of information related to clinical trials. This might explain why these indirect attitude 
measures did not perform well as part of the ARIS model. On a conceptual end, as 
Griffin et al. (2008) stated, future research should continue to examine the 
reconceptualization of this channel belief component. Compared to the findings 
reported in Kahlor (2007), nonetheless, it seems that when the behavioral outcome is 
somewhat foreseeable, such as in the case of global warming, outcome beliefs could 
supply a meaningful replacement for the original channel belief measures. When the 
research context involves behaviors with rather unpredictable outcomes such as 
enrolling in a clinical trial, using outcome beliefs to assess relevant channel beliefs 
might be less suitable. 
Among variables that assessed individual characteristics, minority respondents 
and those with lower household income were more likely to engage in routine 
information seeking as compared to white respondents. It is possible that these 
measures, which are related to people’s overall social economic status, also reflect 
lower accessibility to information on the internet among certain demographic groups. 
In comparison, respondents who have heard a lot about clinical trials were more likely 
to search online for related information. Those who expressed a willingness to enroll 
in a clinical trial against their doctors’ recommendations also paid more attention to 
relevant information from both types of channels. Together, these findings seem to 
suggest that issue salience still plays an important role in people’s decisions to seek 
information. Respondents who were diagnosed with a chronic or acute illness were 
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less likely to engage in non-routine information seeking, but the effect was rather 
minimal.  
Study Limitations 
Among the independent variables, several condensed scales, such as behavioral 
control, have achieved limited reliability, which might have contributed to the lack of 
support for hypotheses that involved this variable. The length of the questionnaire only 
allowed space for one item to measure optimistic feelings associated with clinical 
trials, which also leaves room for improvement in future studies. Lastly, it was 
probably due to the research context that information insufficiency did not emerge as a 
significant motivator for information seeking in this chapter, as compared to other 
similar studies (Griffin et al., 2008; Kahlor, 2007; Kahlor et al., 2006). However, 
future research should consider improving measurement strategies for this construct. It 
might have been too demanding to ask the respondents to estimate their current 
knowledge level and information need related to an unfamiliar topic in a telephone 
survey. This difficult mental task might have forced the respondents into the most 
extreme answers to these two questions. In fact, over 20% of the respondents marked 
zero for the current knowledge item, and almost 40% marked 100 for the information 
need item. 
With cross-sectional survey data, it is difficult to measure actual information 
seeking behaviors, so attention was used as a proxy measure for past information 
seeking activities. The decision to categorize the use of traditional media channels as 
routine information seeking, and the use of health websites and internet support groups 
as non-routine information seeking was also somewhat arbitrary. These compromises 
allowed for the test of theoretical propositions related to different types of information 
seeking, but future research should consider measuring routine and non-routine 
information seeking with greater precision such as via controlled experiments, in-
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depth interviews, or even observations, some of which other scholars have already 
used (Niederdeppe et al., 2007). 
Study Implications 
Between the two samples, a clear distinction exists in the direction and degree 
of impact that risk judgment and negative emotions have on non-routine information 
seeking, which captures those more active information seeking behaviors such as 
searching through health-related websites or participating in internet support groups. 
Based on results from the interaction test, respondents from the two samples might 
have adopted different coping mechanisms when thinking about potential risks 
involved in clinical trials. That is, risk judgment seemed to drive the LLS respondents 
to engage in a “danger control” mode to obtain more information about this topic, but 
respondents in the national sample were more likely to turn away from additional 
information. These findings underscore the need to develop a clear understanding 
about the potential audience when designing public information campaigns. 
Specifically, when the target audiences are patients and their caregivers with certain 
level of familiarity with a health issue, focusing on risk management or using 
emotional appeals might attract their attention and increase information seeking. When 
the target audience is the general public with lower knowledge or even little 
awareness, however, campaign designers should probably shy away from explicit 
messages related to risks and refrain from strategies such as fear appeals in their initial 
contact with the audience. These types of messages might induce responses such as 
risk avoidance or fear control and consequently reduce information seeking 
(Leventhal, 1970; Witte, 1994), as discussed above. In contrast, since optimistic 
feelings were positively related to both types of information seeking across the two 
samples, based on the broaden-and-build theory of positive emotions (Fredrickson, 
2005), embedding optimism in health messages might prompt individuals to engage 
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with their environments and partake in the seeking of additional information. To 
enhance clinical trial enrollment, for instance, campaign messages that encourage 
altruistic behaviors, highlight potential benefits, and emphasize positive contributions 
to the society at large might be effective. 
Consistent with past studies, subjective norms continue to function as an 
important motive for information seeking behaviors. This chapter specifically focused 
on normative influences from doctors, family members, friends, and other important 
people in one’s personal network. Finding that these interpersonal influences could 
lead to greater information seeking through mediated channels seems to speak to the 
“intermedia processes” that communication scholars have demonstrated in their 
research on media effects (Rogers, 2002). Whether the underlying motive is to 
maintain attitudes that are socially acceptable or to fulfill other people’s anticipations, 
interpersonal communication about a health issue such as clinical trial enrollment 
seems to have the potential to facilitate the effects of media campaigns. On the other 
hand, in relation to improving communications about clinical trial enrollment, these 
findings also suggest that campaign messages could promote clinical trial participation 
as a socially acceptable, or even desirable, action for which even ordinary individuals 
should develop some awareness and understanding. 
Chapter Conclusions 
Overall, key findings from this chapter indicate that risk judgment, affective 
responses, and social normative influences motivate individuals’ seeking of 
information related to clinical trial enrollment through routine and non-routine 
information channels in different ways. Further, the results suggest that the ARIS 
model could be applied to guide formative research for health campaigns to improve 
the communications of clinical trial enrollment. Guided by the RISP model, 
subsequent chapters will examine these two samples separately in greater details. 
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CHAPTER 4 
MOTIVATION FOR HEALTH INFORMATION SEEKING AND PROCESSING ABOUT CLINICAL 
TRIAL ENROLLMENT AMONG PROSPECTIVE HEALTHY VOLUNTEERS
5 
While the last chapter primarily compared general information seeking 
behaviors among cancer patients and prospective healthy volunteers, it is important to 
probe further motivations behind not only information seeking, but also information 
processing activities. The current chapter, therefore, will focus on prospective healthy 
volunteers first to explore what might drive them to engage in these communication 
activities. As mentioned earlier, clinical trials are important research processes for the 
advancement of medical science, such as the ones conducted with cancer patients to 
explore “whether promising approaches to cancer prevention, diagnosis, and treatment 
are safe and effective” (National Cancer Institute, 2001). Past research has indicated 
that less than five percent of adults with cancer participate in clinical trials annually 
(Umutyan et al., 2008; Siminoff & Thomas, 2008). These low enrollment rates have 
spurred interest in detecting barriers for accrual in the research community (see, for 
example, Abraham et al., 2006; Albrecht et al., 2003; Mills et al., 2006; Sharp et al., 
2006). In general, these barriers include patient-related factors such as lack of 
awareness or access, distrust, and fear due to the loss of control in a randomized trial; 
physician-related factors such as conflict of interest, lack of awareness and resources, 
uncertainty, and inadequate communication; and institutional factors such as lack of 
available trials and difficulty with logistics (see, for example, Avis et al., 2006; Baquet 
et al., 2006; Fallowfield et al., 1998; Grady et al., 2006; Harris et al., 1996; Jenkins & 
Fallowfield, 2000).6 
                                                 
5 A version of this chapter has been accepted for publication in Health Communication. 
6 These barriers are reviewed more extensively in Chapter 1. 
 
 60 
 
In addition, past research has identified general positive attitudes toward 
clinical trials despite low levels of participation. For instance, a national probability 
sample of 1,000 adults expressed an overall positive opinion toward clinical trials, 
saying that they would consider participation if given the opportunity (Comis et al., 
2003). Studies that compare cancer trial participants and nonparticipants also 
identified positive attitudes towards clinical research in both groups (Madsen et al., 
2002). In contrast, a survey of almost 6,000 people with cancer found that among 
those who were aware of the clinical trial option, most declined to participate, citing 
reasons such as fear of getting a placebo, being a “guinea pig”, or believing that 
standard treatment was better than what they would be offered in clinical trials 
(National Cancer Institute, 2001). 
Some researchers have argued that improving physicians’ communication with 
their patients would bridge the gap between patient attitudes and behavior (Albrecht et 
al., 1999; Fallowfield et al., 1997; Grant, Cissna, & Rosenfeld, 2000). However, 
doctors are not compensated for talking to patients, and most primary care doctors 
have to squeeze more patients in a given amount of time to balance off increasing 
costs (Brody, 2008). Even when doctors are willing to talk to patients, they have to 
maintain a delicate balance between offering too little information, which might lead 
to confusion and distrust, or offering too much information, which might result in 
anxiety and despair (Leydon et al., 2008; Thorne, Hislop, Armstrong, & Oglov, 2008; 
Thorne, Hislop, Kuo, & Armstrong, 2006). An audience-based approach to 
communication, therefore, seems extremely important, which entails that we should 
try to communicate with patients or at least understand their communication behaviors 
better. 
As a result, researchers have paid more attention to the role that patients play 
in this communication process. Studies have shown that when patients are involved in 
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treatment decisions, they experience greater perception of control and self-
responsibility (Lerman et al., 1993) and improved health outcomes (Garrity & 
Lawson, 1989). In particular, Krupat and Irish (2007) offered an excellent review of 
literature that examines the “active” role that patients could play in managing their 
care, focusing on their desire for information, desire to be involved in decision 
making, and desire for emotional support. In general, these authors conclude that 
patients need to know how to participate in the medical decision making process to 
fulfill these desires. Echoing this proposition, Parker-Pope (2008) also suggests that 
doctors need to not only acknowledge their patients’ effort in search of more 
information and alternative opinion but also guide them in this process. Therefore, it 
seems important to improve communication about clinical trial enrollment so that the 
most relevant and useful information gets conveyed in the short amount of time that 
doctors have for each patient. 
Since clinical trial enrollment entails crucial ethical concerns for medical 
research, communication about clinical trial enrollment encompasses much more than 
everyday doctor-patient interaction. Due to the uncertainties involved in clinical trials, 
doctors’ role as information sources for their patients seems indisputable. In fact, 
previous studies have identified that cancer clinical trial participants strongly value a 
trusting doctor-patient relationship (Catania et al., 2008; Madsen et al., 2007; 
Verheggen, Jonkers, & Kok, 1996). However, increasing the rate of clinical trial 
enrollment should not be the ultimate goal for medical researchers or doctors. There is 
consensus in the research community that the trial process should not override the 
rights and needs of a clinical trial participant, especially in relation to proper 
information disclosure about risks and benefits, protection of vulnerable population, 
and equal access to research opportunities (Beauchamp & Childress, 1994; Epstein, 
2003, 2007; Stryker et al., 2006). When it comes to communication about clinical trial 
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enrollment, therefore, efforts should be focused on how to motivate ordinary 
individuals to actively seek information about clinical trial opportunities. This way, 
when there is a need to make a decision about enrollment, they will be prepared to join 
in the discussion with their doctors.  
Focusing on motivations for clinical trial enrollment, past research has 
suggested that individuals’ decisions to accept a clinical trial are influenced more by 
non-rational factors such as general beliefs about clinical trials, message cues, and 
affective evaluation of doctor-patient interactions, rather than knowledge and 
understanding of the clinical trial process (Curbow, Fogarty, McDonnell, Chill, & 
Scott, 2006). These findings seem alarming, especially when juxtaposed with evidence 
from health psychology research indicating that patients who use the cognitively 
effortful information-seeking and information-processing decisional strategies are 
more effective in coping with life-threatening illnesses (Petersen, Heesacker, & 
Marsh, 2001). If the goal of communication is to assist ordinary individuals in 
reaching informed decisions, not to simply persuade them to enter a trial blindly, it is 
even more important to study factors that influence individuals’ health-related 
communication behaviors.  
Presenting a context for this chapter, clinical trial participation offers a unique 
case study for risk and health communication. Even though clinical trial enrollment is 
likely a critical issue for medical researchers and cancer patients, most people do not 
view it as a topic that bears great personal relevancy (National Institutes of Health, 
National Cancer Institute, 1997; 2004). Therefore, when applying the RISP model to 
examine health information seeking and processing about clinical trial enrollment, it is 
very likely that potential risks involved in clinical trials would not be “readily seen as 
posing a direct personal threat” to most of the respondents (Kahlor et al., 2006, p. 
165). On a conceptual front, therefore, this analysis also expands the evaluation of the 
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RISP model into the venue of impersonal risk involved in health decision making, 
which is likely to determine that certain components of the RISP model, such as 
informational subjective norms, might act as stronger motives for information seeking 
and processing. 
Theoretical Framework 
Key Components of the RISP Model in this Analysis 
Since Chapter 2 has provided an overview of the RISP model and its key 
propositions, this section will only review those key variables that are relevant to the 
analysis in this chapter: 
Information insufficiency (sufficiency threshold). Occupying the central part of 
the RISP model, this concept describes how the need to achieve information 
sufficiency could motivate individuals to process risk information more systematically 
and less heuristically or adopt a more active and non-routine type of information 
seeking. Previous analyses of the RISP model have found support for a relationship 
between information insufficiency and more effortful information seeking and 
processing (Griffin et al., 2004; Kahlor et al., 2003; Kahlor et al., 2006; Trumbo, 
2002). In regards to clinical trial enrollment, the drive for information sufficiency 
could lead people to search health information from a variety of sources or seek an 
alternative opinion. The link between information insufficiency and information 
seeking, according to the RISP model, is moderated by individuals’ evaluation of the 
validity and usefulness of existing information, termed as relevant channel beliefs. 
Relevant channel beliefs. The RISP model extends HSM’s account for 
accuracy motivation and defense motivation and posits that beliefs about the 
information channel that delivers risk messages would influence individuals’ 
information seeking and processing behaviors. Past studies have mainly focused on 
the mass media to assess this component. Given the doctor-patient communication 
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context in the present chapter, individuals’ overall trust in their doctors was used as a 
measure for channel beliefs. Previous analyses of the RISP model have examined 
institutional trust as part of the multi-dimensional concept of perceived hazard 
characteristics, emphasizing the influence of trust on an individual’s overall risk 
perception. This analysis included trust in doctors as a proxy measure for relevant 
channel beliefs because trust in this context directly relates to an information source 
with whom the respondents personally interact. More importantly, past research has 
shown that a trusting doctor-patient relationship plays an important role in individuals’ 
decisions to enroll in clinical trials (Battaglia, Ash, Prout, & Freund, 2006; Nurgat et 
al., 2005). Therefore, it is reasonable to argue that trust in doctors might have more 
direct influence on information seeking and processing, and therefore, deserves a more 
salient role in the RISP model than contributing as a sub-category concept. Griffin et 
al. (2008) have suggested future studies to explore the possibilities of 
reconceptualization or new measurement strategies for the relevant channel beliefs 
component. Thus, the current analysis also represents an exploratory effort in testing 
alternative measures for this construct. 
Informational subjective norms. Reflecting on HSM’s notion of impression 
motivation and Ajzen’s (1988) concept of normative beliefs, the original proposition 
of the RISP model indicates that social expectations for individuals to stay informed 
could contribute to their sense of information insufficiency and, therefore, indirectly 
motivate effortful information seeking and processing. Recent studies have suggested 
a need to adjust this component’s position in the RISP model because it seems to 
produce a more direct impact on active information seeking and processing (Griffin et 
al., 2008; Kahlor, 2007, Kahlor et al., 2006). In relation to clinical trial enrollment, 
those who believe that others who are important to them would want them to know 
more about clinical trial opportunities might pay more attention to relevant messages, 
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even when they do not wish to gather more information to meet their own need. This 
chapter compares the direct and indirect impact of this component. 
Perceived hazard characteristics and affective responses. The RISP model 
proposes that affective responses result from risk perceptions, both of which then 
contribute to the sense of information insufficiency. However, informed by cognitive 
theories of emotions (Lazarus & Folkman, 1984), I believe that the “causality is 
bidirectional” (p. 274) between cognition and emotion. That is to say, perceived 
hazard characteristics and affective response are equally likely to influence each other. 
Previous studies based on the RISP model have found that cognitive reasoning (such 
as causal attribution and risk judgment) has an impact on affective responses (such as 
worry and anger) (Griffin et al., 2008; Griffin et al., 2004). Adding to these findings, 
research in communication and psychology has provided sufficient evidence that 
emotions could also affect cognitive activities in many different ways, especially when 
positive emotional states are considered (Isen, 1999, 1987; Slovic et al., 2005).  
Past studies based on the RISP model have primarily examined negative 
emotions, which often concur with risky situations. This chapter, however, examines 
the impact of a positive emotion on communication behaviors related to clinical trial 
enrollment. There is evidence showing that positive affective state not only could 
foster more careful information processing (see Aspinwall, 1998 for a review), but it 
may also enhance individuals’ interest in potentially negative information (Trope & 
Neter, 1994). Compared to negative emotions that are likely to highlight the 
importance to know about a potential risk, a positive affective state or association 
might create a greater interest or curiosity for more information. In other words, a 
positive affect such as feeling optimistic about clinical trial participation could bring 
forward a tendency or predisposition to engage in more information seeking and 
processing. This latter premise is also consistent with past studies that have identified 
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positive relationships between dispositional optimism and attention to health risk 
information (Aspinwall & Brunhart, 1996). 
Based on social learning theory (Bandura, 1977; Rotter, 1954), Ortony and 
Clore (1981) have stated that a positive expectation with an unclear outcome could 
result in hopeful feelings. Previous research has identified the important role of a 
sense of optimism in facilitating treatment and maintaining positive attitude among 
patients (Cohen, de Moor, & Amato, 2001; Kodish & Post, 1995; Nowotny, 1991; 
Sardell & Trierweiler, 1993). Even unrealistic optimism has been found to act as a 
resource that protects individuals’ mental and physical health in the context of 
detrimental illness (Taylor, Kemeny, Reed, Bower, & Gruenewald, 2000; Taylor, 
Lichtman, & Wood, 1984). Therefore, given the uncertainties embedded in clinical 
trial enrollment, I believe that it is important to evaluate the relative impact of risk 
judgment and optimistic feelings on information insufficiency and, subsequently, 
information seeking and processing. 
Research Questions and Hypotheses 
While focusing on testing the role of optimistic feelings in motivating 
information seeking and processing related to clinical trial enrollment, this chapter 
also examine relationships among other key components of the RISP model to 
evaluate its applicability to this context of health decision making. Based on past 
studies (Griffin et al., 2008; Griffin et al., 2004; Griffin et al., 1999; Kahlor et al., 
2003), the following hypotheses are proposed in regards to the endogenous variables: 
H1: Information insufficiency will be positively related to information seeking 
(H1a) and systematic processing (H1b), and negatively related to heuristic processing 
(H1c). 
Among the exogenous variables, there has been evidence in support of direct 
relationships that informational subjective norms have with information insufficiency, 
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information seeking and systematic processing (Griffin et al., 2008; Griffin et al., 
2004; Kahlor, 2007; Kahlor et al., 2006), but the relationship between informational 
subjective norms and heuristic processing has been less consistent. Given the context 
of this chapter, I believe that respondents who value other people’s opinion about how 
much they should know about clinical trial enrollment would also be more likely to 
engage in systematic processing. Therefore, the second set of hypotheses is: 
H2: Informational subjective norms will be positively related to information 
insufficiency (H2a), information seeking (H2b), systematic processing (H2c), and 
negatively related to heuristic processing (H2d). 
Past studies have also supported a positive relationship between perceived 
hazard characteristics and information insufficiency in a variety of risk contexts 
(Griffin et al., 2008; Griffin et al., 2004). Therefore, the next hypothesis is: 
H3: Perceived hazard characteristics (risk judgment) will be positively related 
to information insufficiency. 
This chapter represents a first attempt to examine positive emotions as part of 
the RISP model. Even though there has been research suggesting the positive 
influences that optimistic feelings have on health behaviors and health decision 
making, how optimistic feelings will work together with risk judgment to influence the 
key variables remain an empirical question. In addition, given the evidence on 
optimistic bias (Weinstein, 1989), it is also important to study how optimistic feelings 
relate to risk judgment itself. Therefore, the first research question is: 
RQ1: What relationship do optimistic feelings about clinical trial enrollment 
have with risk judgment, informational subjective norms, information insufficiency, 
and information seeking and processing?  
Research based on the RISP model has emphasized different aspects of 
relevant channel beliefs, such as the information channel’s trustworthiness and 
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usefulness (Kahlor et al., 2003). Most of the existing research, however, has focused 
on the mass media. This chapter examines a new context of communication to 
determine the role of trust in doctors, as a proxy measure for relevant channel beliefs, 
in motivating information seeking and processing. Therefore, the second research 
question is: 
RQ2: How does individuals’ trust in their doctors relate to their information 
seeking and processing about clinical trial enrollment?  
Method 
Sample 
In the national sample, respondents ranged in age from 18 to 90 (Median = 50, 
M = 50, SD = 16). Education levels ranged from eighth grade or less to post-graduate 
training (mean and median level both equated to “some college”). Household income 
ranged from less than $10,000 to $150,000 or more (Median = $60,000, M = $54,000, 
SD = $24,100). Among the respondents, 51% were female, and 81% were White. 
Compared to the 2006 American Community Survey (U.S. Census Bureau, 2007), the 
sample seemed to have slightly over represented individuals with higher income, but 
the other parameters were quite similar. 
Measurement 
  The survey introduced clinical trials as studies that use volunteer patients to 
test new drugs, treatments, or new uses for approved drugs and treatments. Measures 
for key variables were adopted from past analyses based on the RISP model (Griffin et 
al., 2008; Griffin et al., 2002). The survey is reproduced in Appendix 2A; below, 
footnotes indicate which questions on the survey were used for each measure. 
Information seeking. Intentions for information seeking and avoidance were 
measured with two items previously tested based on the RISP model. The avoidance 
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item was reverse-coded.7  
Information processing. Six information processing items were subjected to a 
factor analysis (principle axis factoring, oblique rotation).8 Similar results emerged in 
comparison to past analyses (Griffin et al., 2008; Kahlor et al., 2003) of these items for 
heuristic processing (omega = .56) and systematic processing (omega = .57).9  
To further test the validity of these endogenous variables, zero-order 
correlations were computed between these variables and measures of individuals’ self-
reported attention paid to various channels that contain information about clinical 
trials. All the correlation coefficients were significant in the expected directions (Table 
4.1). Overall, respondents who reported greater intention for information seeking and 
systematic processing also indicated that they had paid more attention to information 
about clinical trial enrollment from a variety of information sources.  
Information insufficiency. Two variables that asked respondents to assess how 
much they knew about clinical trial enrollment and how much they needed to know to 
fully understand this issue (sufficiency threshold) measured this concept. Consistent 
with past analyses based on the RISP model (Griffin et al., 2004), rather than using the 
calculated difference in absolute values between these two items to create an 
“information insufficiency” measure, current knowledge was entered as an exogenous 
variable and information sufficiency threshold as an adjacent endogenous variable. As 
Kahlor (2007) mentioned, this technique helped to avoid potential reliability issues 
                                                 
7 Items 15 & 17 in the questionnaire 
8 Items 16 & 18-22 in the questionnaire 
9 According to Carmines and Zeller (1979), omega provides the closest estimate to the true reliability of 
the measure (p. 62). We recognize that the reliability coefficients for the information processing items 
did not meet the minimal standard (.60) that other scholars have argued for (Robinson, Shaver, & 
Wrightsman, 1991). However, the structural equation modeling technique used in our data analysis 
accounts for potential measurement errors when indicating overall fit of the specified model. These 
measures are also consistent with past studies based on the RISP model. 
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and the influence of ceiling effects in current knowledge. 
 
Table 4.1 
Correlation of information seeking and processing measures (composite scales) 
with attention to information (partial correlation coefficients) 
 
Information channels Information seeking Systematic processing Heuristic processing 
Family .17** .10* -.20* 
Medical experts .22** .22** -.20** 
Patient advocacy groups .17** .19** -.18** 
Newspapers .12* .10* -.13** 
Health newsletters .16** .19** -.14** 
Websites .21** .14** -.16** 
Internet support groups .12* .13** -.10* 
* Attention to information was measured on a scale from zero (none) to ten (a lot). 
Significance key:  *p ≤ .05; **p ≤ .01. 
Relevant channel beliefs. Since most communications about clinical trial 
opportunities occur in interpersonal contexts between doctors and patients, this 
concept requires a measurement strategy that is different from most existing analyses 
based on the RISP model. Therefore, respondents’ overall trust in their doctors was 
chosen as a proxy measure. To measure trust, three items (alpha = .70) from past 
research that has demonstrated their validity and reliability were adopted (McComas et 
al., forthcoming).10  
Informational subjective norms. This component was measured by assessing 
whether respondents perceive others’ expectations that they should stay on top of 
information about clinical trial enrollment.11 
Perceived hazard characteristics: Risk judgment. This multi-dimensional 
component deals with many different aspects of risk that has included self-efficacy, 
causal attributions, and risk judgment among others. Since the evaluation of risk 
involved in clinical trials bears a lot of complexity, this analysis resorted to the most 
                                                 
10 Items 25-27 in the questionnaire 
11 Item 11 in the questionnaire 
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generic and arguably most frequently used measure for risk - using an estimate of the 
likelihood and severity of potential harm that clinical trial enrollment might induce 
(Gregory & Mendelsohn, 1993; Slovic, 1992). 
Affective responses: Optimistic feelings. Among three other emotions, 
respondents indicated how optimistic they feel when they think about enrolling in a 
clinical trial on a scale from zero to ten.  
Analysis 
Data were analyzed with LISREL 8.80 structural equation modeling (SEM) 
program. LISREL provides tests of the adequacy of the entire model, simultaneous 
estimation of all structural coefficients, and tests of statistical significance for all 
coefficients. To test the overall model, a two-step procedure recommended by Kline 
(2005) was followed. Through confirmatory factor analysis, a measurement model 
was first specified and refined, based on which estimation of the structural model was 
completed. The overall goal was to find a parsimonious structural model that 
explained the data reasonably well (Kline, p. 217). This technique also permits greater 
precision in the assessment of the reliability and validity of these latent constructs 
(Schemer, Matthes, & Wirth, 2008). 
The χ2 goodness-of-fit statistic is reported as an index of model adequacy, 
where a nonsignificant value indicates good fit. Because χ2 has been shown to be 
sensitive to sample size (Bollen, 1989), the χ2/df ratio is also reported, where a value 
less than five indicates a good fit (Klein, p. 137). Other indices reported here include: 
root mean square error of approximation (RMSEA), the Comparative Fit Index (CFI), 
the Goodness-of-Fit Index (GFI), and the Adjusted Goodness-of-Fit Index (AGFI), 
which demonstrate how well the specified model accounts for the data. RMSEA 
values less than .05 typically indicate good fit. For CFI, GFI and AGFI (values 
ranging from .00 to 1.00), .90 and above is generally considered to represent good fit. 
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Regression coefficients for the hypothesized structural relations are reported along 
with their statistical significance. A probability level of p < .05 was used as the base 
level of statistical significance. 
Results 
The effective sample size for data analysis with list-wise deletion was 392. 
Through the imputation function in PRELIS, 37 more cases were added, which 
resulted in a final effective sample size of 429. Imputation in PRELIS substitutes the 
missing value of a case with a real value obtained from another case that has a similar 
response pattern over a set of matching variables (Jöreskog & Sörbom, 1996a, p. 153). 
Table 4.2 presents descriptive statistics including correlation coefficients in the upper 
triangle of the matrix, covariance coefficients in the lower triangle, and variances 
along the diagonal. The zero-order correlation matrix was generated in SPSS16.0 prior 
to data imputation using the raw data; the covariance matrix was generated in the 
PRELIS package of LISREL 8.80 after data imputation. The covariance matrix was 
used for SEM tests (Jöreskog & Sörbom, 1996b). To reduce potential measurement 
error, for those variables that were measured with a single item, an arbitrary reliability 
value of .85 was specified, which was equivalent to an error variance of .15 times the 
variance of the observed variable (Jöreskog & Sörbom, 1996b, p. 37). 
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Table 4.2 
Descriptive statistics 
 
Key Variables 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1. Current 
knowledge 
838.23 -.08 .08 .02 .19** .12* .21** .16** .11* .11* .16* -.11* -.15** -.07 -.10* -.00 -.03 
2. Information 
sufficiency 
-47.94 530.57 .07 .06 .04 -.05 .07 .03 .08 .01 .08 -.06 -.07 -.01 .07 .09 -.00 
3. Risk 
likelihood 
72.80 43.78 685.25 .57** -.17** -.10* -.12** -.07 -.12* -.18** .03 -.02 .09 -.05 -.13** -.05 -.11* 
4. Risk severity 7.33 63.28 383.56 776.52 -.21** .01 -.10* -.01 -.03 -.11* -.04 -.00 .03 -.08 -.03 -.01 -.05 
5. Optimistic 
feelings 
42.16 3.84 -24.38 -29.83 7.19 .23** .33** .33** .28** .22** .19** -.12* -.32** -.16** .09* .05 .05 
6. Subjective 
norms 
3.56 -1.58 -2.06 -.21 1.69 1.17 .25** .29** .27** .17** .10* -.01 -.19** -.09* .01 .01 .04 
7. Avoidance 
(reverse)  
6.39 .54 -1.90 -1.84 1.59 .22 1.19 .36** .39** .20** .17** -.26** -.35** -.29** -.03 .02 .02 
8. Seeking 4.09 .02 -.76 .41 1.65 .24 .24 1.41 .43** .27** .24** -.23** -.42** -.24** .02 .07 .05 
9. SYS1 3.32 1.59 -1.87 -.48 1.75 .28 .36 .34 1.22 .39** .24** -.07 -.42** -.21** .03 .16** .07 
10. SYS2 5.35 1.24 -3.20 -2.71 1.99 .23 .28 .27 .57 1.25 .08 -.06 -.25** -.15** .09 .07 .06 
11. SYS3 4.48 1.98 1.34 .70 1.04 .09 .12 .14 .20 .13 1.07 -.03 -.27** -.08 .07 .01 -.03 
12. HEU1 -3.71 -1.15 .04 -.49 -.78 .00 -.24 -.16 -.12 -.15 .00 .89 .19** .22** -.01 -.08 -.03 
13. HEU2 -4.95 -.81 1.46 -.11 -1.89 -.18 -.30 -.26 -.36 -.29 -.17 .18 .79 .28** -.04 .02 -.02 
14. HEU3 -1.69 -.31 -.77 -1.43 -.52 -.08 -.20 -.13 -.14 -.13 -.04 .17 .15 .95 .01 .01 -.00 
15. TRUST1 -2.60 1.55 -2.86 .02 .54 .02 -.01 .02 .07 .18 .06 -.03 -.03 -.01 1.26 .43** .41** 
16. TRUST2 .95 1.57 -1.21 .42 .35 .02 .04 .06 .20 .16 .04 -.08 .01 -.00 .40 .82 .49** 
17. TRUST3 -.78 -.47 -2.80 -1.09 .20 .04 .01 .04 .07 .13 -.04 -.06 .01 .01 .32 .38 1.01 
M 26.27 83.80 50.55 51.45 4.95 3.15 3.44 3.09 2.88 3.10 2.73 3.82 4.05 3.32 3.57 3.85 3.62 
SD 28.95 23.03 26.18 27.86 2.68 1.08 1.09 1.19 1.10 1.12 1.03 .94 .89 .97 1.12 .91 1.01 
* Pearson correlation coefficients are provided in the upper triangle of the matrix, variances are located 
on the diagonal, and covariances are reported in the lower triangle.  
Significance key:  *p ≤ .05; **p ≤ .01. 
The CFA model indicated moderate fit to the data even though the p-value was 
significant (Table 4.3). Based on the refined CFA model (χ2 = 161.76, df = 79, χ2/df = 
2.05, p < .05, RMSEA =.049, CFI = .96), a conceptual model was specified. Results 
for the overall fit of the conceptual models are presented in Table 4.3. Analysis of the 
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overall model fit along with tests of individual paths indicated that the baseline 
conceptual model could be improved. After deleting non-significant paths and setting 
the error covariances of information seeking, heuristic processing, and systematic 
processing free, the final model was specified (χ2 = 181.56, df = 95, χ2/df = 1.91, p < 
.05, RMSEA = .046, CFI = .96). The χ2/df ratio of 1.91 indicated a relatively good 
model fit to the data given the sample size.  
 
Table 4.3 
Summary of fit indicators 
 
Models  χ
2
 df p χ
2
/df RMSEA GFI AGFI CFI 
Baseline CFA model 176.33 80 <.05 2.20 .053 .95 .91 .95 
Revised CFA model a 161.76 79 <.05 2.05 .049 .96 .92 .96 
Baseline conceptual model 463.87 97 <.05 4.78 .094 .89 .82 .84 
Revised model b 181.56 95 <.05 1.91 .046 .95 .92 .96 
*RMSEA = root mean squared error of approximation; GFI = Goodness-of -Fit Index; AGFI 
= Adjusted Goodness-of-Fit Index; CFI = Comparative Fit Index. 
a. Revision from baseline CFA model to final CFA model: added error 
covariance between two heuristic processing measures. 
b. Revision from baseline model to final model: deleted nonsignificant paths and 
set the error covariances between systematic processing, heuristic processing, and 
information seeking free. 
Error variances of the three endogenous variables were allowed to covary 
because those who actively search for more information about clinical trial enrollment 
are also likely to pay more attention to existing information and process it more 
carefully. Past analyses of the RISP model have examined these three variables as 
dependent variables in separate multiple regression models, but theoretically, they 
should relate to each other. On the other hand, both the factor analysis and the 
measurement model fit index indicated that discriminative validity among these 
variables was assured. After adding these error covariances, the overall fit of the 
model improved substantially. As reported in Table 4.3, GFI, AGFI, and CFI all 
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exceeded the conventional value of .90, indicating good fit. RMSEA also reached the 
conventional cutoff value of .05. HLM analysis based on the raw data was also 
conducted to examine the robustness of the results obtained from SEM modeling, and 
the results held consistent for the most part. The unstandardized regression 
coefficients obtained from HLM path analyses are displayed in parentheses next to the 
standardized structural coefficients generated in SEM analyses in Figure 4.1. 
 
 
 
-.16* (-.01*) 
-.15* (-.04) 
-.41* (-.09**) 
.39 (.22***) 
 
Optimistic 
Feelings 
 
Informational 
Subjective 
orms 
Trust in doctors 
Information 
Seeking 
Systematic 
Processing 
Knowledge 
 
.28 (.14**) 
.22*(.04) 
.26* (.17***) 
Heuristic 
Processing 
Risk  
Likelihood 
.15* (.15*) .28* (2.34***) 
.20* (.01***) 
Figure 4.1 
Results for the conceptual model with statistically significant paths 
* The standardized solution from structural equation modeling (SEM) analysis and 
the unstandardized solution from hierarchical linear modeling (HLM) path analysis 
are reported, with the latter in parentheses. 
.37 (.36***) 
 76 
 
 
To enhance the readability of the figure, only paths with significant regression 
coefficients and t-values are displayed. Different from the hypothesized positive 
relationships, after current knowledge was controlled, information sufficiency 
threshold did not relate to any of the endogenous variables to a statistically significant 
degree. Rather, current knowledge was positively related to information seeking (β = 
.20, t = 3.44, p < .05) and negatively related to heuristic processing (β = -.16, t = 2. 85, 
p < .05). Therefore, H1a through H1c were not supported. On the other hand, 
informational subjective norms significantly related to information seeking (β = .37, t 
= 5.42, p < .05), systematic processing (β = .26, t = 4.23, p < .05), and heuristic 
processing (β = -.15, t = 2.15, p < .05). Therefore, H2b through H2d were supported. 
Neither current knowledge nor information sufficiency threshold was significantly 
related to informational subjective norms, even though the zero-order correlation 
indicated a marginal relationship between current knowledge and informational 
subjective norms (r = .12, p <.05). For the two variables that measured perceived 
hazard characteristics, only risk likelihood was significantly related to current 
knowledge (β = .15, t = 2.71, p < .05), so H3 was partially supported. 
To answer the research questions, optimistic feelings were significantly related 
to current knowledge (β = .28, t = 5.29, p < .05), information seeking (β = .39, t = 
6.00, p < .05), systematic processing (β = .28, t = 4.71, p < .05), and heuristic 
processing (β = -.41, t = 6.07, p < .05). The paths between optimistic feelings and 
perceived hazard characteristics were not significant, even though correlation 
coefficients based on the raw data suggested negative relationships between optimistic 
feelings and risk likelihood (r = -.17, p < .001) and risk severity (r = -.21, p < .001).  
Trust in doctors, as a proxy measure for relevant channel beliefs, did not 
exhibit a significant relationship with information seeking or heuristic processing, but 
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it did show a positive relationship with systematic processing (β = .22, t = 4.14, p < 
.05). Overall, the structural model explained 46% of the variance in information 
seeking, 25% of the variance in systematic processing, and 29% of the variance in 
heuristic processing. These results are comparable to past analyses of the RISP model 
in different contexts (Griffin et al., 2008; Kahlor et al., 2006).  
Discussion 
This chapter applies the RISP model to examine communication behaviors 
such as information seeking and processing related to clinical trial enrollment. By 
recognizing the uncertainties embedded in clinical trial results, clinical trial enrollment 
was viewed as a case study of risk. This analysis examined the relative influences on 
information seeking and processing from individuals’ self-assessed current knowledge 
about this topic, need for more information, risk judgment, normative beliefs, affective 
responses, and overall trust in their doctors. Overall, the model achieved adequate fit 
to the data, even though some of the hypothesized relationships were not supported. 
Compared to a cognitive need for more information, optimistic feelings and normative 
beliefs seem to exert greater impact on individuals’ information seeking and 
processing. These findings seem to reflect past research showing that non-rational 
factors, such as general attitudes toward clinical trials, tend to have stronger influence 
than knowledge on people’s decisions about clinical trial participation (Curbow et al., 
2006). However, there is also broader implications of these results both theoretically 
in regards to the RISP model, as well as practically in relation to communication about 
clinical trial enrollment. 
First, even though clinical trial enrollment is an important issue for the medical 
research community and cancer patients who might view trials as their final option, 
the public’s overall awareness and interest in this topic are much more tepid. In fact, 
over half of the respondents in the national sample said they had never heard about 
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clinical trial opportunities or had only heard a little about this issue. Therefore, clinical 
trial enrollment was not a topic that bore much relevancy or salience among these 
respondents, which might explain why some of the relationships that past analyses of 
the RISP model have identified did not emerge in this chapter. For instance, for cancer 
patients, clinical trial participation might carry many forms of risks such as the 
probability of receiving a placebo rather than the treatment, the potential of enduring 
side-effects, or the chance to jeopardize a good relationship with their primary care 
doctors. None of these risks might seem tangible for survey respondents who were 
mostly healthy adults (only a third of the respondents reported having ever been 
diagnosed with a chronic or acute illness). In this sample, risk severity judgment was 
the only variable that had more than 10% missing responses, which also seemed to 
support this conjecture. Thus, only risk likelihood judgment was significantly related 
to individuals’ current knowledge about clinical trial enrollment. After current 
knowledge was controlled, neither dimension of risk perception had a significant 
impact on these respondents’ sense of information sufficiency. Nonetheless, those who 
reported knowing more about clinical trial enrollment also seemed to believe that 
enrolling in a clinical trial could put their health at risk, which was an interesting 
finding on its own. 
Optimistic feelings exhibited the strongest relationships with all three 
endogenous variables. These results indicated that those who felt more optimistic 
when thinking about clinical trials were also more likely to actively gather information 
about this topic and process it more systematically and less heuristically. 
Theoretically, these findings supported the inclusion of this positive emotion as part of 
the affective responses component in the RISP model, when examined within an 
appropriate research context. Optimistic feelings also had both a direct impact on 
information seeking and an indirect impact through current knowledge, even though 
 79 
 
the direct relationship was much stronger. These findings suggest that an emotional 
response to a risky issue not only contributes to one’s greater motivation for 
information seeking, but also cues into the assessment of one’s current level of 
knowledge and information about this topic.  
More importantly, consistent with Lazarus and Folkman’s (1984) notion of 
emotion-focused form of coping, optimistic feelings about clinical trial enrollment 
also guided these respondents’ decisions about the information processing strategies 
they need to employ to deal with this issue. In this case, optimistic feelings about 
clinical trial enrollment seem to serve as an important “psychological resource” for 
coping with the intrinsic uncertainties embedded in clinical trials because of the 
potential to get effective treatment or contribute to medical research. Interestingly, 
even though optimistic feelings were negatively related to the judgment of potential 
risk involved in clinical trials, they did not direct individuals’ attention away from 
clinical trial information or make the act of processing this information seem trivial. 
Similar to other strong negative emotions such as worry and anger, more optimistic 
feelings actually led to more effortful information seeking and processing among these 
respondents. These results suggest that when communicating about an issue that does 
not pose immediate or personal threat to the well-being of the audience, emotional or 
attitudinal factors might serve as stronger motives for communication behaviors. 
Consistent with past studies, rather than having an indirect relationship with 
information seeking and processing through information insufficiency, informational 
subjective norms had more direct relationships with these variables. Specifically, those 
who believe that people who are important to them would want them to stay on top of 
information about clinical trial opportunities also tend to engage in more effortful 
information seeking and processing about this topic. Similar to other tests of the RISP 
model in settings such as fish consumption and drinking water quality as related to 
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health risks (Griffin et al., 2004; Kahlor et al., 2003), or the adoption of renewable 
energy (Griffin et al., 2005) and information seeking about global warming (Kahlor, 
2007) as related to the environment, normative beliefs continue to shape individuals’ 
decisions about whether and how they should attend to risk information. More 
importantly, social norms seem to play an even greater role in the communication of 
clinical trial enrollment because these respondents’ personal needs for more 
information were rather limited.  
Tested as a new measure for relevant channel beliefs in this context of health 
decision making, trust in doctors was studied together with the endogenous variables. 
Results indicated that those who had greater trust in their doctors were also more 
likely to process information about clinical trial enrollment carefully, but this trusting 
relationship did not translate into more active acquisition of new information on this 
topic. These findings indicated a potential to use trust measures to assess individuals’ 
beliefs about information channels and the quality of messages that they deliver. 
However, even though these respondents said that they paid the most amount of 
attention to health information coming from medical experts (M = 7.64, SD = 2.54, on 
a ten-point scale), doctors might not be the only source for information about clinical 
trial opportunities. Among the information channels included in this questionnaire, 
family members and patient advocacy groups also received attention from these 
respondents. Therefore, to refine the measurement for this component of the RISP 
model, it seems important to take into account the type of information channel 
involved in the context of the analysis. When mass media channels are the primary 
sources of information, as in past research contexts in which the RISP model were 
tested, an assessment for the validity and usefulness of the message might be 
sufficient. However, when mass media and interpersonal communication channels 
seem equally important, it is necessary to measure the relational aspect of beliefs 
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related to specific information channels, such as trust in the source of information. 
Limitations 
 With the focus on motivations, contributions from one’s perceived capacity to 
gather information about this topic might have been left out. For instance, past studies 
have shown this construct to strongly influence people’s decisions to gather more 
information and determine their ability to process this information (Griffin et al., 
2002). Given the length of the questionnaire, both optimistic feelings and 
informational subjective norms were measured with a single item. Even though 
appropriate procedures were followed to minimize possible measurement error in the 
SEM analysis, these simplistic measures might have compromised the explaining 
power of the analyses. The overall model might account for additional variances in 
information seeking and processing if these remedies were taken. Future studies 
should also consider extending the relevant channel beliefs measure to include 
alternative channels such as the internet as important information sources for clinical 
trial enrollment. 
Consistent with past research, current knowledge was controlled for while the 
impact of information sufficiency threshold was evaluated. However, since almost half 
of the respondents marked the highest value in their responses to information 
sufficiency threshold, this technique did not seem effective in avoiding the impact of 
ceiling effects. Subsequent analysis attempted to normalize the distribution of 
information sufficiency threshold or use asymptotic covariance matrix for the SEM 
analysis, but results from either route were similar to the ones reported. Asking these 
respondents to assess their current knowledge and information need about clinical trial 
enrollment could be rather demanding tasks during a telephone survey. For those 
respondents who were predominantly healthy adults, this lack of variation in the 
perceived need for information sufficiency about clinical trial enrollment seemed to 
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have limited the explaining power of this construct. Lastly, since there is a lack of 
consensus about how to include control variables in a conceptual model for SEM 
analysis, the block of “individual characteristics” variables was not included, which 
have been found to explain a decent amount of variance in the formulation of the RISP 
model.  
In general, this chapter’s most important findings lie in the evidence that 
affective responses and normative beliefs influence likely communication behaviors 
not only through moderating individuals’ cognitive need for information sufficiency 
but also on their own. These variables have consistently showed an impact on 
information seeking and processing even when little within-audience variation exists 
in terms of information need. As mentioned earlier, the goal in this research project is 
not to target those individuals who are most likely to become clinical trial participants 
and persuade them to volunteer. Rather, it is important to identify factors that draw 
people’s attention to this issue and use these findings to prepare them for active 
involvement in health decision making. These results provide valuable insight on how 
to improve communication about clinical trial enrollment. 
Practical Implications 
In our society, increasing privatization of medical research is producing more 
and more proprietary knowledge, and the spread of health information is getting 
overwhelming (Clarke, Shim, Mamo, Fosket, & Fishman, 2003). As health and risk 
communicators, we need to guide ordinary individuals through this storm of 
information and help them form the best decision possible about treatment option and 
health care. To do this, it is important to take an audience-based perspective to 
examine what truly matters in people’s decisions to gather more information on a 
particular topic. As mentioned earlier, clinical trial enrollment is not an issue that 
attracts great attention from the public unless a major breakthrough in scientific 
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research occurs or a dramatic event takes place. Most of the respondents reported very 
low levels of knowledge about this topic, and over half of the respondents said that 
they need to know “everything there is to know” to fully understand this issue. 
Therefore, to communicate about clinical trial enrollment, it is not enough just to 
provide more information. As shown in the data, even though most people are aware 
that a discrepancy exists between how much they already know and how much they 
need to know about clinical trials, people will be unlikely to take action to fill this gap 
unless this issue becomes relevant and important to them. 
To break through this initial barrier for communication, we need to explore 
other means to introduce clinical trial opportunities to the general public. Based on 
results from this chapter, a general sense of optimism and the desire to fulfill social 
expectations seem to drive communication behaviors related to clinical trial 
enrollment. Therefore, messages that emphasize certain components of hope might 
prove beneficial. As Nowotny (1991) proposed, these components could include 
confidence in the outcome, helping others and getting help from others, belief in the 
possibility of a future good, and active involvement in setting a goal. These aspects of 
hope also reflect Lazarus and Folkman’s theory on the reappraisal of positive 
emotions such as a generalized belief that an individual has the potential and capacity 
to control the process, get efficacious treatment, and achieve a positive outcome. 
Based on these ideas, information about clinical trial enrollment could highlight the 
researchers’ competence in conducting the study and success rates based on past 
research, the importance of helping others through participation, and an individual’s 
ability to perform the action. Creating an environment in which more information 
about this topic is viewed as desirable might also stimulate greater interest in this 
issue. 
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Chapter Conclusion 
To improve the communications of clinical trial research, it is important to 
increase awareness among the general public because healthy volunteers form an 
important pool of prospective subjects. More importantly, those who are generally 
healthy might not have the same level of understanding about the clinical trial 
procedure as compared to patients of cancer and other terminal diseases. Based on 
results from this chapter, the RISP model seems to have some applicability in 
explaining what cognitive and affective factors work together to motivate greater 
information seeking and processing about clinical trial enrollment among this sample 
of potential healthy volunteers. Echoing past research on this topic, non-rational 
factors such as emotional responses and anticipation from others seem to drive these 
respondents’ communication behaviors more than a personal need for information 
sufficiency. Based on these results, communication about clinical trial enrollment 
should focus on the maintenance of hope and the formation of social norms so that 
more people might pay attention to information about clinical trial enrollment. 
Acquiring more information about this topic will eventually help most individuals 
make better decisions about clinical trial participation. Moving on to the cancer 
patients in the LLS sample, the next chapter will primarily focus on their decisions to 
enroll in a future trial since general awareness and past experience are both relatively 
high among these respondents. 
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CHAPTER 5 
FROM INFORMATION PROCESSING TO BEHAVIORAL INTENTIONS:  
EXPLORING CANCER PATIENTS’ MOTIVATIONS FOR CLINICAL TRIAL ENROLLMENT12 
Given their general positive attitudes, high awareness and past experience with 
clinical trial research, when focusing on cancer patients, motivations for 
communication behaviors such as information seeking and processing seem a less 
pressing issue, as compared to factors that actually shape their decisions to participate 
in a future trial. This chapter, therefore, will explore what happens after the acquisition 
of information among cancer patients. According to the American Cancer Society 
(2008), cancer accounts for nearly 25% of deaths in the United States, taking the lives 
of more than 1,500 people per day. Even though clinical trials represent the most 
important step in the process of discovering better therapies and improving cancer 
prevention and diagnosis, less than five percent of adults nationwide enroll in clinical 
trials when up to 20% are eligible (National Cancer Institute, 2006). Past research has 
identified an overall lack of awareness about available trial opportunities among 
cancer patients and healthy adults alike (Barrett, 2002; Crosson, Eisner, Brown, & 
Maat,, 2001; Roberson, 1994). Improving clinical trial awareness, not surprisingly, has 
been one strategy used to increase accrual rates (Lara et al., 2005). Simply focusing on 
awareness, however, may not address other barriers to enrollment. For example, some 
research has found that among newly diagnosed cancer patients who were eligible for 
trials, 49% declined to participate when approached by their physicians, citing reasons 
such as geographical distance, fear of randomization, and concerns with payment or 
                                                 
12 A version of this chapter has been accepted for presentation to the Health Communication Division of 
the National Communication Association Annual Convention in Chicago, IL, November 2009. 
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insurance coverage (Lara et al., 2001).  
These and other studies suggest that understanding patients’ attitudes is an 
important first step in the communication process. For example, a recent national 
survey found that respondents’ knowledge and understanding of the clinical trial 
procedures were related to positive attitudes towards clinical trial participation (Comis 
et al., 2003). Several other studies have found similar results (Baquet et al., 2006; 
Ellis, Butow, Tattersall, Dunn, & Houssami, 2001).  
Focusing on cancer patients, past research has identified many individual or 
social factors that could motivate or deter them from participating in a clinical trial. 
These findings can be categorized into cognitive evaluations of potential risks and 
benefits related to participation (Abraham et al., 2006; Avis et al., 2006; Daugherty et 
al., 1995; Jones et al., 2006; Linden et al., 2007; Mettlin, Cummings, & Walsh, 1985; 
Stryker et al., 2006; Verheggen, Nieman, & Jonkers, 1998); affective responses such 
as anxiety, fear, worry, and discomfort related to randomization, placebo, side effects, 
as well as hope for therapeutic benefits (Bevan, Chee, Mcghee, & Mcinnes, 1993; 
Catania et al., 2008; Daugherty et al., 1995; Madsen et al., 2002; Meropol et al., 2007; 
Mills et al., 2006); and relational concerns such as a trusting physician-patient 
relationship and perceived influences from other people in one’s personal social 
network, such as family members and friends (Agrawal et al., 2006; Catania et al., 
2008; Gordon & Daugherty, 2001; Grady et al., 2006; Howerton et al., 2007; Jenkins 
& Fallowfield, 2000; Linden et al., 2007; Madsen et al., 2007; Nurgat et al., 2005; 
Verheggen et al., 1996; Yeomanskinney et al., 1995). 
Compared to healthy volunteers, cancer patients may have greater occasion to 
encounter information about clinical trials, either from their physicians, specialists, or 
other support services. They may also seek out information in the media and over the 
Internet. It is crucial to study how cancer patients deal with information about clinical 
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trial enrollment and how these information processing styles influence their attitudes 
toward clinical trials and subsequent behavioral intentions to participate. To generate 
results with meaningful practical implications, we also need to consider what 
individual and social factors work together to shape these attitudes and behavioral 
intentions. This chapter, therefore, tests a theoretical proposition that links relevant 
constructs of the RISP model and the TPB in an attempt to better account for cancer 
patients’ motivations for clinical trial participation. 
Theoretical Framework 
Key Components of the RISP Model in this Analysis 
As mentioned earlier, the RISP model seems like a pertinent theoretical 
framework to examine communication issues related to clinical trials because it 
integrates various cognitive, affective, and relational factors that past research has 
identified to urge or discourage potential participants to pay attention to information 
about clinical trials. Specifically related to clinical trial enrollment, the relevant 
components of the RISP model include: 
Information sufficiency threshold. This concept follows the HSM’s assumption 
of a validity-seeking motive and describes how the need to achieve information 
sufficiency could drive cancer patients to invest in more cognitive resources to process 
clinical trial information. Previous analyses of the RISP model have generally 
supported the proposition that a need for information sufficiency will lead to more 
effortful information processing (Griffin, Neuwirth et al., 2004; Griffin et al., 2002; 
Kahlor et al., 2006; Kahlor et al., 2003). 
Relevant channel beliefs. This concept relates to the individuals’ beliefs about 
the message’s channel. Since the RISP model was originally proposed under the 
assumption that the mass media convey most risk information to the general public, it 
incorporates ideas from classical communication theories that describe how the 
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audiences select media channels to gratify their varying needs (Katz, Blumler, & 
Gurevitch, 1974). Past tests of the RISP model have mainly focused on how perceived 
usefulness, accessibility, and trustworthiness of the relevant channel influence 
information processing behavior (Kahlor et al., 2003). In the context of clinical trial 
communication, however, most people still rely on their doctors as primary source of 
information (Castel et al., 2006; Comis et al., 2003; Crosson et al., 2001). Therefore, 
this component of the RISP model warrants some conceptual adaptation. Specifically, 
based on past research, cancer patients’ trust in their doctors seems to greatly 
influence their decisions to enroll in a clinical trial (Grady et al., 2006; Jenkins & 
Fallowfield, 2000). Consequently, this analysis will operationalize this construct by 
measuring cancer patients’ general trust in their doctors as channels of health 
information. 
Perceived information gathering capacity. Similar to other dual-process 
theories, the HSM assumes that besides motivation, capacity is also an important 
determinant of systematic processing. Based on the HSM, the RISP model also 
suggests that individuals’ perceived information gathering capacity is likely to 
moderate the relationship between the validity-seeking motivation for sufficiency and 
information processing. Specifically related to this research context, this analysis will 
focus on cancer patients’ perceived capacity to locate and comprehend information 
about clinical trial enrollment.  
Informational subjective norms. Besides seeking validity to achieve 
information sufficiency, the desire to defend particular attitudinal positions and the 
desire to form or hold socially acceptable attitudinal positions could also motivate 
systematic processing (Chaiken et al., 1989; Eagly & Chaiken, 1993). The RISP 
model incorporates these alternative motives through the informational subjective 
norms component, which suggests that individuals’ information processing may be 
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motivated by what they believe others, who are close to them, would expect them to 
know. Recent studies have presented evidence in support of this proposition (Griffin et 
al., 2008; Kahlor, 2007; Kahlor et al., 2006). In relation to clinical trial enrollment, 
cancer patients who believe that others who are important to them would want them to 
know more about clinical trial opportunities might pay more attention to relevant 
messages. 
Perceived hazard characteristics. The RISP model also proposes that cognitive 
evaluations of a potential risk, defined through a multidimensional construct which 
includes risk judgment, institutional trust, personal control, and causal attribution, 
could contribute to one’s sense of information sufficiency and indirectly influence 
information processing. Previous studies based on the RISP model have mainly tested 
these propositions step-by-step, showing significant relationships between different 
components of perceived hazard characteristics and affective responses such as worry 
and anger (Griffin, Neuwirth et al., 2004; Griffin et al., 2008). The results from these 
studies suggest that risk judgment seems most consistent across different research 
contexts in representing this construct and showing significant relationships with 
information processing. In the present chapter, since clinical trial enrollment involves 
a wide range of risk factors that would be difficult to assess on an individual basis, this 
broadly defined and frequently used approach will be used. 
Affective responses. Social psychology research has accumulated a vast 
amount of evidence showing that both positive and negative affects could motivate 
systematic processing (Aspinwall, 1998; Bless & Schwarz, 1999; Clore, Schwarz, & 
Conway, 1994; Isen, 1999, 2004; Schwarz & Bohner, 1996). Recent development of 
the RISP model have identified indirect and direct relationships between affective 
responses and systematic processing (Griffin et al., 2008; Kahlor, 2007). However, 
very few studies have examined the influence of discrete emotions on information 
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processing in field settings (Griffin, Neuwirth et al., 2004), and even fewer studies 
have compared the relative impacts of negative and positive emotions. Further, even 
though the RISP model’s original propositions acknowledged that positive affects 
could impact information processing, past studies have only examined negative 
emotions. This chapter is less interested in how an induced positive or negative 
affective state would influence information processing. Rather, it mainly assess 
whether negative and positive affective associations with the risk issue would make 
cancer patients more likely to incorporate clinical trial information into their health 
decision making process and influence their overall attitudes and behavioral intentions 
toward clinical trial enrollment. 
This comparison is meaningful because even though negative emotions are 
likely to highlight a need for greater attention to specific risk information (Bless & 
Schwarz, 1999), evidence suggests that positive emotions could also enhance 
individuals’ interest in potentially negative information (Aspinwall & Brunhart, 1996; 
Trope & Neter, 1994). In the current chapter, three negative emotions and one positive 
emotion were examined. With the exception of optimistic feelings associated with 
clinical trial participation, most existing literature has only identified negative 
emotions, such as fear, worry, and anxiety, as having an impact on cancer patients’ 
decisions to participate in clinical trials (Catania et al., 2008; Jenkins & Fallowfield, 
2000; Madsen et al., 2002; Meropol et al., 2007; Mills et al., 2006; Schain, 1994; 
Sharp et al., 2006). These negative and positive emotions are expected to influence 
belief-based attitudes and behavioral intentions in different ways. Specifically, while 
negative emotions are likely to decrease the amount of positive attitudes that cancer 
patients associate with clinical trials and potentially deter them from participation, 
positive emotions such as optimistic feelings might make them more interested or 
curious about clinical trials and therefore, more willing to deal with the intrinsic 
 91 
 
uncertainties involved in clinical trials. 
Linking the RISP model with the TPB 
Since the RISP model has laid out key individual and social factors that 
contribute to people’s decisions to process risk information more systematically and 
less heuristically, in an examination of cancer patients’ motivations for clinical trial 
enrollment, linking the RISP model with the TPB also help to draw connections 
between patients’ communication behaviors, attitude formation, and behavioral 
intentions more effectively. The MODE model (Fazio, 1986) has similar propositions, 
assuming that different information processing strategies could activate general 
attitudes in different manners, which in turn, could influence specific behaviors 
consistent with perceptions of the attitude object. Thus, the aim of this chapter is to 
investigate whether key components of the RISP model would exert similar influences 
on cancer patients’ attitudes and behavioral intentions related to clinical trial 
enrollment. On the conceptual front end, testing the impacts of different information 
processing styles on attitude formation and behavioral intentions also represents one of 
the first attempts to empirically test how these communication behaviors “might 
ultimately affect individuals’ risk-related behaviors” (Griffin et al, 1999. p. S230). 
Specifically, the TPB suggests that attitudes toward the behavior, subjective 
norms, and perceived behavioral control serve as antecedents to behavioral intentions 
(Ajzen & Albarracin, 2007). Consistent with the original proposition of the 
relationship between the RISP model and the TPB (Griffin et al., 2002), to examine 
cancer patients’ decisions to enroll in clinical trials, the current chapter will primarily 
focus on the impact of RISP constructs on individuals’ belief-based attitudes 
(behavior-based beliefs by corresponding evaluations) and behavioral intentions 
related to clinical trial participation (Ajzen, 1991). Past studies informed by the TPB 
have accumulated robust evidence showing that “attitudes correlate strongly with 
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behavior when they are assessed at the same level of generality or specificity” (Ajzen, 
2004). However, TPB critics have pointed out that this reasoned action approach 
assumes rationality and ignores the role of emotion in the prediction and 
understanding of human behavior. In response, Fishbein (2007) argued that the 
reasoned action approach actually allows one to determine exactly how emotions 
influence a given behavior, either as a measure of attitude, outcome expectancies or as 
a “distal variable that influences behavior directly or indirectly”. Thus, this chapter 
explores the role that emotion might play in influencing cancer patients’ belief-based 
attitudes and behavioral intentions.  
Hypotheses and Research Questions  
While primarily focusing on how systematic and heuristic processing influence 
cancer patients’ attitudes and behavior intentions related to clinical trial enrollment, 
this chapter also tests how other parts of the RISP model contribute to these TPB 
constructs, especially when both negative and positive emotions are present as part of 
the model. Based on past studies (Griffin et al., 2008; Griffin et al., 2004; Griffin et 
al., 1999; Kahlor et al., 2003), the following hypotheses were posited: 
H1: Systematic processing will be positively related to cancer patients’ 
positive belief-based attitudes (1a) and intent to participate in clinical trials (1b). 
H2: Heuristic processing will be negatively related to cancer patients’ positive 
belief-based attitudes (2a) and intent to participate in clinical trials (2b). 
H3: Positive belief-based attitudes will be positively related to cancer patients’ 
intent to participate in clinical trials. 
As one of the first studies to examine negative and positive emotions together, 
no directional hypotheses were drawn because mixed evidence still exists. Therefore, 
the first research question was: 
RQ1: What relationships will negative and positive emotions have with cancer 
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patients’ belief-based attitudes and intent to participate in clinical trials? 
Linking the RISP model to the TPB, this analysis also examined the amount of 
variance that other RISP components explained in cancer patients’ attitudes and 
behavioral intentions related to clinical trial enrollment: 
RQ2: What are the relationships between other RISP components and cancer 
patients’ belief-based attitudes and intent to participate in clinical trials? 
Lastly, this chapter also looked at how demographic variables and individual 
characteristics such as a patient’s health status influence their belief-based attitudes 
and behavioral intentions.  
RQ3: How do demographic variables and individual characteristics relate to 
cancer patients’ belief-based attitudes and intent to participate in clinical trials? 
Method 
Data  
To construct a patient sample for the current analysis, only those respondents 
who have had cancer diagnosis were included, which was over 80% of the LLS 
sample ( = 411). 
Measurement 
Measures for key variables were adopted from past analyses based on the RISP 
model (Griffin et al., 2008; Griffin et al., 2002). The full questionnaire is reproduced 
in Appendix 2B; specific items used for each variable are indicated below in 
footnotes. 
  Information processing. Factor analysis (principle axis factoring, oblique 
rotation) of six information processing items generated two factors with two higher-
loading items each.13 Summed scales were then created for systematic processing 
                                                 
13 Items 16, 18-22 in the questionnaire 
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(omega = .48, M = 8.52, SD = 1.32) and heuristic processing (omega = .44, M = 4.84, 
SD = 1.75) for further analysis. To test the validity of these scales, zero-order 
correlations were conducted between these variables and measures of individuals’ 
self-reported attention paid to various channels that contain information about clinical 
trials. All the correlation coefficients were significant in the expected directions (Table 
5.1). Overall, respondents who reported greater intention for systematic processing 
also indicated that they had paid more attention to information about clinical trial 
enrollment from a variety of information sources.  
 
Table 5.1 
Correlation of information processing measures (composite scales) with attention 
to information 
 
 Information Channels Systematic processing Heuristic processing 
Family .27** -.16** 
Friends .18** -.13* 
Medical experts .20** -.04 
Newspapers .18* -.14** 
Radio / TV .15** -.13** 
Health newsletters .19** -.12** 
Websites .15** -.13** 
Internet support groups .15** -.14** 
* Attention to information was measured on a scale from zero (none) to ten (a lot). 
Significance key:  *p ≤ .05; **p ≤ .01. 
Information insufficiency. On scales from zero to 100, information 
insufficiency was measured with two variables that asked respondents to assess how 
much they knew about clinical trial enrollment and how much they needed to know to 
fully understand this issue (information sufficiency threshold). Consistent with past 
analyses based on the RISP model (Griffin et al., 2008; Griffin et al., 2004), this 
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chapter did not use the calculated difference in absolute values between these two 
items to create an “information insufficiency” measure but controlled for current 
knowledge in the regression model. As Kahlor (2007) advised in her analysis, this 
technique helps avoid potential reliability issues and the influence of ceiling effects. 
Relevant channel beliefs. To adapt to the current research context, this chapter 
used three previously-tested items (McComas et al., forthcoming) to measure cancer 
patients’ general trust in their doctors as a measure for relevant channel beliefs.14 
These items were checked for reliability (α = .65) and subsequently combined for 
analysis (M = 12.22, SD = 2.24). 
Perceived information gathering capacity. To assess this construct, this chapter 
measured cancer patients’ perceived ability to locate relevant information, as well as 
their perceived efficacy to comprehend this information (r = .22, p < .001).15 They 
were summed to create a capacity scale (M = 6.77, SD = 2.93) 
Informational subjective norms. This chapter also examined whether cancer 
patients perceive that others important to them expect them to stay on top of 
information about clinical trial enrollment (M = 3.90, SD = 1.06).  
Perceived hazard characteristics: Risk judgment. On scales from zero to 100, 
risk judgment was measured based on an estimate of the likelihood (M = 48.28, SD = 
24.95) and severity of potential harm (M = 52.43, SD = 25.85) that clinical trial 
enrollment might involve. The risk judgment scale (likelihood * severity) based on 
raw scores was a bit skewed (skewness = 1.07, kurtosis = 1.13), so a new scale was 
created based on square root transformation for further analysis (M = 48.32, SD = 
23.34, skewness = -.20, kurtosis = -.23). 
                                                 
14 Items 25-27 in the questionnaire 
15 Items 23 & 24 in the questionnaire 
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Affective responses. Respondents indicated on 10-point scales how optimistic, 
afraid, worried, and anxious they feel when thinking about enrolling in a clinical trial. 
Reliability among the three negative emotions was sufficient (α = .93) so that they 
were condensed to create a negative affect scale (M = 16.72, SD = 8.35). This scale 
was negatively correlated (r = -.19, p < .001) with optimistic feelings (M = 6.93, SD = 
2.06).  
  Belief-based attitudes. Respondents indicated their agreement with five 
statements describing beliefs associated with clinical trial enrollment ranging from 
financial concerns to altruistic reasons.16 These beliefs were included because past 
studies have identified them as among the most salient beliefs cancer patients have 
cited when expressing their willingness or reluctance to enroll in clinical trials (Comis 
et al., 2003; Schain, 1994). Belief-based attitudes were measured by linking these 
beliefs with their corresponding evaluations.17 These attitudes were also condensed 
into a single scale (α = .76), with higher scores indicating more positive attitudes 
toward clinical trial participation (M = 79.51, SD = 18.03). As the key dependent 
variable, this scale satisfied the normality assumption for regression analysis 
(skewness = .06, kurtosis = .03).18 
Behavioral intention. This variable examined cancer patients’ self-reported 
intent to participate in a future trial (M = 4.26, SD = .86, skewness = -1.07, kurtosis = 
.57).19 
                                                 
16 Items 29-33 in the questionnaire 
17 Items 34-38 in the questionnaire 
18 To ensure discriminant validity (Campbell & Fiske, 1959), correlations among measures of positive 
attitudes (average r = .36, ranging from .19 to .81) were compared to those between optimistic feelings 
and positive attitudes (average r = .27, ranging from .14 to .36). The lower inter-variable correlation 
indicates that the item used to measure optimistic feelings was indeed measuring a construct that differs 
from positive attitudes related to clinical trial enrollment. 
19 Item 3 in the questionnaire 
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Demographic variables included age (M = 53.95, SD = 12, ranging from 21 to 
86), gender (55.7% female), education from 1 = eighth grade or less to 7 = post-
graduate training (M = 5.54, SD = 1.40), with the largest group being those with post-
graduate training, and household income from less than $10,000 to $150,000 or more 
(M = $58,700, SD = $21, 610). Other individual characteristics included: (a) 
awareness of clinical trial opportunities measured from 0 = never heard about 
opportunities to 4 = heard a great deal (M = 2.42, SD = 1.21, only 5% have never 
heard about clinical trial opportunities); (b) prior experience with clinical trials (42.2% 
have enrolled before); and (c) visits to doctors in the past 12 months (M = 46.94, SD = 
55.79, ranging from zero visits to daily visits). 
Analysis 
Hierarchical ordinary least squares (OLS) regression was employed to test 
hypotheses and examine research questions. Hierarchical OLS allowed for the entry of 
these variables in a series of blocks with the results at each step indicating the relative 
influence of the variables on the dependent variable while controlling for variables 
entered in previous steps (Cohen et al., 2003). Variables in each block were entered 
together. 
To test hypotheses using attitudes as the dependent variable, individual 
characteristics were entered in the first block, followed by RISP components in 
subsequent blocks, and heuristic or systematic processing as the final block. To test 
hypotheses using the intent to participate in clinical trials as the dependent variable, 
the independent variables were entered in the same sequence as above and added the 
final block, belief-based attitudes. 
Results 
The first set of hypotheses predicted that systematic processing would be 
positively related to cancer patients’ positive belief-based attitudes (H1a) and intent to 
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participate in a future trial (H1b). The first regression model, which controlled for 
demographics and other dependent variables of the RISP model, confirmed a positive, 
significant relationship between systematic processing and positive attitudes toward 
clinical trials, but not to the intent for participation. Thus, H1a was supported but not 
H1b.  
The second set of hypotheses predicted that heuristic processing would be 
negatively related to cancer patients’ positive belief-based attitudes (H2a) and intent to 
participate in clinical trials (H2b). The results showed that heuristic processing was 
not significantly related to either one of the dependent variables. Therefore, neither 
H2a nor H2b were supported.  
H3 predicted that positive attitudes would be significantly related to behavioral 
intentions. Consistent with the TPB, in both regression models, controlling for all the 
RISP variables, positive attitudes were consistently related to behavioral intentions in 
the positive direction (Table 5.2). Therefore, H3 was supported. Overall, these results 
seemed to indicate that patients who were more likely to process clinical trial 
information in a consistent and effortful manner were also more likely to hold positive 
attitudes toward participation. However, when both systematic processing and positive 
attitudes were present in the regression model with participation intention as the 
dependent variable, positive attitudes seemed to drive respondents’ decisions to 
participate in a future trial. 
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Table 5.2 
OLS regression analysis for belief-based attitudes and behavioral intention 
(Standardized regression coefficients (betas) except where indicated) 
 
 Belief-based Attitudes Behavioral Intention 
Individual characteristics    
Age -.02 -.02 .04 .05 
White -.01 -.01 -.02 -.02 
Gender -.06 -.08 -.03 -.04 
Income .07 .07 .02 .01 
Education -.13** -.14** .00 .00 
Awareness -.02 -.01 .21** .21*** 
Prior experience .15** .15** .10 .10 
Visits to a doctor -.07 -.07 .04 .04 
RISP components    
Risk Judgment              -.15** -.12* -.12* -.11* 
Optimistic Feelings .29*** .28*** .27*** .27*** 
Negative Affects -.15** -.15** -.03 -.03 
Current knowledge .03 .02 -.02 -.03 
Sufficiency threshold -.01 -.02 .02 .02 
Informational Subjective Norms .01 .00 .06 .05 
Trust in Doctors .21*** .23*** -.09 -.08 
Information Gathering Capacity .07 .06 -.08 -.08 
Systematic Processing .11* -- .04 -- 
Heuristic Processing -- -.09 -- -.10 
Belief-based Attitudes -- -- .19** .19** 
Multiple R .58*** .58*** .56*** .56*** 
Adjusted   R
2
 .30 .30 .27 .28 
ANOVA F17,300 = 9.00 F17,299 = 8.81 F18,299 = 7.48 F18,298 = 7.69 
*Significance regression coefficients are in bold: *p ≤ .05; **p ≤ .01; ***p ≤ .001.  
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The first research question sought to explore relationships among respondents’ 
negative and positive emotions, belief-based attitudes, and intent to participate in 
clinical trials. After controlling for other preceding RISP variables, significant 
relationships were identified between both positive and negative emotions and cancer 
patients’ attitudes toward clinical trials. Only positive emotions were significantly 
related to behavioral intentions, however. That is, respondents who reported feeling 
optimistic when thinking about clinical trials also had more positive attitudes toward 
clinical trials and said they were more likely to participate in a future trial. In 
comparison, respondents who felt negative emotions such as anger, worry, and anxiety 
when thinking about clinical trials were less likely to hold positive attitudes toward 
participation. These negative emotions did not impact on behavioral intentions when 
positive attitudes were included in the regression model. 
The second research question asked about the relationships among other RISP 
components, belief-based attitudes, and intent to participate in clinical trials. Other 
RISP variables that significantly related to dependent variables included risk judgment 
and trust in doctors. Specifically, cancer patients who perceived greater risks in 
clinical trials also reported fewer positive attitudes and less intention to participate in a 
future trial. Those who trusted their doctors, however, were more likely to hold 
positive attitudes toward clinical trials but not necessarily more likely to participate in 
the future.  
The third research question sought to examine the relationships among 
demographic variables, individual characteristics, belief-based attitudes, and intent to 
participate in clinical trials. Regarding individual characteristics, respondents who had 
participated in at least one previous trial were more likely to hold positive attitudes 
toward clinical trials. Those with higher education, however, were less likely to have 
positive attitudes toward clinical trials. Nonetheless, cancer patients who had heard 
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more about clinical trial opportunities reported stronger intentions to participate in a 
future trial. No other demographic or control variable had a significant relationship 
with the dependent variables. Overall, these regression models explained about one 
third of the variances in the two dependent variables. 
Discussion 
This chapter focused on how the outcome variables of the RISP model, 
systematic and heuristic processing, would relate to two key constructs of the TPB: 
attitudes toward clinical trials and intentions to participate in a future trial. Other 
variables of the RISP model were also tested to see how they would relate to attitudes 
and intentions in hope of identifying important social and individual factors that might 
shape cancer patients’ beliefs and decisions related to clinical trial participation. In 
particular, this chapter was primarily interested in how affective responses, both 
negative and positive, would impact respondents’ belief-based attitudes and behavioral 
intentions.  
Data collected from cancer patients who use the services of the LLS indicated 
that systematic processing of clinical trial information is significantly related with 
positive attitudes that cancer patients maintain toward clinical trials. Neither 
systematic nor heuristic processing, however, was significantly related to intentions to 
participate in a future trial. Nonetheless, as proposed in the TPB, positive attitudes 
were significantly related to behavioral intentions, even after controlling for other 
RISP variables. Among other variables that were examined, education, prior 
experience, awareness, risk judgment, affective responses, and trust in doctors also 
had significant relationships with the dependent variables. 
In viewing the results, it is important to recall that cancer patients might have 
more experience with clinical trials than average awareness among general population 
samples. Ninety-five percent of the respondents had heard about clinical trial 
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opportunities and almost half had participated in at least one trial, which is a much 
higher proportion than previously identified among cancer patients and healthy 
volunteers alike. Thus, clinical trial enrollment is a topic that is highly relevant to this 
group of cancer patients.  
These data suggest that those who have heard a great deal about clinical trial 
opportunities expressed greater intention for future participation. On the other hand, 
respondents with higher education were less likely to hold positive attitudes toward 
clinical trials. This comparison warrants attention because a gap seems to exist 
between mere awareness and deeper understanding in terms of their impacts on cancer 
patients’ beliefs about clinical trial enrollment. Since education is often an indicator of 
one’s ability to comprehend and integrate complex information (Viswanath & 
Finnegan, 1995), the negative relationship between education and positive attitudes 
seems to suggest that those who are more capable to access and absorb additional 
information about clinical trials might possess more realistic and balanced opinions 
about clinical trial enrollment. That is, they tend to view clinical trial enrollment as 
carrying disadvantages as well as advantages.  
Relationships among the key variables, however, suggest a more complex 
picture. Taking into account the impact of different education levels, respondents who 
were likely to process clinical trial information in a more in-depth and thoughtful 
manner were also more likely to hold favorable attitudes toward participation. These 
results indicate that even though education might influence one’s ability to gain 
additional information, when cancer patients are motivated to invest in more cognitive 
resources to process existing information, they might form opinions that could 
potentially be different from their initial, more skeptical impressions. These data also 
indicate, however, that the effects of information processing styles seem limited to the 
belief system. Information processing strategies showed no significant impact on 
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behavioral intent, especially when belief-based attitudes were part of the regression 
model. In fact, after the attitudes block was entered in the final regression model, the 
initial significant, negative relationship between heuristic processing and behavioral 
intention disappeared.  
Similar to results from past analyses of the TPB (see Ajzen, 2004 for a 
review), positive attitudes toward clinical trials had significant relationships with 
cancer patients’ intentions to participate in a future trial, even after controlling for 
demographic and individual characteristics, awareness, prior experience, current 
knowledge, information need, risk judgment, information gathering capacity, 
informational subjective norms, trust in doctors, and information processing strategies. 
These results seem to attest to the TPB’s robustness in depicting relationships between 
belief-based attitudes and corresponding health behaviors.  
With regard to the goal to assess the RISP model as an antecedent to the TPB, 
only systematic processing held a significant relationship with positive attitudes in this 
chapter. Neither processing strategy showed a significant link to behavioral intent. 
Since the TPB has largely informed the development of the RISP model, future 
theoretical explorations should seek to draw more dynamic linkages between these 
two frameworks.  
In particular, relevant results indicate that risk judgment and affective 
responses had consistent, significant relationships with belief-based attitudes and 
behavioral intentions. These findings suggest that these variables might not only 
contribute to individuals’ cognitive stability by exerting an influence on their 
information processing styles. Rather, the cognitive and affective evaluations of 
potential risks might have more direct impact on individuals’ cognitive structure, 
which subsequently shape their attitudes related to a particular behavior. In this 
analysis, cancer patients’ risk judgment and negative emotions were negatively related 
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to their positive attitudes toward participation, while optimistic feelings had 
significant, positive relationship with both attitudes and behavioral intentions. These 
results seem intuitive, but they also bear important practical implications in regards to 
how to communicate effectively about the risks and benefits involved in cancer 
clinical trials. Specifically, when we decrease the amount of complex risk information 
in a health campaign to help cancer patients deal with the uncertainties involved in 
clinical trials, or simply frame risk in a more positive tone to reduce negative feelings, 
are we potentially encouraging false hope or pushing cancer patients into premature 
decisions to participate in a clinical trial? If so, is this increase in positive emotions 
associated with clinical trial enrollment necessarily an undesirable consequence? Past 
research has found that even unrealistic optimism might have positive impact on 
cancer patients’ ability to cope with a detrimental disease and maintain physical and 
psychological well-being (Taylor et al., 2000). Therefore, health communicators need 
to fully consider and carefully balance possible emotional responses and ethical 
implications that messages about clinical trial enrollment might generate. 
On a related note, the more consistent influence of optimistic feelings on 
respondents’ positive attitudes and behavioral intentions seems to support the broaden-
and-build theory of positive emotions (Fredrickson, 2001). In particular, the 
broadening hypothesis of this theory argues that positive emotions could “widen the 
array of thoughts and actions that come to mind” (p. 221). Even though this chapter 
did not artificially induce specific positive or negative emotions, the level of optimistic 
feelings that the respondents reported, either due to predispositions or priming effects, 
seem to lead to greater openness and willingness to consider clinical trial participation 
as an alternative form of treatment. Fredrickson (2005) has also argued that positive 
emotions could function as “efficient antidotes” that undo the lingering effects of 
negative emotions. We found that optimistic feelings preceded the other three negative 
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emotions in the survey, which might have made this undoing effect even stronger. 
Again, since these comparisons between positive and negative emotions are based on 
self-report data, future studies should investigate these conjectures with greater 
precision. 
In regards to the relationship between trust in doctors and positive attitudes 
toward clinical trials, the unique characteristics of the patient sample might have 
largely shaped this finding. Even though there is evidence showing that primary care 
physicians do not always encourage and sometimes even dissuade their patients from 
participating in clinical trials (Battaglia et al., 2006), for this group of cancer patients, 
clinical trials might have been a frequent discussion topic during their interactions 
with their doctors. The number of visits they have paid their doctors in the previous 12 
months also implies that most of them have fairly frequent interactions with their 
doctors. The sense of trust in doctors, therefore, might root in a broader sense of trust 
in the health system and in medical sciences. Thus, it is not surprising that a trusting 
doctor-patient relationship would be positively related to more positive attitudes 
toward clinical trials in general. However, since trust in doctors did not show a 
significant relationship with behavioral intentions when positive attitudes were 
included in the regression analysis, these respondents seemed to base their 
participation decisions more on their own attitudes. 
These patients were also recruited from a list of users of the services of the 
LLS, which also actively seeks to publicize clinical trial opportunities among its user 
base. Since a large proportion of the respondents already have substantive knowledge 
and experiences with clinical trials, the fundamental assumptions behind the RISP 
model might not have suited this study context very well because cancer patients’ 
motivations for information seeking and processing, as well as the actual behavior of 
participation, are less likely driven by a perceived mental need for more information. 
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As results indicate, risk judgment and emotional responses primarily influenced these 
respondents’ attitudes toward clinical trial enrollment and their subsequent behavioral 
intentions. Therefore, when self-relevancy and familiarity are both preexisting 
conditions related to a risky situation, the RISP model might have much more limited 
applicability as compared to the TPB. 
In viewing the results, it is important to point out study limitations. The key 
independent variables, the systematic and heuristic processing scales, had rather low 
reliability scores, which might have caused a lack of findings between these two scales 
and the dependent variables. Earlier studies have highlighted the importance of 
diversifying measurement strategies for these concepts (Schemer et al., 2008). Future 
research should continue to explore these alternative measures, especially the ones that 
might apply better to this context of health decision making. Due to the an effort to 
keep the telephone survey as brief as possible, several key constructs of the RISP 
model, such as informational subjective norms and optimistic feelings, as well as key 
dependent variable, behavioral intention, were measured with one question. Future 
research should also build up these single-item measures. Finally, interpretations 
based on these findings have limited external validity to a non-cancer population or to 
cancer patients that are not linked in with patient advocacy groups, such as the LLS.  
Chapter Conclusion 
In conclusion, even though most dependent variables of the RISP model did 
not have significant relationships with these respondents’ belief-based attitudes and 
behavioral intentions related to clinical trials, this analysis did observe a strong impact 
of risk judgment and affective responses on these variables. Trust in doctors also had 
positive relationships with cancer patients’ attitudes toward clinical trial enrollment. In 
addition, this chapter provided further evidence in support of the TPB proposition that 
attitudes toward a particular behavior will lead to corresponding behavioral intentions. 
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Together, these results suggest that communication about clinical trial enrollment 
should move beyond simply increasing awareness toward giving greater attention to 
cancer patients’ cognitive and affective evaluations of potential risks involved in the 
research process. Following these two chapters that examined prospective healthy 
volunteers’ communication behaviors and cancer patients’ enrollment decisions 
separately, the next chapter offers another comparative investigation across the two 
samples. Specifically, this comparison will link relevant communication behaviors 
together with subsequent decision making related to clinical trial enrollment. Data 
from the national sample and LLS sample will be compared based on a variety of key 
parameters that past research has identified as having strong influence on individuals’ 
decisions about clinical trial participation. 
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CHAPTER 6 
COMPARING CLINICAL TRIAL ENROLLMENT DECISIONS OF CANCER PATIENTS AND 
PROSPECTIVE HEALTHY VOLUNTEERS – THOUGHTS, FEELINGS, OR SOCIAL INFLUENCE? 
Introduction 
Following the general assumptions of this research project, effective 
communication activities are viewed as necessary steps toward informed decision 
making. This final empirical chapter, therefore, extends the RISP model to explore the 
relative impact of various cognitive and affective processes on individuals’ decisions 
to enroll in a future trial. Compared to other forms of decision making, health 
decisions are often more complex because individuals’ physical or psychological well-
being is at stake. Within the decision making literature, a vast amount of evidence 
shows that individuals are often subject to common fallacies in their reasoning 
(Kahneman, Slovic, & Tversky, 1982; Tversky & Kahneman, 1974). On the other 
hand, unconscious “deliberation-without-attention” could at times lead to superior 
decisions for complex problems (Dijksterhuis et al., 2006). Health care experts, 
therefore, have increasingly argued that the “best” health decision often depends on a 
given patient’s personal preferences (Nelson, Han, Fagerlin, Stefanek, & Ubel, 2007). 
These personal preferences, in general, involve an effective information exchange 
between doctors and patients, a good interpersonal relationship, and involvement in 
the process of decision making (for a review, see Krupat & Irish, 2007). 
Ryan and Sysko (2007) pointed out that U.S. patients tend to have a preference 
for active involvement in medical decision making because the endeavor to reduce 
“power distance” is intrinsic to the American culture. Empirical work also supported 
this argument (Degner et al., 1997; Harris, 1998). Given the greater relevancy to their 
personal lives, cancer patients and their families are likely to differ from healthy 
individuals when they make treatment decisions. Therefore, in this chapter, I will 
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report findings in regard to the relative impact of cognitive processing, affective 
responses, and social influences on attitudes and enrollment decisions among cancer 
patients and their families, as compared to the sample of prospective healthy 
volunteers. Previous chapters first examined general information seeking patterns 
among prospective healthy volunteers and cancer patients in the two comparable 
samples. Then, cancer patients’ and healthy respondents’ motivations for higher-level 
information processing and behavioral intentions related to clinical trial participation 
were studied. This chapter, using data from both samples, will provide the most robust 
evidence that speaks to the overall ethical and practical implications of this research 
project. 
Decision Making related to Clinical Trial Participation 
Existing literature on decision making related to clinical trial participation 
seems to suggest an interesting paradox with regard to how prospective participants 
deal with clinical trial information. Some researchers have argued that detailed 
information enabled patients to understand and participate in treatment decisions, 
which improved their attitudes and knowledge about clinical trials (Davis, Nealon, & 
Stone, 1993; Jensen, Madsen, Andersen, & Rose, 1993). Other studies, however, 
found that patients who refused clinical trial entry tended to be more independent 
decision-makers (Ellis, 2000; Llewellyn-Thomas, McGreal, Thiel, Fine, & Erlichman, 
1991; Mancini et al., 2007), which suggested that greater attentiveness toward clinical 
trial information might not necessarily lead to the decision for participation. A 
preliminary project related to the current chapter also found that individuals’ 
willingness to discuss about clinical trial opportunities mediated the relationship 
between their intent to participate in a future trial and the perception that their 
physicians treated them in a fair manner during the interactions (McComas et al., 
forthcoming). 
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Therefore, the intent to enroll in a clinical trial seems based on more than an 
understanding and comprehension of clinical trial information. Other factors, such as 
general attitudes toward clinical trials, might also contribute to this decision making 
processes. In fact, focusing on treatment choices, recent investigations have suggested 
that patients’ medical decisions are often based on general attitudes, beliefs, and 
values (Cameron, Leventhal, & Levanthal, 1995; Trauth, Musa, Siminoff, Jewell, & 
Ricci, 2000), whereas physicians’ decisions are usually based on symptoms and 
diagnosis (Barry, Fowler, Mulley, Henderson, & Weinberg, 1995). On a related note, 
past research has also associated the decision to participate in a clinical trial with 
dispositions and personality traits such as social anxiety (Almeida et al., 2008), 
treatment-specific optimism (Cohen et al., 2001), and self-protectiveness (Schain, 
1994).  
From a conceptual front end, health psychologists have applied several 
different approaches to examine medical decision making among cancer patients, 
some of which are directly applicable to clinical trials because both decision processes 
require the devotion of similar cognitive and affective resources. One of these 
approaches focuses on patients’ internal cognitive processing of medical information 
(Miller, Shoda, & Hurley, 1996; Petersen et al., 2001). Both social learning theory and 
dual-processing models have guided research in this domain. In general, based on 
social learning theory, researchers have found that cancer patients cope with aversive 
health information to varying degrees based on the approach or avoidance strategies 
they adopt (Miller, 1989). 
Studies informed by dual-processing models, on the other hand, have presented 
mixed evidence. One line of research has shown decision making strategies that are 
based on effortful information processing to relate to effective coping with cancer 
(Petersen et al., 2001). Other studies specifically related to clinical trials, however, 
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have found that breast cancer patients’ decisions to enter a trial were associated with 
lower levels of information processing (Curbow et al., 2006). Therefore, it seems 
critical to examine whether the intent to enroll in a clinical trial mainly results from 
active decision making based on careful evaluation of clinical trial information, or 
whether it implies a passivity to hand over decision making to physicians and other 
medical researchers. The two samples in this chapter offer an opportunity to test 
whether comparable factors contribute to this intent among healthy respondents and 
cancer patients. 
Past research hints at some aspects of this problem. For instance, Sharma et al. 
(2001) found that clinical trial patients were significantly more likely than other 
patients to be involved in treatment decisions, which seems to suggest that they 
assume a more active participating role. However, clinical trial participants might take 
part in the decision making process for other reasons as well. Several studies have 
shown that rather than a role in clinical decision-making, cancer patients appeared to 
desire information to satisfy “psychological autonomy” related to increased 
knowledge (Cox, 2002; Sutherland, Llewellyn-Thomas, Lockwood, & Till, 1989). The 
motivations to maintain physical and psychological well-being (such as optimism) 
also drive cancer patients to engage in the communication and decision-making 
process with their physicians (Nurgat et al., 2005; Thorne, Hislop, Armstrong, & 
Oglov, 2008). In fact, when evaluating the risks and benefits of phase II cancer clinical 
trials, institutional review board members estimated that similar to physical and 
therapeutic treatment, the psychological empowerment of hope also benefited patients 
(van Lujin, Aaronson, Keus, & Musschenga, 2006). Therefore, besides cognitive 
processing of clinical trial information, psychological and emotional factors might also 
precede individuals’ enrollment decisions. 
More importantly, these cognitive and affective processes might work together 
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to influence decision making related to clinical trial participation. In particular, 
Tiedens and Linton (2001) have shown that emotions characterized by certainty 
appraisals promote heuristic processing, whereas emotions characterized by 
uncertainty appraisals result in systematic processing. Based on results from their 
experiments, emotions associated with feeling uncertain about an outcome (regardless 
of its valence), such as worry and surprise, led to more systematic processing of 
relevant information. Given the nature of clinical studies, affects related to clinical 
trial participation are often linked to greater uncertainty appraisals. For instance, as 
two emotions most frequently identified among clinical trial participants (Abraham et 
al., 2006; Catania et al., 2008; Madsen et al., 2002; Meropol et al., 2007), anxiety and 
fear both scored low on certainty appraisal scales (Frijda, Kuipers, & ter Schure, 
1989). Therefore, it is also possible that emotions associated with the idea of clinical 
trial participation might lead to more systematic processing of clinical trial 
information, which in turn, contributes to enrollment decisions. 
Both the risk-as-value model (Finucane & Holup, 2006) and the affect-as-
information proposition (Schwarz & Clore, 1988) support these conjectures. Since 
randomization and clinical equipoise are fundamental ideas behind all clinical trials, 
risk assessment is likely an intrinsic part of the decision making process related to 
clinical trial participation. As Finucane and Holup suggested, a combination of 
affective and analytic evaluations of risk information would assure more efficient and 
sound judgment. Similarly, evidence from a series of studies that Schwartz and Clore 
conducted also indicated that affective states could serve informative functions, such 
as providing judgment heuristics for individuals facing complex decisions so that they 
could “compute it in a piecemeal fashion.” Therefore, to examine decision making 
related to clinical trial participation, it is vital to take into account both the impact of 
cognitive evaluation of clinical trial information, as well as the influence of affective 
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assessment of the situation. 
On a related note, upon entering a health care consumer paradigm where 
individual patients are potentially independent decision makers who could benefit 
from the large amount of available public information (Sharf & Street, 1997), decision 
making related to clinical trial participation is likely a communicative process that 
involves more actors than physicians and patients. Gordon and Daugherty (2001) 
found that cancer patients did not regard referring physicians as key providers of 
information but specified that their family members had influenced them the most to 
enter a trial. Other studies have also identified family pressure as a driving force 
behind cancer patients’ decisions to enroll in a trial, together with trust in physicians 
and the hope to receive therapeutic benefits (Agrawal et al., 2006; Almeida et al., 
2008; Daugherty et al., 1995). Since the decision to enter a trial will not only change 
treatment regimens for individual patients but also influence the coping strategies that 
patients and their families adopt, normative influences from individuals’ immediate 
social environment could also play a role in their decision making process. 
To examine the issues reviewed above within a sound theoretical framework, 
this chapter will continue to test linkages between the RISP model and the TPB. 
Specifically, this chapter will investigate the relationships among information 
processing strategies, affective responses, normative beliefs, attitudes toward clinical 
trials, and behavioral intentions. Previous chapters have generated some evidence in 
support of a more cohesive framework informed by the RISP model and the TPB. This 
chapter, using structural equation modeling for multiple group comparison, will reveal 
similarities and differences in the factors that work together to shape enrollment 
decisions among prospective volunteers and cancer patients and their family members. 
Rather than providing rationale for research questions and hypotheses that previous 
chapters have stated to some extent, key elements of the RISP model and the TPB will 
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involve the following: 
Cognitive Processing Strategies. Based on Eagly and Chaiken’s HSM, the 
RISP model describes dual forms of information processing strategies. As cognitive 
misers, most people employ the less effortful yet more economic heuristic strategy to 
process information unless motivated by a need to gain greater judgment confidence to 
engage in the more effortful and elaborate type of systematic processing. In their 
seminal work and subsequent empirical tests, Griffin and his fellow researchers 
suggested that higher level of information processing contributes to more stable and 
consistent attitudinal positions and subsequently, lead to the intention to perform a 
preventive behavior (Griffin et al., 1999; Griffin et al., 2002). Therefore, focusing on 
attitudes based on behavioral beliefs and behavioral intentions adopted from the TPB, 
this chapter hypothesizes that: 
H1: Systematic processing will be positively related to positive attitudes 
toward clinical trial participation. 
H2: Heuristic processing will be negatively related to positive attitudes toward 
clinical trial participation. 
Affective Responses. Developed for risk communication, the RISP model 
differs from other mental processing models because it recognizes that affective 
evaluations of a risk issue would influence communication behaviors such as 
information seeking and processing. However, based on recent theoretical 
development and empirical evidence (Griffin et al., 2008; Huurne et al., forthcoming), 
the original positioning of affective responses in the RISP model seems outdated. 
Besides the direct relationships between affective response and information processing 
observed in recent studies (Griffin et al., 2008), as Griffin et al. (1999) posited, 
affective responses might also have direct influence on individuals’ behavioral 
intentions. Therefore, this chapter investigates whether negative and positive emotions 
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associated with clinical trial participation relate to information processing strategies, 
attitudes and behavioral intentions. Specifically: 
R1: How do negative emotions relate to systematic and heuristic processing, 
attitudes and behavioral intentions? 
R2: How do positive emotions relate to systematic and heuristic processing, 
attitudes and behavioral intentions? 
ormative Beliefs. The RISP model adopted the original TPB concept of 
normative beliefs and conceptualized it as informational subjective norms that work 
together with other components of the model to motivate systematic processing of 
relevant information. Similar to affective responses, recent empirical tests in a variety 
of research contexts have shown informational subjective norms to have more direct 
influence on information processing (Griffin et al. 2008; Kahlor et al., 2006). 
Therefore, this chapter examines normative beliefs’ direct effects on information 
processing, as well as its direct and indirect effects on behavioral intentions, which 
lead to the next set of hypotheses: 
H3: Normative beliefs will be positively related to systematic processing 
(H3a), negatively related to heuristic processing (H3b), and positively related to 
behavioral intentions (H3c). 
Lastly, following TPB’s theoretical proposition, the last hypothesis is focused 
on the relationship between attitudes and behavioral intentions: 
H4: Belief-based attitudes will be positively related to behavioral intentions 
related to clinical trial participation. 
Method 
Data 
Viewing these two datasets together, respondents in the national sample 
appeared to be slightly younger (MAT = 49.83, SDAT = 16.04; MLLS = 53.99, SDLLS = 
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12.00; t [985] = 4.61, p < .001), with less education (MAT = 4.96, SDAT = 1.69;  MLLS = 
5.53, SDLLS = 1.41; t [995] = 5.87, p < .001, ranging from eighth grade or less [coded as 
1] to post-graduate training [coded as 7]), and less income (MAT = 54,100, SDAT = 
24,100; MLLS = 59,500, SDLLS = 21,160; t [917] = 3.66, p < .001, ranging from less than 
$10,000 to $150,000 or more). Both samples were predominantly White, but the LLS 
sample had more female respondents (χ2 [1] = 5.83, p < .05). Compared to the 2006 
American Community Survey (U.S. Census Bureau, 2007), the national sample 
seemed to have slightly over represented individuals with higher income, but the other 
parameters were quite similar. 
Measurement 
Measures for key variables were adopted from past analyses based on the RISP 
model (Griffin et al., 2008; Griffin et al., 2002). As with the previous chapters, the 
specific questionnaires appear in Appendix 2A and 2B, whereas the particular items 
used to measure each variable are indicated below in footnotes. 
Cognitive Processing Strategies. Six items measured respondents’ cognitive 
processing strategies.20 Past analyses have primarily used exploratory factor analysis 
to examine the construct validity of these six items in measuring systematic and 
heuristic processing. The current chapter, following the recommendation of Schemer 
et al. (2008), tested construct validity through a confirmatory factor analysis. Overall, 
respondents in the LLS sample scored higher for items intended to measure systematic 
processing, and lower for those intended to measure heuristic processing. Mean 
comparisons through independent samples t-test found significant differences between 
these two samples in all these measures. 
Affective Responses. Respondents indicated on 10-point scales how optimistic, 
                                                 
20 Items 16 & 18-22 in the questionnaire 
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afraid, worried, and anxious they felt when thinking about enrolling in a clinical trial. 
LLS respondents gave higher ratings on measures of optimism (t [980] = 12.78, p < 
.001) and anxiety (t [986] = 3.24, p < .001), but their scores for fear and worry were not 
significantly different from respondents in the national sample. 
ormative Beliefs. Consistent with past research, respondents also indicated 
whether they believed that people who were important to them would want them to 
stay informed about enrolling in a clinical trial.21 Mean comparison test indicated that 
LLS respondents sensed greater normative influence in general (t [982] = 11.33, p < 
.001). 
Belief-based attitudes. Respondents indicated their agreement with five 
statements describing beliefs associated with clinical trial enrollment ranging from 
financial concerns to altruistic reasons.22 Past research has identified these beliefs 
among cancer patients facing the decision to enroll in a clinical trial (Comis et al., 
2003; Schain, 1994). These behavioral beliefs and their corresponding evaluations23 
were linked together to measure belief-based attitudes (Ajzen, 1988). In general, LLS 
respondents indicated more positive attitudes toward clinical trial participation.24 
Behavioral intention. Two items measured respondents’ general behavioral 
intentions related to clinical trial enrollment, based on their own willingness to enroll 
in a trial and the likelihood that they would encourage someone they know to enroll. 
                                                 
21 Item 11 in the questionnaire 
22 Items 29-33 in the questionnaire 
23 Items 34-38 in the questionnaire 
24 Similar to the analysis in Chapter 5 where optimistic feelings were examined along with positive 
attitudes, assuring discriminant validity, inter-variable correlations (average r = .35, ranging from .24 to 
.40) was lower than correlations among measures of positive attitudes (average r = .41, ranging from 
.27 to .80). 
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25Again, LLS respondents scored higher on both items, indicating higher intentions for 
clinical trial enrollment. 
Analysis 
This chapter used the LISREL 8.80 structural equation modeling (SEM) 
program for data analysis. LISREL provides tests of the adequacy of the entire model, 
simultaneous estimation of all structural coefficients, and tests of statistical 
significance for all coefficients. To test the overall model, we followed a two-step 
procedure recommended by Kline (2005). Through confirmatory factor analysis, a 
measurement model was first specified and refined, based on which estimation of the 
structural model was completed. The overall goal was to find a parsimonious 
structural model that explained the data reasonably well (Kline, p. 217). This 
technique also enabled this analysis to assess the reliability and validity of these latent 
constructs with greater precision (Schemer et al., 2008). In order to compare 
relationships among key variables, a structural equation model was analyzed across 
the two samples. According to Kline, the main question addressed in a multiple-
sample SEM is whether values of model parameters vary across groups, which 
provides another tool to examine whether group membership moderates the relations 
specified in the model. In other words, the goal of this analysis was to estimate the 
same model within these two samples and then compare the unstandardized solutions 
across the samples. 
As Jöreskog & Sörbom (1996b) pointed out, in a multi-sample analysis, the χ2 
goodness-of-fit statistic is a measure of fit of all models in all groups, where a 
nonsignificant value indicates good fit. Because χ2 has been shown to be sensitive to 
sample size (Bollen, 1989), the χ2/df ratio is also reported, where a value less than five 
                                                 
25 Items 3 & 4 in the questionnaire 
 119 
 
indicates a good fit (Klein, p. 137). The root mean square error of approximation 
(RMSEA) and the Comparative Fit Index (CFI), the Goodness-of-Fit Index (GFI), and 
the Adjusted Goodness-of-Fit Index (AGFI) are also reported, which demonstrate how 
well the specified model accounts for the data. RMSEA values less than .05 typically 
indicate good fit. For CFI, GFI and AGFI (values ranging from .00 to 1.00), .90 and 
above is generally considered to represent good fit. Regression coefficients for the 
hypothesized structural relations are reported along with their statistical significance. 
A probability level of p < .05 was used as the base level of statistical significance. 
Results 
The effective sample size for data analysis with list-wise deletion was 886. 
Through the imputation function in PRELIS, 61 more cases were added, which 
resulted in a final effective sample size of 947. Imputation in PRELIS substitutes the 
missing value of a case with a real value obtained from another case that has a similar 
response pattern over a set of matching variables (Jöreskog & Sörbom, 1996a, p. 153). 
Table 6.1 and Table 6.2 present descriptive statistics of the two samples, including 
correlation coefficients in the upper triangle of the matrix, covariance coefficients in 
the lower triangle, and variances along the diagonal. The zero-order correlation matrix 
was generated in SPSS17.0 prior to data imputation using the raw data; the covariance 
matrix was generated in the PRELIS package of LISREL 8.80 after data imputation. 
The covariance matrix was used for SEM tests (Jöreskog & Sörbom, 1996b). To 
reduce potential measurement error for those variables that were measured with a 
single item, this analysis assumed an arbitrary reliability value of .85, which was 
equivalent to an error variance of .15 times the variance of the observed variable 
(Jöreskog & Sörbom, 1996b, p. 37). 
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Table 6.1 
Descriptive statistics (national sample) 
 
Key Variables 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
1. TPB1 23.64 .77** .49** .23** .24** .38** .36** .26** -.11* -.31** -.15** .34* .30** .14** .36** .01 -.03 .03 
2. TPB2 90.54 20.75 .55** .28** .27** .32** .34** .20** -.13** -28** -.16** .29** .30** .10** .28** -.03 -.04 .02 
3. TPB3 56.23 51.70 22.76 .25** .30** .30** .33** .21** -.08 -.29** -.11* .27** .20** .12** .27** -.07 -.05 -.01 
4. TPB4 12.90 14.20 11.13 22.01 .38** .19** .16** .10* -.09 -.14** -.14** .15** .15** .10* .17** -.19**-.18**-.08 
5. TPB5 6.69 6.20 6.39 4.77 21.08 .30** .21** .14** -.10* -.14** -.15** .25** .12** .15** .26* -.13** -.15**-.10* 
6. BHINTself 5.13 3.58 3.11 .98 .81 1.61 ..62** .28** -.14** -.36** -.16** .37** .22** .17** .41** .01 -.05 .06 
7. BHINTother 4.86 4.02 3.90 .90 .61 .78 1.54 .25** -.08 -.33** -.14** .28** .24** .13** .40** -.02 -.04 .04 
8. NORM 3.90 2.31 2.38 .65 .44 .33 .31 1.17 -.01 -.19** -.09* .27** .17** .10* .23** .00 -.04 -.02 
9. HEU1 -1.55 -1.36 -.89 -.46 -.25 -.13 -.09 -.02 1.22 .19** .22** -.07 -.06 -.03 -.12* .01 .03 -.04 
10. HEU2 -3.25 -2.48 -2.29 -.55 -.27 -.33 -.33 -.19 .17 1.25 .28** -.42** -.25** -.27** -.32** -.03 -.01 -.02 
11. HEU3 -.86 -1.01 -.64 -.53 -.27 -.09 -.09 -.07 .17 .14 1.07 -.21** -.15** -.08 -.16** -.02 -.02 .00 
12. SYS1 4.06 3.10 2.73 .90 .65 .40 .31 .31 -.10 -.37 -.12 .89 .39** .24** .28** .00 -.03 .02 
13. SYS2 5.07 4.25 2.67 1.03 .36 .26 .25 .22 -.15 -.27 -.13 .56 .79 .08** .22** .06 .02 .07 
14. SYS3 1.59 .96 1.03 .45 .30 .16 .15 .11 .00 -.17 -.03 .22 .10 .95 .19** -.00 -.03 .02 
15. OPTIMISM 30.57 20.44 18.39 5.13 4.21 2.94 2.84 1.73 -.93 -1.18 -.64 1.99 1.90 1.13 7.19 .14** .06 .10* 
16. FEAR -3.77 -5.58 -9.89 -10.50 -3.90 -.55 -.77 -.18 -.02 -.04 .00 -.42 .40 -.08 9.01 9.36 .84** .64** 
17. WORRY -4.36 -3.72 -3.91 -5.27 -2.52 -.51 -.42 -.35 .12 -.12 -.06 -.34 .09 -.05 1.84 47.37 9.62 .71** 
18. ANXIETY -.06 -.51 -1.40 -2.03 -1.58 .17 .16 -.18 -.19 -.12 .00 -.04 .48 .15 3.69 34.84 20.93 9.48 
M 14.85 15.68 14.07 11.02 9.85 3.03 3.30 3.15 2.88 3.10 2.73 3.82 4.05 3.32 4.95 5.41 5.47 5.22 
SD 4.86 4.56 4.77 4.69 4.59 1.27 1.24 1.08 1.10 1.12 1.03 .94 .89 .97 2.68 3.06 3.10 3.08 
*Pearson correlation coefficients are provided in the upper triangle of the matrix, variances are located 
on the diagonal, and covariances are reported in the lower triangle.  
Significance key:  *p ≤ .05; **p ≤ .01. 
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Table 6.2 
Descriptive statistics (LLS sample) 
 
Key Variables 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
1. TPB1 27.72 .79** .44** .21** .25** .27** .25** .14** -.08 -.07 -.02 .13** .08 .11* .30** -.19** -.18** -.14** 
2. TPB2 34.72 24.39 .52** .22** .30** .30** .29** .15** -.06 -.10* .03 .16** .10* .12** .35** -.10* -.12** -.08 
3. TPB3 8.92 22.97 29.11 .26** .31** .30** .35** .18** .00 -.17** -.04 .11* .07 .11* .39** -.18** -.20** -.16** 
4. TPB4 1.48 3.73 1.87 25.67 .32** .18** .16** .05 -.10* -.16** -.02 .10* -.06 .04 .19** -.09* -.11* -.14** 
5. TPB5 3.64 9.65 4.30 1.64 24.95 .20** .22** .02 -.01 -.07 -.00 -.06 .02 .13** .30** -.20** -.22** -.20** 
6. BHINTself 1.55 3.63 1.69 .36 .77 .80 .57** .13** -.10* -.18** -.03 .08 .00 .12** .39** -.20** -.23** -.20** 
7. BHINTother 1.49 3.51 1.91 .36 .82 .81 .82 .11* -.03 -.12** .03 .06 -.04 .04 .40** -.14** -.16** -.12** 
8. NORM .94 2.18 1.20 .12 .10 .25 .19 1.11 -.11* -.23** -.08 .15** .07 .24** .17** .05 .04 .02 
9. HEU1 -.31 -.72 -.05 -.16 .02 -.10 -.05 -.15 1.37 .29** .17** -.22** -.04 -.20** -.08 -.04 -.04 -.01 
10. HEU2 -.28 -.82 -.62 -.21 -.14 -.14 -.10 -.24 .21 1.03 .14** -.37** -.11* -.26** -.09* -.04 -.00 .02 
11. HEU3 -.13 -.09 -.23 -.03 -.04 -.04 .01 -.08 .12 .09 1.11 -.06 .03 -.10* .00 .05 .05 .05 
12. SYS1 .87 2.45 .83 .25 .24 .10 .08 .36 -.27 -.41 -.08 .65 .26** .22** .03 .09* .08 .02 
13. SYS2 .58 1.92 .48 -.10 .14 -.04 -.11 .23 -.08 -.15 .01 .68 .74 .07 -.05 .13** .13** .19** 
14. SYS3 .59 1.39 .53 .06 .51 .14 .08 .32 -.18 -.22 -.07 .38 .17 .90 .09* .03 -.00 .01 
15. OPTIMISM 7.74 20.64 9.49 1.64 5.34 2.69 2.60 1.31 -.40 -.41 -.01 .11 -.36 .43 4.38 -.16** -.19** -.20** 
16. FEAR -5.87 -8.54 -5.44 -.81 -4.18 -1.76 -1.41 .29 -.27 -.09 .20 .51 .99 .11 -6.32 8.72 .88** .79** 
17. WORRY -4.08 -6.83 -4.11 -.66 -3.18 -1.38 -1.08 .22 -.22 .05 .17 .31 .70 -.05 -5.52 24.39 8.81 .84** 
18. ANXIETY -3.10 -4.92 -3.38 -.92 -2.92 -1.11 -.81 .11 -.09 .10 .14 .02 1.02 .09 -5.29 22.26 16.53 8.50 
M 18.03 18.57 16.47 13.14 12.59 4.25 4.27 3.92 2.54 2.32 2.52 4.25 4.26 3.64 6.91 5.55 5.45 5.84 
SD 5.27 4.94 5.40 5.07 5.00 .90 .91 1.05 1.17 1.01 1.06 .81 .86 .95 2.09 2.95 2.97 2.92 
*Pearson correlation coefficients are provided in the upper triangle of the matrix, variances are located on 
the diagonal, and covariances are reported in the lower triangle.  
Significance key:  *p ≤ .05; **p ≤ .01. 
 
The initial CFA model, simultaneously fitted to covariance matrices for the 
national sample and the LLS sample, was rejected because the assumed invariance 
across all model parameters was not supported (χ2 = 1903.24, df = 280, χ2/df = 6.80, p 
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< .05, RMSEA =.111, CFI = .75). The revised CFA model assumed different error 
variances across the two groups, which improved model fit (χ2 = 1009.37, df = 271, 
χ2/df = 3.72, p < .05, RMSEA =.076, CFI = .91). The next CFA model allowed factor 
loadings to be different for variables that measured belief-based attitudes and negative 
emotions, which led to a much more improved measurement model (χ2 = 660.49, df = 
265, χ2/df = 2.49, p < .05, RMSEA =.056, CFI = .95), but the RMSEA was still above 
the cutoff point of .05. The last steps of revision allowed several error covariances to 
be different across the groups, including attitude measures and the error covariance of 
fear and optimism, which resulted in the final CFA model (χ2 = 570.47, df = 261, χ2/df 
= 2.19, p < .05, RMSEA =.050, CFI = .96). Since these observed variables were 
designed to measure similar constructs, these revisions were justified conceptually. 
Based on the refined CFA model, a structural model was specified. Results for 
the overall model fit are presented in Table 6.3.  
 
Table 6.3 
Summary of fit indicators 
 
Models  χ
2
 df P χ
2
/df RMSEA  GFI CFI 
Baseline CFA model 1903.24 280 <.05 6.80 .111  .78 .75 
Revised CFA model a 570.47 261 <.05 2.19 .050  .94 .96 
Baseline conceptual model 749.87 264 <.05 2.84 .062  .91 .94 
Revised model b 533.58 259 <.05 2.06 .047  .94 .97 
*RMSEA = root mean squared error of approximation; GFI = Goodness-of -Fit Index; 
CFI = Comparative Fit Index. 
a. Revision from baseline CFA model to final CFA model: allow error variances 
and factor loadings to be different across groups; allow error terms between 
attitude measures and between fear and optimism to covary. 
b. Revision from baseline model to final model: allow path coefficients for key 
endogenous variables to be different across groups, deleted non-significant 
paths. 
 
Analysis of the overall model fit along with tests of individual paths indicated 
that allowing regression coefficients to be estimated differently for paths leading to 
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key endogenous variables, attitudes and behavioral intentions, could improve model 
fit. After deleting non-significant paths across the two groups, the final model (χ2 = 
533.58, df = 259, χ2/df = 2.06, p < .05, RMSEA = .047, CFI = .97) fit the data 
relatively well. Even though fixing several path coefficients to be equal could result in 
a slightly more parsimonious model, in order to compare across the two samples, all 
the path coefficients were estimated separately. Figure 6.1 shows unstandardized 
regression coefficients for the national sample and the LLS sample, with the latter in 
the parentheses. 
In regards to specific research questions and hypotheses, as proposed in the 
first hypothesis, systematic processing was positively related to positive attitudes 
toward clinical trial participation in both the national sample (β = .37, t = 4.88, p < 
.05)  and the LLS sample (β = .19, t = 2.29, p < .05). Comparing unstandardized 
regression coefficients, this relationship was stronger in the national sample, as shown 
in Figure 6.1. Therefore, H1 was supported in both samples. In addition, taking into 
account the indirect effects through attitudes, systematic processing also seemed to 
have greater total effects on behavioral intentions in the national sample than in the 
LLS sample (unstandardized total effects: .42 NAT vs .10 LLS; standardized total effects: 
.29 NAT vs .07 LLS). Heuristic processing, on the other hand, was only significantly 
related to attitudes in the national sample (β = -.14, t = -2.10, p < .05) and thus, had 
marginally significant indirect effects on behavioral intentions (unstandardized total 
effects: -.33 NAT; standardized total effects: -.11 NAT). Therefore, H2 was supported in 
the national sample but not in the LLS sample. 
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The third set of hypotheses focused on normative beliefs’ relationships with 
information processing and behavioral intentions. In the national sample, all three 
hypotheses received support. Normative beliefs were positively related to systematic 
processing (β = .35, t = 7.12, p < .05), negatively related to heuristic processing (β = -
.25, t = -4.85, p < .05), and positively related to behavioral intentions (β = .07, t = 
2.07, p < .05). In the LLS sample, however, even though normative beliefs were 
significantly related to systematic (β = .33, t = 5.55, p < .05) and heuristic processing 
(β = -.26, t = -4.22, p < .05), constraining regression coefficients to be equal across the 
two samples results in a more parsimonious model without sacrificing model fit. 
Therefore, these two parameters were not estimated separately. Normative beliefs 
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Figure 6.1  
Results for the conceptual model with statistically significant paths 
*Unstandardized solution from structural equation modeling (SEM) analysis for 
the national sample and the LLs sample, with the latter in parentheses. 
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were not significantly related to behavioral intentions in the LLS sample. Including 
indirect effects, normative beliefs had stronger total effects on behavioral intentions 
(unstandardized total effects: .17 NAT vs .09 LLS; standardized total effects: .18 NAT vs 
.12 NAT) and attitudes (unstandardized total effects: .94 NAT vs .58 LLS; standardized 
total effects: .17 NAT vs .10 LLS) in the national sample. 
Lastly, the relationships between belief-based attitudes and behavioral 
intentions were significant in both samples, as stated in the final hypothesis. However, 
this relationship was stronger in the national sample (β = .78, t = 9.77, p < .05) than in 
the LLS sample (β = .36, t = 5.17, p < .05). Overall, in the national sample, the model 
explained 51% of the variance in behavioral intentions and 68% of the variance in 
attitudes, whereas in the LLS sample, it accounted for 50% of the variance in 
behavioral intentions and 49% of the variance in attitudes. 
Discussion 
The purpose of this chapter is to examine a theoretical linkage between the 
RISP model and the TPB in depicting socio-psychological factors that shape clinical 
trial enrollment decisions of cancer patients and their caregivers, as well as 
prospective healthy volunteers. Rather than testing how various RISP components 
explain individuals’ motivations to engage in higher-level information processing, this 
analysis aimed at exploring what originates from these information processing 
strategies to shape individuals’ health decisions. Therefore, following Griffin et al.’s 
(1999) original theoretical projection, cognitive processing strategies were juxtaposed 
with positive and negative emotions, as well as normative beliefs to investigate their 
impact on belief-based attitudes and behavioral intentions, within the TPB’s 
overarching framework. In order to compare the relative influence of each exogenous 
variable on endogenous variables, the same model was specified across the two 
samples even though path coefficients were estimated separately when appropriate. 
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Through multiple-sample structural equation modeling, key findings indicate that 
attitudes, cognitive processing strategies, affective responses, and normative beliefs 
could account for about half of the variances in behavioral intentions related to clinical 
trial participation in both samples. 
However, these two samples also differ in several key aspects. First of all, 
information processing strategies did not influence attitudes and behavioral intentions 
in the LLS sample to the same degree as in the national sample. In fact, in the LLS 
sample, heuristic processing was not significantly related to attitudes or behavioral 
intentions at all. Upon a first look, these results seem to suggest that healthy 
respondents are more likely to base their enrollment decisions on careful evaluations 
of available clinical trial information. However, since cancer patients and their 
caregivers are in general more knowledgeable and experienced with clinical trials, an 
alternative explanation could be that respondents in the national sample responded to 
these questions based on a general preference for more information and better 
comprehension when it comes to health decision making. Since respondents in the 
LLS sample are already, presumably, well-informed about clinical trial opportunities, 
too much information might actually turn them away and make them feel 
overwhelmed. Their responses to these questions, therefore, might express a tendency 
to avoid information to reduce distress, as a coping mechanism. Past studies have 
identified similar phenomena among cancer patients and clinical trial participants 
(Brashers et al., 2002; Leydon et al., 2008). Thus, compared to other predicting 
variables, information processing strategies did not influence their attitudes and 
behavioral intentions as much. Therefore, the stronger relationships between 
systematic processing and positive attitudes shown in the national sample might not 
indicate a lack of cognitive involvement among cancer patients and their caregivers 
when it comes to decision making related to clinical trial enrollment. Rather, these 
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findings suggest that among those who might not be fully aware of clinical trial 
opportunities, the more effortful and engaged information processing strategy might 
enhance their overall attitudes toward clinical trial participation and indirectly lead to 
greater willingness to enroll in a clinical trial. 
On the contrary, affective responses played a bigger role in influencing 
attitudes and behavioral intentions among cancer patients and their caregivers. 
Together with existing evidence showing the importance of emotions in shaping 
people’s enrollment decisions (Catania et al., 2008; Jones et al., 2006), these findings 
indicate that health communication efforts, especially those targeted at enhancing 
clinical trial enrollment, should pay close attention to patients’ emotional reactions to 
specific messages and their interactions with physicians and other medical researchers. 
More importantly, positive emotions (optimistic feelings, in this case) not only had 
direct relationships with attitudes and behavioral intentions in the LLS sample but also 
had indirect effects on attitudes through systematic processing. These findings seem to 
support the idea that when the task is important, positive emotions not only do not 
deter systematic processing, as some researchers have argued (Schwarz & Bless, 
1991), but could actually prompt people to invest in more cognitive resources to 
process relevant information more effectively, especially when the decision involves 
some degree of risk taking (see Isen, 1999 for a review). Additional support for this 
conjecture comes from social psychology studies showing optimistic beliefs about 
one’s health as related to greater attention to risk information, especially when the 
information is self-relevant (Aspinwall & Brunhart, 1996). Therefore, following the 
assumption that clinical trial participation offers a unique case study of risk, it was not 
surprising that positive emotions (optimistic feelings) stood out as the most influential 
predicting variable in this model that investigates the direct and indirect linkages 
among affects, cognitive processing, attitudes, and behavioral intentions. 
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On the other hand, comparing the different emotions examined in this chapter, 
optimistic feelings had stronger total effects on attitudes and behavioral intentions than 
negative emotions across the two samples. Since all emotions were assessed based on 
self-report measures, they were most likely associated with individuals’ innate 
dispositions. As Scheier and Carver (1992) pointed out, dispositional optimism is 
often associated with active, problem-focused coping and involves a more generalized 
expectancy (as compared to self-efficacy) toward future events that facilitates the 
practice of health-enhancing behaviors. Therefore, it is possible that cancer patients 
and their caregivers in this study are indeed more motivated by optimistic feelings 
associated with clinical trial enrollment when they make decisions about future 
participation, either in anticipation for beneficial outcomes or in an effort to maintain 
active control over their regimen. On a related note, both the cognitive adaptation 
theory (Taylor, 1983) and the broaden-and-build theories of positive emotions (see 
Fredrickson, 2005 for a review) suggest that positive beliefs and feelings could serve 
as important psychological resources that help people adapt to stressful events and 
protect health. Therefore, not only did optimistic feelings outperformed negative 
emotions in motivating systematic processing of clinical trial information, they also 
incited more positive attitudes toward clinical trials and a great likelihood for future 
participation, especially among cancer patients and their caregivers.  
While most of the results confirmed existing beliefs based on theoretical 
proposition and empirical evidence, there were also some unexpected findings. In 
particular, even though normative beliefs were significantly related to information 
processing in both samples, they also influenced healthy respondents’ enrollment 
decisions more than cancer patients and their caregivers. These findings seem to 
contradict the strong influence of cancer patients’ physicians, family members and 
friends in shaping their decisions about clinical trial enrollment, as past research has 
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revealed (Albrecht et al., 2008). However, a closer examination of existing literature 
indicates that compliance with social norms has always acted as a critical motive 
among healthy prospective volunteers (Almeida et al., 2008; Pentz et al., 2002). 
Therefore, these results seem to suggest that it is possible to encourage greater 
awareness and attention to this issue among the general public by emphasizing that 
clinical trial participation is an altruistic act that will facilitate scientific advancement 
and benefit medical research.  
Similarly, the relationship between belief-based attitudes and behavioral 
intentions was also stronger in the national sample as compared to the LLS sample. 
Considering this finding together with the one previously discussed, an alternative 
explanation might also be true. That is, rather than viewing normative beliefs and 
positive attitudes as less important to cancer patients and their caregivers, they might 
simply have generated greater influence on healthy respondents’ decision making 
processes because cancer patients and their caregivers gave overall higher ratings on 
these measures. In other words, since LLS respondents generally hold positive 
attitudes about clinical trials and value the opinion of those who are important to them, 
other factors, such as affects, might seem more salient when linked together with 
enrollment decisions. 
It is important to consider potential limitations to this study. First of all, even 
though error variances were specified for observed variables that assessed normative 
beliefs and optimistic feelings to account for possible measurement error, these two 
constructs need to be evaluated more precisely in future research given the predicting 
power they seem to possess. At the same time, consistent with previous chapters, the 
item used to measure normative beliefs was more information-oriented rather than 
participation-oriented. That is, the social expectation examined was more related to 
being on top of information about clinical trial enrollment, rather than actual 
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participation. This compromise with measurement strategy, due to model complexity 
in multiple-sample comparison, might also explain why normative beliefs were more 
consistently related to information processing across the samples, rather than 
behavioral intentions. Lastly, even though the exogenous variables included in the 
model accounted for a decent proportion of variances in the endogenous variables, 
several other key components of the RISP model and the TPB, such as risk judgment, 
efficacy, and channel beliefs, were left out. Future analysis will continue to explore 
other SEM techniques that will allow the addition of these important predicting 
variables while ensuring model convergence. 
Chapter Conclusions 
Key findings from this analysis suggest that to improve clinical trial 
enrollment, campaigns that disseminate information broadly, with a format that 
promotes careful evaluation of the pros and cons of participation as related to each 
individual, as well as an emphasis on establishing social norms might be most 
effective among the general public. However, to target a specific group of cancer 
patients and their caregivers, health interventions need to include a mechanism that 
monitors the emotions that these individuals associate with the processes of subject 
accrual, informed consent attainment, and actual trial procedure, especially when it 
comes to maintaining a sense of optimism without fostering unrealistic or defensive 
optimism. As Schwarzer (1994) pointed out, it is insufficient to suppress defensive 
optimism by arousing fear among the patients. Rather, health and risk communication 
efforts should aim at triggering the perception of optimistic self-beliefs as a 
“prerequisite for the adoption of instrumental precautions” (p. 177). In other words, 
Schwarzer argued that some sense of vulnerability is not only necessary, but also 
indispensible for behavioral change, when operated jointly with beliefs about positive 
health outcomes, instrumental actions, and appropriate coping resources. Upon similar 
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reasoning, some degree of uncertainty might also be a necessary condition for the 
adoption of communication behaviors such as information seeking and processing 
related to clinical trial enrollment. Based on this and previous chapters, promoting 
these communication behaviors, while assisted by other practices such as 
incorporating individuals’ disposition toward risk and uncertainty, as well as their 
willingness to subject to social desirability, will improve the communications of 
clinical trial enrollment among both the general public and specific patient groups. 
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CHAPTER 7 
OVERALL CONCLUSION AND FUTURE RESEARCH 
Reflection 
Following a review of the propositions and development of the RISP model, 
the four chapters that immediately precede this final chapter have tested the 
applicability of the model and its extensions in a context of health decision making, 
specifically related to clinical trial enrollment decisions. Overall, results from the 
national sample and the LLS sample, through separate analyses and comparative 
investigations, seem coherent in shaping up the bigger picture. Key components of the 
RISP model have shown significant impact on respondents’ motivations for routine 
and non-routine information seeking, as well as systematic and heuristic processing. 
When the RISP model was linked together with the TPB framework, different parts of 
the model also exemplified varying degrees of explanatory power in belief-based 
attitudes and behavioral intentions. Along with the rationale presented in Chapter 2, 
these results indicate that viewing clinical trial enrollment as a unique case study for 
risk seems a reasonable strategy to deal with this health communication problem. The 
RISP model also seems to offer a useful framework to shape formative research for 
the design of communication campaigns related to clinical trial enrollment. This final 
chapter reflects on how results from these substantive chapters have complemented 
each other in approaching a tentative conclusion for this question. A comprehensive 
overview of these empirical findings, naturally, also sheds light on areas that future 
research should continue to explore. 
Before elaborating on these findings in this final chapter, it is important to 
reiterate the main purpose of this research project, which is to explore how to improve 
the communications of clinical trial enrollment in order to facilitate informed decision 
making among cancer patients and prospective healthy volunteers. To do this, key 
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results from the preceding four chapters have not only offered evidence in argument 
for the refinement of the RISP model, but they have also suggested important 
strategies with which practitioners could improve the accrual of clinical trial 
participants to make this procedure more effective and ethical. An important caveat 
here is that even with the best intention, scientific findings, including those from social 
science research, might be exploited to profit certain interest groups or organizations. 
It is important, therefore, to highlight the ethical implications of results from this 
dissertation. Given the unique composition of the LLS respondents in this 
investigation, they might have mainly viewed clinical trial research as related to the 
improvement of cancer treatment. Respondents in the national sample, however, might 
have taken clinical trials as referring to a broader range of clinical studies that also 
include drug testing and other biomedical research. When evaluating the patterns of 
results in these two samples, it is important to take into consideration this important 
distinction in the respondents’ profiles.  
In addition, even though similar vocabularies were used to describe research 
background for this dissertation, such as the detection of the barriers that keep 
individuals from volunteering in clinical trials, this research effort is fundamentally 
different from the general forms of “recruitmentology” studies that Epstein (2007) 
criticized. Specifically, the underpinning issue here is to discover how to engage 
cancer patients and healthy respondents in the communication process, which is 
different from how to manipulate their penchant or foster blind trust in medical 
research or medical researchers. In other words, risk and health communication 
research aims at increasing awareness and facilitating understanding of important risk 
and health issues to prepare ordinary citizens to take on a participatory role in the 
decision making process. As a basic assumption, acquisition and comprehension of 
information are crucial stages to reach informed decision making. In terms of the 
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construction and management of risk on a societal level, this audience-based 
orientation might seem a bit narrow as compared to the focus on “system builders,” 
including actors such as policy makers and influential interest groups, as Hilgartner 
(1992) proposed. However, the prospect of constructing new models of trusting 
relationships between patients and researchers in the long term will deliver on more 
meaningful expectations for this research effort. 
Viewing the results from individual chapters together, the most important 
finding arises from the comparison between the national sample and the LLS sample. 
In general, cognitive processing strategies had a stronger impact on attitude formation 
and behavioral intention among prospective healthy volunteers, whereas affective 
responses primarily influenced LLS respondents’ decisions about clinical trial 
enrollment (comparing results from Chapters 4, 5 and 6). A plausible conclusion, 
based on these results, could be that cancer patients and their caregivers were more 
likely to base their decisions on “irrational” feelings rather than thinking. However, it 
is important to stress that this relatively stronger relationship took shape within a 
unique research context. That is, as compared to respondents in the national sample, 
cancer patients and their caregivers in the LLS sample had more education, income, 
and previous experience with clinical trial enrollment. More importantly, they also 
reported much higher base-level awareness and knowledge with clinical trial 
enrollment. Thus, when questioned about preferences for information processing 
strategies along with emotional reactions to the idea of clinical trial participation, it is 
possible that emotions have taken precedence in their responses because in general, 
emotions could have more direct impact on risky choice behaviors. This reasoning 
comes in line with the “risk as feelings” hypothesis (Loewenstein et al., 2001). These 
authors argue that immediate emotional reactions during the decision making process 
could play a large role in choice behavior, independent of the outcome, resulting in 
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evaluations that may diverge from the desired cognitive or analytic evaluation. 
Therefore, a more reasonable conclusion from this comparison is that when it comes 
to forming decisions related to clinical trial enrollment, emotional reactions are 
important, but only when accompanied with sufficient information and 
comprehension. When existing knowledge does not suffice individuals to reach a 
sound judgment, cognitive processes still seem more salient in influencing their 
decisions.  
Risk perception, albeit measured by the most generic form of risk judgment 
based on an estimate of probability and severity, was one of the RISP components that 
performed most consistently across the different chapters. An interesting finding worth 
noting is that even though risk judgment was positively related to routine information 
seeking in both samples, it was related to non-routine information seeking in opposite 
directions across the two samples (Chapter 3). Focusing on respondents from the 
national sample, Chapter 4 also identified risk judgment as indirectly related to 
information seeking through current knowledge. That is, risk judgment seemed to 
highlight a greater need for information by influencing respondents’ estimate of how 
much they already know about clinical trial enrollment. In comparison, risk judgment 
was negatively related to both positive attitudes and behavioral intention among LLS 
respondents (Chapter 5). Viewing these findings together, perceived risk seemed to 
have a rather distinctive influence on respondents in these two samples. Even though it 
motivated prospective healthy volunteers to engage in more information seeking, this 
effort was embodied through routine activities such as paying attention to information 
in the mass media, rather than through more purposive and targeted activities such as 
searching for information on the internet. For cancer patients and their caregivers, 
perceived risk motivated information seeking from a variety of sources. Greater risk 
perception and increased information seeking, however, resulted in a less positive 
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attitude and lower intention to participate in a future trial. Thus, as Slovic (1992) 
pointed out, risk indeed seemed to be a concept that helped individuals to understand 
and cope with the prevalent uncertainties in their lives. For LLS respondents, since the 
risks and uncertainties related to clinical trial enrollment are more tangible and salient, 
perceived risk had a much more complex impact on their communication behaviors 
and subsequent health decisions. The seeming discrepancy in its relationships with 
greater information seeking and less behavioral intention also indicates that health 
communicators should not assume that more exposure to information automatically 
translates to the decision to participate. Based on findings from Chapter 3 and Chapter 
5, when perceived risk is high, more information might actually correlate with less 
intention for clinical trial enrollment.  
One of the most unique aspects of this research project involves the 
comparison of the motivating effects of negative and positive emotions within the 
context of the RISP model. Overall, optimistic feelings, representing positive 
emotions, had a consistent, strong impact on both forms of information seeking and 
information processing, as well as on attitudes and behavioral intentions across the 
two samples (synthesizing from Chapters 3 to 6). Negative emotions (measured as a 
latent construct represented by fear, worry, and anxiety) were the primary driving 
force behind information seeking through non-routine sources. Negative emotions also 
primarily influenced LLS respondents’ attitudes and behavioral intentions. In general, 
these results indicated that as compared to negative emotions, optimistic feelings 
might play a more important role in motivating communication behaviors and 
influencing individuals’ decisions related to clinical trial enrollment. Theoretically, 
this comparison would warrant a role for positive emotions as part of the affective 
response component of the RISP model. More importantly, these findings seemed to 
speak to the phenomena of “positivity offset” and “negativity bias” that social 
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psychologists have discussed in relation to the co-existence of two motivational 
systems (Cacioppo & Berntson, 1994). That is, the activation function of these two 
motivational systems tends to work in different ways. At low levels of exposure to 
evaluative input, which is what stimulates people to make an evaluative judgment, the 
positive motivational system responds more than the negative motivational system 
(positivity offset). As evaluative input increases, however, the negative motivational 
system usually responds more intensely (negativity bias). Since the available 
evaluative input related to clinical trial enrollment was rather limited, given the 
amount of information presented in a survey questionnaire, it is possible that a 
positivity offset was at work to shape our respondents’ responses, resulting in the 
stronger impact of optimistic feelings on key dependent variables. Further, Ito and 
Cacioppo (2005) found that individual variability exists in these affective asymmetries 
related to evaluation. Individuals with a stronger positivity offset tend to respond with 
even more positivity in relatively neutral situations than individuals with a weaker 
positivity offset. Comparing the two samples, a much higher proportion of the LLS 
respondents have participated in clinical trials, and they also reported more positive 
attitudes toward clinical trials in general. Therefore, it was not surprising that positive 
emotions had a stronger impact overall on other evaluative responses to the survey 
questions, especially among the LLS respondents. 
As for normative beliefs, even though its influence on information seeking and 
processing were rather similar across the two samples (see Chapters 3 and 6), it 
seemed to have stronger relationship with behavioral intentions in the national sample. 
The consistent direct relationships between informational subjective norm and 
information seeking and processing supported the proposition of a more direct linkage 
between these components of the RISP model. Reviewing the practical implications 
drawn in previous chapters, even though creating pro-enrollment social norms could 
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be an effective strategy for communication campaigns, it also brings about important 
ethical concerns. As Beauchamp and Childress (1994) mentioned, in relation to 
participation in biomedical research, “the primary function and justification of 
informed consent is to enable and protect individual autonomous choice” (p. 142). If 
we believe that the decision to enroll in a clinical trial should come from nothing less 
than an autonomous authorization from the individual, does the emphasis on social 
influence lead to an unethical manipulation of individuals’ free will? Based on results 
from Chapter 5 and Chapter 6, normative beliefs’ relatively weaker influence on 
cancer patients’ and their caregivers’ intentions to enroll in a future trial seem to offer 
a solution for ethical health communication practice. That is, even though normative 
beliefs were effective in motivating both routine and non-routine information seeking 
and greater systematic processing among prospective healthy volunteers, cancer 
patients and their caregivers were less likely to base their enrollment decisions on 
these beliefs. Therefore, if a campaign message mainly stresses improving knowledge 
about clinical trial research as a socially desirable behavior, instead of framing clinical 
trial participation as the ideal option for all patients, it could still facilitate informed 
decision making without compromising individual autonomy. However, similar to the 
challenge of maintaining hope without inducing unrealistic optimism among cancer 
patients, as underscored in earlier chapters, using social norms to improve the 
communications of clinical trial enrollment will be another delicate balancing act for 
health communicators. 
Treated as a proxy measure for relevant channel beliefs, individuals’ general 
trust in their physicians had limited impact on systematic processing in the national 
sample and on positive attitudes in the LLS sample. Among other variables included 
in these analyses, awareness was significantly related to non-routine information 
seeking in both samples and on cancer patients’ behavioral intentions; prior experience 
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was also significantly related to cancer patients’ positive attitudes. However, since 
these relationships did not remain consistent throughout different chapters, no further 
elaboration seems necessary here. Nonetheless, these findings, along with other RISP 
propositions that did not receive empirical support in this dissertation deserve future 
attention by communication researchers. 
Future Research 
A tentative adjustment of the RISP model, based on this dissertation and other 
studies reviewed in Chapter 2, is presented in Figure 7.1. The most important 
difference between the original RISP model and this newer version is the 
reconceptualization of information insufficiency. Specifically, the original RISP 
model argues that individuals’ cognitive need to decrease the gap between current 
knowledge and the sufficiency threshold serves as the most fundamental motive for 
higher-level information seeking and processing. In the adjusted RISP model, this 
dynamic process is subjected to the type of uncertainties involved in the risk issue that 
is under investigation. In particular, when the risk issue entails a predictable outcome 
or a satiable uncertainty that could be minimized by information acquisition, 
information insufficiency will motivate information seeking and processing. When the 
risk issue is characterized by unclear outcome expectancy or an uncertainty that is 
unlikely to be resolved by more information, an alternative motive, such as an action 
tendency induced by affective responses, might be more likely to promote information 
seeking and processing activities. Motives related to the intention to defend or 
maintain one’s social image, as related to normative beliefs, might also engender 
information seeking and processing activities.  
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Within the information insufficiency component, this reconceptualization 
depicts information sufficiency as a threshold that presents two additional possibilities, 
besides simply serving as an achievable cognitive state. That is, when one’s perceived 
current knowledge exceeds their information sufficiency threshold, the lack of 
information insufficiency might deter individuals from engaging in communication 
activities because the task of information seeking and processing might not seem 
relevant or important enough. Alternatively, if the goal of reaching information 
sufficiency is too daunting, the gap between current knowledge and a sufficiency 
threshold also might not lead to greater seeking and processing because these tasks 
would be beyond one’s capacity. That is, the sense of information insufficiency might 
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lead to varying degrees of information seeking and processing depending on whether 
it is feasible, or possible, to achieve information sufficiency. In addition, this adjusted 
RISP model also includes direct paths from affective responses and normative beliefs 
to information seeking and processing, as well as linkages between perceived hazard 
characteristics to information insufficiency. Within this framework, however, future 
research should continue to test and refine the RISP model. Informed by findings from 
this dissertation, here are some next-steps that I would like to take.  
Compared to past analyses based on the RISP model, information insufficiency 
did not function well as the most fundamental mechanism that accounts for 
individuals’ motivations for active information seeking and higher level information 
processing. Several factors might have contributed to this unexpected result. First, 
based on descriptive statistics, earlier studies have reported mean scores for current 
knowledge in the range of mid-30s, whereas the mean score for information 
sufficiency threshold was mostly around mid-60s. In contrast, data gathered in this 
project have presented some oddity. The mean score for current knowledge in the 
national sample (M = 26.27, SD = 28.95) was much lower than that from the LLS 
sample (M = 50.68, SD = 30.92), while responses to information sufficiency threshold 
fared similarly in the national sample (M = 85.35, SD = 21.89) and in the LLS sample 
(M = 84.28, SD = 18.59). In addition, a large proportion of the respondents in the 
national sample marked zero for current knowledge and 100 for information 
sufficiency threshold. Even responses from the LLS sample have mainly concentrated 
at 100 for information sufficiency threshold. Therefore, data distributions were heavily 
skewed for these two variables. Remedies such as data transformation were performed 
before these variables were used in inferential statistical analyses, but they failed to 
generate significant results after all.  
From a conceptual front end, information insufficiency might have failed to 
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fulfill its role as the key motive for information seeking and processing due to the 
RISP model’s lack of a mechanism that allows for adequate contextualization across 
different research settings. As Griffin et al. (2008) mentioned, the RISP model is a 
work in progress, which is to say that as compared to a formalized theory, it is a 
theoretical framework that is falsifiable and adjustable. This dissertation has adopted 
the measurement strategy that all previous published studies of the RISP model have 
used. Data collection, which included careful design and pre-test of the questionnaire, 
professional sampling, and scrupulous conduct of the survey instrument, was a 
scrutinized process. All of these efforts should have ensured that measurement error 
would not have impacted the results to any greater extent than it would have in past 
studies. Thus, the proposed adjustment to the RISP model seems necessary to allow 
for greater applicability of the model to different research contexts. In particular, the 
current research context for this dissertation, which involves health decision making 
related to clinical trial enrollment, determines that the uncertainty embedded in the 
risk issue here involves more than “a lack of knowledge” (Mieg, 2001). In other 
words, risks and uncertainties involved in clinical trials might be better accounted for 
or addressed as an emotional issue or a relational concern. 
In particular, MacKenzie (1998) argues that one’s viewpoint influences the 
amount of uncertainty that he or she perceives. Users, for example, of a given 
technology, tend to perceive the least amount of uncertainty, whereas developers of an 
alternative technology that addresses similar problems tend to perceive the highest 
degree of uncertainty. The developers or proponents of the original technology usually 
fall in the middle of what MacKenzie calls the “uncertainty trough.” Applying this 
argument to the current problem, it is likely that respondents from the national sample 
and the LLS sample might position themselves at different parts of this trough. LLS 
respondents, especially cancer patients, are either already or likely future participants 
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of clinical trials. As compared to prospective healthy volunteers, they may have less 
uncertainty and, therefore, might not view the cognitive need for information 
sufficiency as the most urgent reason to engage in communication activities related to 
clinical trials.  
On a related note, as a self-selected group of LLS members, their shared 
identity as cancer patients or caregivers might also have driven them to certain 
response patterns to the questionnaire. For instance, the desire to maintain hope, the 
proclaimed high trust in physicians, and the expression of positive attitudes toward 
clinical research might all have been rather unique to this particular group. Based on 
this speculation, another possible pathway for theory development is to specify a 
clearer scope condition for the RISP model. In particular, when it is reasonable to 
assume a common identity for the targeted audience, the RISP model might not 
function as well to depict within-audience variation in risk-related information seeking 
and processing. This conjecture may ignite future empirical exploration. 
Nonetheless, comparing to past studies based on the RISP model, which have 
examined communication issues related to fish consumption, drinking water quality, 
global warming, urban flooding, and renewable energy, for a distant topic like clinical 
trial enrollment, using raw score estimates to assess current knowledge and 
information sufficiency might not have been the most ideal measurement strategy, 
especially in the national sample. Raw score estimates have traditionally been used to 
assess information insufficiency because research into meta-cognition has indicated 
that individuals can “evaluate and monitor their own cognitive processes and memory” 
(Griffin, Neuwirth et al., 2004, p. 36). However, when collecting data through a 
telephone survey with specific time constraint for each question, this strategy might 
not have allowed respondents to fully contemplate on what they already know and 
how much more they would need to know about a particular issue. Future research, 
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depending on the method for data collection, might need to consider alternative 
strategies to measure this construct.  
Based on the sufficiency principle, information insufficiency primarily deals 
with a mental calculation related to judgment confidence. Related to motivations for 
communication behaviors, it describes the sense of uncertainty that individuals 
experience before engaging in information seeking and processing. Looking beyond 
survey instrument, therefore, a controlled experiment might offer a more precise 
assessment for this concept. For instance, one possible design is to develop a type of 
knowledge-based test or “quiz” that manipulates how much subjects believe they 
know about clinical trials and then tests the impact of this manipulation on their 
subsequent information seeking and processing. Specifically, research subjects could 
be randomly assigned to one of three conditions: confidence reducing, confidence 
boosting and the control group. After taking the knowledge test, researchers will 
inform them of an arbitrary score, perhaps even offering a comparison to an average 
score of some sort. This evaluation is expected to either reduce or boost their 
confidence in their current knowledge level. They will then have an option to end their 
participation without requesting more information about clinical trials or taking a 
tutorial about this topic on a computer. Besides time spent on getting more 
information, the number of pre-embedded links that they click could also be tracked to 
measure their engagement in information seeking and processing. Following the key 
assumption of the RISP model, participants in the “confidence reducing” condition are 
expected to score higher on the dependent measures than those in the “confidence 
boosting” condition. 
Besides a more stringent measure for information insufficiency, another 
important task to further improve the RISP model involves the relevant channel belief 
component, which has always been the weakest predictor in the model. Given the 
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current research context, Chapter 4 and Chapter 5 tested using trust in doctors as a 
proxy measure for individuals’ beliefs about the most important information channel 
where they could obtain information about clinical trial enrollment. In contrast, 
informed by Kahlor’s augmented risk information seeking model, Chapter 3 included 
general attitudes toward clinical trial participation to assess its influence on routine 
and non-routine information seeking. Both strategies have limitations given their 
assumptions about where information about clinical trial enrollment is generally 
located. Using attitudes toward clinical trial participation, rather than attitudes toward 
information seeking activities, was even further removed from the conceptual meaning 
of this component. Reflecting on the cost-benefit analysis approach adopted in past 
research, further investigation is necessary to determine whether it is sufficient to 
measure individuals’ beliefs about the usefulness and accessibility of the information 
from specific channels, or if relational aspect such as trustworthiness is indeed worthy 
of consideration. As Case (2002) argued, information seeking is a fundamental human 
behavior that should not be constrained or even linked to specific sources or channels. 
However, if we wish to assess how specific sources or channels in turn influence 
information seeking, or how beliefs associated with these sources and channels 
influence information seeking, it will be meaningful to search for an appropriate 
pathway without limiting our research scope too much. 
Similar to relevant channel beliefs, perceived information gathering capacity is 
another RISP component that deserves more attention in the next stage of my research. 
Given the limited space in the questionnaires, this construct did not get an adequate 
assessment in this dissertation. However, as an important part of the RISP model, it 
was developed based on the idea of capacity from dual-processing theories, as well as 
the notion of self-efficacy from the TPB. Thus, a clearer conceptualization and 
assessment for this construct are necessary in future studies. In this dissertation, this 
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component was included as part of the analysis in Chapter 5, but it failed to show any 
significant impact on cancer patients’ attitudes and behavioral intentions related to 
clinical trial enrollment. Since the capacity required for communication behaviors 
related to clinical trial enrollment could be complex and difficult to measure, this 
concept was purposefully left out from most other parts of this dissertation. Future 
research, however, needs to investigate not only its direct impact on health-related 
information seeking and processing, but also test possible interactions between 
gathering capacity and relevant channel beliefs in moderating the effect of information 
(in)sufficiency. As Griffin et al. (2005) pointed out, when an individual weighs the 
likelihood that a channel could deliver useful information versus the amount of effort 
he or she would need to invest, channel beliefs and capacity are very likely to work 
together to determine subsequent communication behaviors. 
Tracing back to the main purpose of the current dissertation, which is to 
facilitate informed health decision making through the improvement of 
communications, another important issue with broader societal impact is to identify 
the boundary for informed decision making related to clinical trial enrollment. That is 
to say, when we focus on encouraging individuals to make informed, uncoerced 
choices to participate in a clinical trial, are we appealing to personal responsibility to 
an excessive degree or even forcing the decisions onto individual patients? For those 
who feel perfectly comfortable to rely on their physicians to make a decision for them, 
what would qualify a third party to decide whether the decision would work to their 
benefit? In other words, are informed, autonomous health decisions always the best 
decisions? The present dissertation does not offer answers to this paradox, as it was 
operationalized under the assumption that an ethical conduct for clinical trial 
enrollment has to be based on the free will of the participant. Nonetheless, future 
research should address these issues. As Guttman and Ressler (2001) pointed out, 
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communication campaigns that promote personal responsibility should recognize the 
conflicting demands they elicit. When we emphasize the importance of independent 
decision making, we should also acknowledge that expertise and experience are 
essential to good decisions sometimes, especially for health-related decisions. Thus, it 
is not feasible to anticipate that all the patients will make the decision for clinical trial 
enrollment on their own, no matter how equipped with information they are or how 
willing they are to do so.  
To continue this research effort, future studies should also address several 
limitations reflected in this dissertation. For instance, additional measures are 
necessary for those RISP components assessed with a single item, such as positive 
affective responses and informational subjective norms. Besides risk judgment, other 
dimensions of the perceived hazard characteristics component, such as causal 
attributions and institutional trust, might suit other research contexts more to represent 
this construct. The routine and non-routine information seeking activities examined in 
Chapter 3 were subjected to an arbitrary categorization. In our current media 
environment, it is perhaps debatable that newspaper, radio, and television are more 
probable environment for casual information exposure as compared to online sources. 
This is especially true for health-related information that is widely available through 
health organizations and online patient advocacy groups. In fact, typing in “clinical 
trial” in Google search generates about 9,990,000 results. Thus, in addition to studying 
individuals’ motivation for information seeking, it is conceivably a more critical issue 
to investigate how to promote greater systematic processing of health and risk 
information that is readily available. On a related note, given the varying degrees of 
impact from cognitive processing, affective responses and social norms on attitude 
formation and behavioral intention across the two samples, even though no 
comprehensive framework that links the RISP model and the TPB is presented in this 
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dissertation, these associations await more formal theory building in the future. 
Conclusion 
To facilitate informed decision making related to clinical trial enrollment, this 
dissertation adopts a risk communication theoretical framework, the Risk Information 
Seeking and Processing model, to identify socio-psychological factors that motivate 
communication behaviors such as information seeking and processing. In comparing 
the responses from a national sample of primarily healthy respondents and a sample of 
cancer patients and their caregivers, interesting psychological mechanisms related to 
risk perception, affective responses, trust, and normative beliefs emerged as the main 
driving force behind these communication behaviors and subsequent attitude 
formation and behavioral intentions related to clinical trial enrollment. Even though 
hundreds of studies have sought to understand the low patient accrual rates for clinical 
trial research in the United States, few have guided their investigation with established 
communication theories. This dissertation attempts to introduce the RISP model to this 
context of health decision making, which also represents my conviction that various 
disciplines of communication research should inform and advance each other.  
Along with the theoretical pursuit to test and refine the RISP model, this 
dissertation also generates important practical and ethical implications to improve the 
communications of clinical trial enrollment. To be most effective, the dissemination of 
information related to clinical trial research needs to go along with mechanisms that 
monitor current and prospective participants’ emotional reactions to the conduct of 
patient accrual. Working to create a social environment that recognizes the value of 
clinical trial studies in advancing scientific knowledge will also benefit medical 
researchers and ordinary citizens in the long run. 
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APPENDICES 
Appendix 1. IRB Approval Application (approved on June 12, 2007) 
INITIAL APPROVAL REQUEST 
for Social and Behavioral Studies Involving Human Participants 
 
CORNELL UNIVERSITY  
Institutional Review Board 
 
Click in shaded fields to enter information 
SECTIO I 
Name of Investigator: Dr. Katherine A. McComas 
 Email address kam19@cornell.edu 
 Campus address 313 Kennedy Hall 
 School & Department CALS & Communication 
 Administrative Mgr. Ann Bianchi 
 Status:  Faculty  Ph.D. candidate  
   Post-doc  Staff 
Title of Project:  Improving methods for patient accrual to clinical trials 
Other Members of Research  
     Teams (include students): 
  
 Zheng Yang (PhD student) Communication, Cornell  
 Ithaca 
Have all investigators and other researchers working on this project successfully passed the 
IRB, the NIH, or another university’s human participant’s training online?       Yes      
No    If not, you need to inform them that Cornell must have written documentation of training 
in human participant protection. 
Start Date of Project (initial contact with subjects): August 1, 2007 Estimated End Date of 
Project: July 31, 2008 
 
1. Is this research funded by an external (non-Cornell) sponsor(s)?      Yes      No      
Pending approval 
 If Yes (or Pending), what is the name of the sponsor(s)? Leukemia and Lymphoma 
Society 
 If you know the project’s SPS #(s), please provide:       
 If you are awaiting funding to develop instruments and/or consent forms, etc., please 
check here:  (Draft instruments are included with this application. Final instruments 
will be submitted before initiation of contact with potential participants.) 
 If this is a new proposal, please submit a copy of the proposal. 
 
2. Is this research being conducted for a course?      Yes      No 
For IRB Use Only 
 
IRB ID# 07-06-025______ 
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  If Yes, name of course:       
  Name of instructor:       
 
3. Is this research being conducted for your thesis or dissertation?      Yes     No 
  If Yes, attach a copy of your thesis or dissertation proposal. 
 
4. REQUIRED: Provide in layman’s terms a brief summary description of the hypotheses or 
goals (if applicable). Limit to one paragraph. 
Low patient accrual in clinical trials poses a serious concern for the advancement of 
medical science in the United States. This research will apply the model of Risk 
Information Seeking and Processing (RISP) and the Theory of Planned Behavior to 
examine factors that influence people’s communication behaviors related to information 
seeking and processing about clinical trials and subsequent behavioral intentions. We 
aim for this study to lay the groundwork for a multi-year research program that seeks to 
investigate pathways to decision making about clinical trial enrollment. The overall aim 
of the project is to investigate factors underlying low enrollment in clinical trials in an 
effort to provide data-supported recommendations for the accrual of patients in clinical 
trials. 
 
5. Describe the design of your research and planned use of human participants. Be sure to 
include the specific location at which any interaction with human participants will take 
place. (Please limit to a maximum of one page.)  
We will conduct a random telephone survey of samples (500 adults per sample) from 
two populations: (a) the Leukemia and Lymphoma Society (LLS) and (b) the U.S. 
Having the two samples will allow us to compare the communication behaviors of LLS 
members to the general population. To collect the data, we will contract with Cornell’s 
Survey Research Institute (SRI). All contact will occur via telephone, with the 
interviewer being at SRI and the respondent being contacted and interviewed at their 
home number. Interviews will average 25 minutes.  
 
6. Will you ship any biological or diagnostic samples/specimens as part of this research?     
 Yes     No 
If Yes, please contact the Biological Safety Officer at Environmental Health & Safety (4-
4888 or fac2@cornell.edu) for specific shipping requirements. 
 
7. Outline possible benefits the proposed study may provide to an individual participant, 
social group, or society. If there are no direct benefits to the participants as individuals, 
please state this explicitly here. 
There are no direct benefits to the participants as individuals. The benefits to this study 
will occur primarily at the societal level through the development of an enhanced 
understanding of the factors that underlie individual intentions to seek information about 
clinical trials. We hope that this data will form the first step in developing evidence-
based recommendations for enhanced (and ethical) patient accrual in clinical trials. 
 
8. Please outline possible risks to participants in your study, including special or select types 
of participants. 
We believe there are no risks to participants beyond what would be expected in 
everyday life. 
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9. Please describe the steps you have taken to minimize risk to participants. 
Standard methods to protect privacy will be maintained. The identities of participants 
will not be associated with their responses. Data will be securely stored in the Principal 
Investigator’s office on the Principal Investigator’s computers, several hard disks, and 
audiotapes. Hard copies of data will remain in the possession of the researchers in the 
Principal Investigator’s office. All data will be destroyed (i.e., shredded or erased) when 
their use is no longer needed but not before a minimum of five years after data 
collection. 
 
10. Does this study involve secondary data analysis or restricted/limited data (includes 
HIPAA)?      Yes      No  
If Yes, provide a brief description in the field below of each dataset and indicate from 
which databank(s) or source(s) the data will be (has been) obtained. For each dataset, 
please include the following information: 
a. Can the names or identities of participants in the dataset be deduced from the data 
fields?   
b. Is the dataset public-use (no restrictions on use) OR is the dataset restricted or limited 
access?    
If restricted or limited access, attach a copy of the licensing agreement you signed 
with the distributor, as well as a copy of your data security plan. 
c. Are you planning to merge geographic, company, census, community or other 
potentially identifying data into an individual-level dataset during the course of this 
project?        Yes   No  
If yes, attach a description of how you plan to protect the data from unauthorized use. 
d. Will anyone other than you have access to any restricted or limited access dataset(s)?       
 Yes    No 
If yes, provide their names, and ensure that they have completed the required 
education in the use of human participants. Submit copies of affidavits, non-
disclosure agreements, or similar documents they were required to sign with the 
distributor. 
      
 
If your study involves secondary data analyses only, please skip to Section II, question 18. 
For all other studies, please fill out the remaining questions. 
 
SECTION II 
 
Please answer the remaining questions thoroughly and completely. 
 
1. How many participants do you plan to recruit for the entire study?  1,000 
 
2. What is the expected age range of participants?  18 to 99 years [Note: this must match all 
attached documents submitted.] 
 
3. Will your participant sample include Cornell University students?      Yes      No 
If Yes, answer a. – c. below: 
a. do you plan to recruit participants from classes that you personally teach?      Yes     
 No 
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If Yes, provide a justification for the collection of data from your own students in #8 
below.  
b. will participants be obtained from the Psychology Dept. SUSAN website?      Yes     
 No 
 c. will participants be obtained from the University Registrar?      Yes      No  
 
4. Please estimate:  Proportion of female participants 50%        Proportion of minority 
participants (U.S. only) 20% 
 
5. Explain how you plan to recruit your participants. Specify the exact wording of requests, 
notices, or advertisements recruiting subjects. Attach draft advertisements, flyers, letters, 
or descriptions posted on SUSAN. (Please also indicate the specific locations where 
participants will be recruited.) 
National sample: We will use random digit dialing to complete telephone interviews 
with 500 adults residing within the United States. The sample selection procedures will 
ensure that every telephone household within the United States has an equal chance to 
be included in the survey, and that once the household is sampled, every adult will have 
an equal chance to be included in the poll. We are still preparing the exact wording of 
requests to participate but will send a copy to IRB prior to any contact with potential 
participants.   
 
LLS sample: The LLS will provide us with a list of members and their telephone 
numbers who have consented to be contacted for the survey. From this list, we will use 
random selection of names to complete interviews with 500 adult members. Even 
though members may have consented to be contacted, we will assure them that they still 
have the right to decline to particpiate in the interview. Members of the LLS will 
include both individuals with cancer, as well as individuals without cancer (e.g., 
caregivers, family members, health care workers). We do not plan to target more (i.e., 
oversample) from one group or another at this time. If this changes, we will notify the 
IRB prior to any change in recruitment. Finally, as with the national sample, we are still 
preparing the exact wording of requests to participate but will send a copy to IRB prior 
to any contact with potential participants. 
 
6. Will participants be compensated for their time?      Yes      No 
If Yes, please describe the compensation. 
      
 
7. Do you plan to use email or the Internet to recruit your participants?      Yes      No 
If Yes, you should be aware that email and Internet transmission are neither private nor 
secure. Please include a sentence in your consent document that alerts participants that 
there is a chance their answers could be read by a third party. 
 
8. Check which category(ies) of participants will be included in your study. For all 
categories other than the first (mentally competent adults), additional safeguards are 
required to protect these populations from undue influence/coercion in the recruitment 
process, risk during the study, etc. Explain the additional safeguards to be provided. 
 
 Only mentally competent adults or secondary analyses of existing data 
 Children under 18: Active, written parental consent is a federal requirement, unless 
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waived by IRB after review. It is generally expected that you also obtain the written 
assent of minors 7 years of age and older. Attach copies of parental consent form (and 
minor’s assent form when applicable). 
      
 Employees of the investigating group: Please justify the use of this group, and explain 
how undue coercion in the recruitment process will be avoided. 
      
  Students enrolled in your own classes: Please justify the use of this group. Federal 
regulations discourage the use of students enrolled in classes taught by principal 
investigators. 
      
 Cognitively-impaired persons: How will you screen potentially cognitively-impaired 
subjects to determine when proxy consent is required? Attach copy of proxy consent 
form, and subject assent form (if appropriate). 
      
 Pregnant or nursing women 
      
 Prisoners or juveniles under detention or on probation 
      
 People in foreign countries: Please describe how you are collaborating with the local 
communities, government, or other institutions (as relevant to your project), and 
include documentation as appropriate. 
      
 Other potentially vulnerable participants: Who, and why? 
      
 
9. Check additional sources of data that will be used in your study. 
 None 
 Census/public records 
 Discarded human materials 
 Medical records 
 Registries (e.g. cancer registry) Name of registry:       
 Blood, urine, or tissue samples 
  Other (explain)       
 
10. Duration of participant’s participation, through each component of the study, and in total. 
Please provide full information for each component of the study. 
All telephone interviews will be conducted using a Computer Assisted Telephone 
Interviewing (CATI) software system, with the average interview length of around 25 
minutes. 
 
11. Check any/all of the following procedures that apply to your study. For each procedure 
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checked, 1) explain the procedure in detail, and 2) provide the ethical and scientific 
justification for employing the procedure. 
 Deception (When and how will the participants be debriefed? Generally, the nature of 
the deception and its necessity should be explained to the participants. Attach a copy 
of your debriefing form/script.) 
      
 Punishment:       
 Use of drugs:       
 Covert observation:       
 Induction of mental and/or physical stress:       
 Procedures that risk physical harm to the subject:       
 Materials commonly regarded as socially unacceptable:       
 Procedures that might be regarded as an invasion of privacy:       
 
12.  Is confidentiality promised to the participants?      Yes      No   If No, please explain.  
      
a. If confidentiality is promised, will access to names be under your exclusive control?     
  Yes     No 
 If No, who else will have access to the names, and what will be done to protect the 
confidentiality of the subjects?  Because we will contract with Cornell’s Survey 
Research Institute (SRI) for data collection, people working at SRI will have access 
to the names while conducting interviews and entering data. The SRI will follow 
appropriate IRB procedures to ensure that the data are securely stored. 
b. Where will the names be recorded (e.g., on test protocols, on a separate list with code 
numbers, in a computer file, etc.)?  Names of participants will be recorded in the 
aggregate data file sent to the Principal Investigator.  
c. For what purpose(s) will names be recorded?  For record-keeping purposes only. 
Names will never be associated with responses.  
d. If confidentiality is promised, what additional steps are you taking to keep their data 
secure?  Cornell’s SRI is a professional research agency, and they will ensure the 
data are securely stored. The Principal Investigator and other member of the research 
team will have access to the names of the respondents in the aggregate data file, but 
names will never be associated with responses. In addition, all data will be de-
identified prior to their being shared with anyone other than the PI or Zheng Yang.  
e. Will names of participants be included in any publication based on this study?      
Yes      No 
 If Yes, for what reason(s)?        
 
13.  Will any data be gathered through photographic, video or sound-recording devices?      
Yes      No 
If yes, answer a.-d. below, and be sure to include all this information on your consent 
form(s) as well as provide a separate signature line for the participants to agree to be 
video/audio taped and/or photographed. 
a. What types of recording devices will be used and what will be recorded?       
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b. Please provide scientific justification for gathering data using the device(s) 
enumerated above.       
c. What will be done with the still photos, video or audio recordings after the study has 
concluded? (I.e., used in publications, presentations, etc.)       
d. When, if ever, do you plan to destroy these records (specify when for each type)? 
      
e. How will you protect the confidentiality of the materials produced by such devices (if 
so promised)? (Remember that faces alone reveal identity, even if captions with 
names are not provided.) 
      
 
14. Sometimes research findings are presented in a manner that permits 
knowledgeable readers to infer the identity of a person used as a participant, even 
if names are omitted. Do you expect to present findings that may possibly provide 
such clues?      Yes      No      Confidentiality not promised 
If Yes, explain how you will protect the identity of participant, or alternatively how you 
will explain to them that their confidentiality cannot be absolutely protected. This 
information should also be conveyed to participants on the study consent form.  
      
 
15. Will information be obtained pertaining to persons other than immediate participants (e.g., 
their friends)? 
  Yes      No 
If Yes, how will the confidentiality of such persons be protected? If their confidentiality 
is not promised, please explain here. 
Information pertaining to persons other than immediate participants will be obtained 
with no identification to any particular individual. Only questions regarding general 
behavior tendencies or patterns will be asked. For example, respondents will be asked if 
they are aware of any people they know who have participated in clinical trials, but we 
will not ask respondents to identify those people by name. 
 
16. Do you intend to obtain written consent?      Yes      No 
If Yes, refer to Required Components of Informed Consent Documents on the IRB 
website attach a copy of the consent form. If collecting data from minors you must 
address both parental consent and the child’s assent. 
If No, please answer questions a – c below. 
a. Why do you not intend to use such forms? This must be a strong argument (i.e., 
scientific validity). 
Oral consent will be requested at the beginning of telephone interviews.  A 
respondent’s actual participation in the interview will indicate that they fully 
understand the purpose of the research and consent to participate. 
b. In what manner and to what extent will you give potential participants advance 
information about the study procedures? If using a contact letter, please attach it. 
Study procedures will be explained at the beginning of the telephone survey. 
c. In what manner will potential participants be advised that their participation and 
continuation in the project is entirely voluntary? Please provide a copy of the text to 
be used. 
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Potential participants will be advised that their participation and continuation in the 
project is entirely voluntary at the beginning of the telephone survey. They have every 
right to refuse to participate or to discontinue the interview at any time during the 
process. 
 
17. If proposing to use oral consent (e.g., telephone survey, illiterate subjects), provide a copy 
(script) of the text that you will use. 
This text is currently being prepared. I will send IRB a copy for approval prior to any 
contact with potential participants. 
 
18. Has this study been reviewed (or will it be reviewed) by another institution’s Institutional 
Review Board (IRB) or another ethical review body (including Cornell Medical)?     
 Yes      No 
If already reviewed, attach a copy of the approval/deferral notification you received 
from that IRB. If this study will be submitted to another IRB, please indicate below the 
institution and give the approximate date for the review. 
      
 
 
Financial Conflict of Interest Disclosure (non-student investigators 
only) 
 
In order to fulfill the requirements of federal regulations, investigators conducting 
research involving human participants at Cornell must disclose known significant 
financial interests that would reasonably appear to be affected by the research project. 
Significant financial interests include: 
• An equity interest that, when aggregated for the investigator and the 
investigator’s spouse and dependent children exceeds $10,000 in value, or represents 
more than 5% ownership interest in a single entity 
• Salary, royalties, or other payments that, when aggregated for the investigator 
and the investigator’s spouse and dependent children over the next twelve months are 
expected to exceed $10,000 
1. Have you and all key faculty personnel on this project completed the Annual Disclosure 
Statement? Yes     No 
2. Have you and all key personnel disclosed all significant financial interests (including 
those of spouses and dependent children) that would reasonably appear to be affected 
by this research project?  Yes      No 
3. Do any of the investigators, their spouses or dependent children, have any significant 
financial interests that would reasonably appear to be affected by this research?  
Yes      No 
4. Do any of the investigators, their spouses or dependent children, have any financial 
interest or other relationship with any company or entity that sponsors or supports this 
research?  Yes      No 
 
If you answered Yes to either #3 or #4, the Chair of IRB must receive a letter from your 
dean or director stating in summary form how any potential financial conflict of interest 
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involving this research project has been reduced, managed or eliminated. The IRB is not 
able to review this project until receipt of the dean’s/director’s letter. Please address the 
letter to: IRB Chair, 35 Thornwood Drive, Suite 500. 
 
Approximate date the IRB Chair can expect to receive the letter:       
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Appendix 2A. National Sample Questionnaire 
 
Clinical trials are studies that use volunteer patients to test new drugs, treatments, or new uses 
for approved drugs and treatments. 
1. Have you ever heard about opportunities to enroll in clinical trials?  
  <0> Never heard about opportunities 
  <1> Only a little 
  <2> Some 
  <3> Quite a bit 
  <4> A great deal 
2. To the best of your knowledge, have you ever enrolled in a clinical trial? If yes, how many times? 
If no, do you know anyone else who has? (SRI coding) 
3. If you were given an opportunity to enroll in a 
clinical trial, how likely is it that you would? 
No 
chance 
at all 
Not 
very 
likely 
Somewhat 
likely 
Very 
likely 
Unsure 
4. How likely is it that you would encourage 
someone you care about, such as a friend or 
family member, to enroll in a clinical trial? 
No 
chance 
at all 
Not 
very 
likely 
Somewhat 
likely 
Very 
likely 
Unsure 
 
5. Now, we would like you to rate how much you know about 
enrolling in clinical trials. Using a scale of zero to 100, where 
zero means that you know nothing and 100 means that you 
know all there is to know, how much do you think you know 
right now about enrolling in clinical trials? 
 
Write-in Below 
0-100 
[998=DK/999=refused] 
 
<q1> 
6. Think of that same scale again. This time, we would like you to 
estimate how much you think you would need to know in order 
to fully understand how to enroll in clinical trials, with zero 
meaning that you would need to know nothing and 100 
meaning that you would need to know all there is to know.  
Write-in Below 
0-100 
[998=DK/999=refused] 
 
<q2> 
6A.   => +1 if (q5+q6<=100)  
 
You rated your current knowledge about enrolling in clinical trials as 
<q5> and said you need to know <q6> to fully understand. Are you 
saying that you need to know <q6> more than you already do, or are 
you saying that <q6> is all you need to know? 
Need to know <q6> more = 1 
<q6> is all I need to know=2 
[998=DK/999=refused] 
 
7. Now, we would like you to rate how informed your think your 
doctor is about clinical trial enrollment. Using a scale of zero to 
100, where zero means that your doctor knows nothing and 100 
means that your doctor knows all there is to know, how much 
do you think your doctor knows right now about enrolling 
patients in clinical trials? 
Write-in Below 
0-100 
[998=DK/999=refused] 
 
 
8. Do you think that enrolling in a clinical trial could put your 
health at risk? Please use a scale from zero to 100, where zero 
means that it would have no risk whatsoever, and 100 means 
that it is certain to put your health at risk. 
 
Write-in Below 
0-100 
[998=DK/999=refused] 
9. If it were to put your health at risk, how serious do you think 
the risk would be?  Please use a scale of zero to 100, where 
zero means not serious at all and 100 means it would be as 
Write-in Below 
0-100 
[998=DK/999=refused] 
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serious as it could possibly be? 
 
10. Do you think that standard medical treatment for an illness 
could put your health at risk? Please use a scale from zero to 
100, where zero means that it would have no risk whatsoever, 
and 100 means that it is certain to put your health at risk. 
 
Write-in Below 
0-100 
[998=DK/999=refused] 
Next are some statements that people have made about how they personally deal with information about 
enrolling in clinical trials. Please tell me whether each of these statements could apply to you using the 
following scale: strongly disagree (1), disagree (2), feel neutral (3), agree (4), or strongly agree (5): 
11. People who are important to me want me to stay on top of 
information about enrolling in a clinical trial. 
1 2 3 4 5 
12. I feel comfortable talking to my doctor about enrolling in a 
clinical trial. 
1 2 3 4 5 
13. I have no problem bringing up the subject of enrolling in a 
clinical trial with my doctor. 
1 2 3 4 5 
14. If I want to, I can express my wishes to my doctor about 
enrolling in a clinical trial. 
1 2 3 4 5 
15. When the topic of enrolling in a clinical trial comes up, I’m 
likely to tune it out. 
1 2 3 4 5 
16. When I come across information about enrolling in a clinical 
trial, I focus on only a few key points. 
1 2 3 4 5 
17. I'm likely to go out of my way to get more information about 
enrolling in a clinical trial 
1 2 3 4 5 
18. After I encounter information about enrolling in a clinical trial, 
I’m likely to stop and think about it.  
1 2 3 4 5 
19. For me to understand about enrolling in a clinical trial, the 
more viewpoints I get the better.  
1 2 3 4 5 
20. When I see or hear information about enrolling in a clinical 
trial, I don’t spend much time thinking about it.  
1 2 3 4 5 
21. I read or listen to information about enrolling in a clinical trial 
even if I don’t agree with what it says.  
1 2 3 4 5 
22. There is more information on enrolling in clinical trials than I 
personally need. 
1 2 3 4 5 
23. I feel quite capable of finding the information I need about 
enrolling in a clinical trial. 
1 2 3 4 5 
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24. Much of the information about enrolling in a clinical trial is too 
technical for me to understand. 
1 2 3 4 5 
25. I trust my doctor to protect me from any harm that I might face 
from enrolling in a clinical trial. 
1 2 3 4 5 
26. My doctor keeps up to date on the most modern, current 
treatments available to protect my health. 
1 2 3 4 5 
27. My doctor does not let his or her personal beliefs bias how he 
or she makes decisions about my health. 
1 2 3 4 5 
28. If I wanted to enroll in a clinical trial, I would enroll, even if 
my doctor did not support my decision. 
1 2 3 4 5 
The next section includes statements that other people have made about what they think is important to 
consider when deciding whether to enroll in clinical trials. Thinking about your own situation, please 
tell me whether you strongly disagree (1), disagree (2), feel neutral (3), agree (4), or strongly agree (5) 
with these statements. “Enrolling in a clinical trial... 
29. Would make me feel like I am helping other people. 1 2 3 4 5 
30. Would help advance medical research. 1 2 3 4 5 
31. Would help me get better medical treatment. 1 2 3 4 5 
32. Would be personally expensive for me. 1 2 3 4 5 
33. Would cause me inconvenience. 1 2 3 4 5 
Next, consider whether you strongly disagree (1), disagree (2), feel neutral (3), agree (4), or strongly 
agree (5) with the following statements. “When I think about enrolling in a clinical trial, I believe that…  
34. Doing something good for other people would be worth the 
effort.  
1 2 3 4 5 
35. Helping to advance medical research would be worth the effort.  1 2 3 4 5 
36. My getting better medical treatment would be worth the effort.  1 2 3 4 5 
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37. It would be worth the personal expense. 1 2 3 4 5 
38. It would be worth the inconvenience. 1 2 3 4 5 
39. The possible risks to my health beyond standard medical care 
would be worth the effort.  
1 2 3 4 5 
40. I would care a lot about what my doctor thinks I should do. 1 2 3 4 5 
41. I would care a lot about what my friends, family members, and 
people who are important to me think I should do. 
1 2 3 4 5 
Now we would like to know a little bit more about your feelings toward enrolling in clinical trials. 
Please use a number from 0 to 10, where 0 means you have “none of this feeling” and 10 means you 
have “a lot of this feeling.” When you think about enrolling in a clinical trial, how [read adjective 
below] do you feel ... 
42. Optimistic 0          10 
43. Afraid  0          10 
44. Worried 0          10 
45. Anxious 0          10 
On a scale of 0 to 10, where 0 is “none” and 10 is “a lot”, how much attention would you pay to 
information about enrolling in clinical trials from ... 
46. Family members 0          10 
47. Friends and co-workers 0          10 
48. Physicians and medical 
experts 
0          10 
49. Patient advocacy 
organizations 
0          10 
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50. Pharmaceutical 
companies 
0          10 
51. Local newspapers 0          10 
52. Local radio or television 
stations 
0          10 
53. Health magazines and 
newsletters 
0          10 
54. Health-related websites  0          10 
55. Internet support groups 0          10 
Now just a few more questions related to health: 
56. Have you ever been diagnosed with a chronic or acute illness? 
 
No (0) 
Yes (1) 
 
If Yes, are you:  
Currently in treatment (1) 
Diagnosed but not in treatment (2) 
The illness is currently under control or in remission (3) 
998=DK/999=refused 
57. In the last 12 months, how many days have you seen a doctor or visited a medical clinic for any 
reason, including check-ups or visits to the emergency room or hospital outpatient department?  
(Range from 0 to 365 days) 
58. What year were you born? 
59. What is the last grade that you completed in school? (SRI Coding) 
60. What best describes your race? (SRI Coding) 
61. Household income (SRI Coding) 
62. Gender   (Do not read out loud) 
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Appendix 2B. LLS Sample Questionnaire 
 
Clinical trials are studies that use volunteer patients to test new drugs, treatments, or new uses 
for approved drugs and treatments. 
1. Have you ever heard about opportunities to enroll in clinical trials?  
  <0> Never heard about opportunities 
  <1> Only a little 
  <2> Some 
  <3> Quite a bit 
  <4> A great deal 
2. To the best of your knowledge, have you ever enrolled in a clinical trial? If yes, how many times? If 
no, do you know anyone else who has? (SRI coding) 
3. If you were given an opportunity to enroll in a 
clinical trial, how likely is it that you would? 
No 
chance 
at all 
Not 
very 
likely 
Somewhat 
likely 
Very 
likely 
Unsure 
4. How likely is it that you would encourage someone 
you care about, such as a friend or family 
member, to enroll in a clinical trial? 
No 
chance 
at all 
Not 
very 
likely 
Somewhat 
likely 
Very 
likely 
Unsure 
 
5. Now, we would like you to rate how much you know about 
enrolling in clinical trials. Using a scale of zero to 100, where 
zero means that you know nothing and 100 means that you 
know all there is to know, how much do you think you know 
right now about enrolling in clinical trials? 
 
Write-in Below 
0-100 
[998=DK/999=refused] 
 
<q1> 
6. Think of that same scale again. This time, we would like you to 
estimate how much you think you would need to know in order 
to fully understand how to enroll in clinical trials, with zero 
meaning that you would need to know nothing and 100 meaning 
that you would need to know all there is to know.  
Write-in Below 
0-100 
[998=DK/999=refused] 
 
<q2> 
6A.   => +1 if (q5+q6<=100)  
 
You rated your current knowledge about enrolling in clinical trials as 
<q5> and said you need to know <q6> to fully understand. Are you 
saying that you need to know <q6> more than you already do, or are 
you saying that <q6> is all you need to know? 
Need to know <q6> more = 1 
<q6> is all I need to know=2 
[998=DK/999=refused] 
 
7. Now, we would like you to rate how informed your think your 
doctor is about clinical trial enrollment. Using a scale of zero to 
100, where zero means that your doctor knows nothing and 100 
means that your doctor knows all there is to know, how much 
do you think your doctor knows right now about enrolling 
patients in clinical trials? 
Write-in Below 
0-100 
[998=DK/999=refused] 
 
 
8. Do you think that enrolling in a clinical trial could put your health 
at risk? Please use a scale from zero to 100, where zero means 
that it would have no risk whatsoever, and 100 means that it is 
certain to put your health at risk. 
 
Write-in Below 
0-100 
[998=DK/999=refused] 
9. If it were to put your health at risk, how serious do you think the 
risk would be?  Please use a scale of zero to 100, where zero 
means not serious at all and 100 means it would be as serious as 
it could possibly be? 
 
Write-in Below 
0-100 
[998=DK/999=refused] 
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10. Do you think that standard medical treatment for an illness could 
put your health at risk? Please use a scale from zero to 100, 
where zero means that it would have no risk whatsoever, and 
100 means that it is certain to put your health at risk. 
 
Write-in Below 
0-100 
[998=DK/999=refused] 
Next are some statements that people have made about how they personally deal with information about 
enrolling in clinical trials. Please tell me whether each of these statements could apply to you using the 
following scale: strongly disagree (1), disagree (2), feel neutral (3), agree (4), or strongly agree (5): 
11. People who are important to me want me to stay on top of 
information about enrolling in a clinical trial. 
1 2 3 4 5 
12. I feel comfortable talking to my doctor about enrolling in a 
clinical trial. 
1 2 3 4 5 
13. I have no problem bringing up the subject of enrolling in a 
clinical trial with my doctor. 
1 2 3 4 5 
14. If I want to, I can express my wishes to my doctor about 
enrolling in a clinical trial. 
1 2 3 4 5 
15. When the topic of enrolling in a clinical trial comes up, I’m 
likely to tune it out. 
1 2 3 4 5 
16. When I come across information about enrolling in a clinical 
trial, I focus on only a few key points. 
1 2 3 4 5 
17. I'm likely to go out of my way to get more information about 
enrolling in a clinical trial 
1 2 3 4 5 
18. After I encounter information about enrolling in a clinical trial, 
I’m likely to stop and think about it.  
1 2 3 4 5 
19. For me to understand about enrolling in a clinical trial, the more 
viewpoints I get the better.  
1 2 3 4 5 
20. When I see or hear information about enrolling in a clinical trial, 
I don’t spend much time thinking about it.  
1 2 3 4 5 
21. I read or listen to information about enrolling in a clinical trial 
even if I don’t agree with what it says.  
1 2 3 4 5 
22. There is more information on enrolling in clinical trials than I 
personally need. 
1 2 3 4 5 
23. I feel quite capable of finding the information I need about 
enrolling in a clinical trial. 
1 2 3 4 5 
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24. Much of the information about enrolling in a clinical trial is too 
technical for me to understand. 
1 2 3 4 5 
25. I trust my doctor to protect me from any harm that I might face 
from enrolling in a clinical trial. 
1 2 3 4 5 
26. My doctor keeps up to date on the most modern, current 
treatments available to protect my health. 
1 2 3 4 5 
27. My doctor does not let his or her personal beliefs bias how he or 
she makes decisions about my health. 
1 2 3 4 5 
28. If I wanted to enroll in a clinical trial, I would enroll, even if my 
doctor did not support my decision. 
1 2 3 4 5 
The next section includes statements that other people have made about what they think is important to 
consider when deciding whether to enroll in clinical trials. Thinking about your own situation, please 
tell me whether you strongly disagree (1), disagree (2), feel neutral (3), agree (4), or strongly agree (5) 
with these statements. “Enrolling in a clinical trial... 
29. Would make me feel like I am helping other people. 1 2 3 4 5 
30. Would help advance medical research. 1 2 3 4 5 
31. Would help me get better medical treatment. 1 2 3 4 5 
32. Would be personally expensive for me. 1 2 3 4 5 
33. Would cause me inconvenience. 1 2 3 4 5 
Next, consider whether you strongly disagree (1), disagree (2), feel neutral (3), agree (4), or strongly 
agree (5) with the following statements. “When I think about enrolling in a clinical trial, I believe that…  
34. Doing something good for other people would be worth the 
effort.  
1 2 3 4 5 
35. Helping to advance medical research would be worth the effort.  1 2 3 4 5 
36. My getting better medical treatment would be worth the effort.  1 2 3 4 5 
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37. It would be worth the personal expense. 1 2 3 4 5 
38. It would be worth the inconvenience. 1 2 3 4 5 
39. The possible risks to my health beyond standard medical care 
would be worth the effort.  
1 2 3 4 5 
40. I would care a lot about what my doctor thought I should do. 1 2 3 4 5 
41. I would care a lot about what my friends, family members, and 
people who are important to me thought I should do. 
1 2 3 4 5 
Next, consider how you feel about someone you care about, such as a family member or friend. Using 
the same scale from above, please say whether you strongly disagree (1), disagree (2), feel neutral (3), 
agree (4), or strongly agree (5) with the following statements. “When it comes to someone you care 
about enrolling in clinical trials…  
42. Doing something good for other people would be worth the 
effort for them.  
1 2 3 4 5 
43. Helping to advance medical research would be worth the effort 
for them.  
1 2 3 4 5 
44. Getting better medical treatment would be worth the effort for 
them.  
1 2 3 4 5 
45. It would be worth the personal expense for them. 1 2 3 4 5 
46. It would be worth the inconvenience for them. 1 2 3 4 5 
47. The possible health risks beyond standard medical care would be 
worth the effort for them. 
1 2 3 4 5 
Now we would like to know a little bit more about your feelings toward enrolling in clinical trials. 
Please use a number from 0 to 10, where 0 means you have “none of this feeling” and 10 means you 
have “a lot of this feeling.” When you think about enrolling in a clinical trial, how [read adjective 
below] do you feel ... 
48. Optimistic 0          10 
49. Afraid  0          10 
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50. Worried 0          10 
51. Anxious 0          10 
On a scale of 0 to 10, where 0 is “none” and 10 is “a lot”, how much attention would you pay to 
information about enrolling in clinical trials from ... 
52. Family members 0          10 
53. Friends and co-workers 0          10 
54. Physicians and medical 
experts 
0          10 
55. Patient advocacy 
organizations 
0          10 
56. Pharmaceutical 
companies 
0          10 
57. Local newspapers 0          10 
58. Local radio or television 
stations 
0          10 
59. Health magazines and 
newsletters 
0          10 
60. Health-related websites  0          10 
61. Internet support groups 0          10 
Now just a few more questions related to health: 
 168 
 
62. Have you yourself ever been diagnosed with a chronic or acute illness? 
 
No (0) 
Yes (1) 
 
If Yes, are you:  
Currently in treatment (1) 
Diagnosed but not in treatment (2) 
The illness is currently under control or in remission (3) 
998=DK/999=refused 
63. Has someone you care for ever been diagnosed with a chronic or acute illness? 
 
No (0) 
Yes (1) 
 
If Yes, is the person you care for:  
Currently in treatment (1) 
Diagnosed but not in treatment (2) 
The illness is currently under control or in remission (3) 
Deceased (4) 
998=DK/999=refused 
64. In the last 12 months, how many days have you seen a doctor or visited a medical clinic for any 
reason, including check-ups or visits to the emergency room or hospital outpatient department?  
 
(Range from 0 to 365 days) 
65. What year were you born? 
66. What is the last grade that you completed in school? (SRI Coding) 
67. What best describes your race? (SRI Coding) 
68. Household income (SRI Coding) 
69. Gender (Do not read out loud) 
 
 
 
 
 169 
 
REFERENCES 
Abraham, N. S., Young, J. M., & Solomon, M. J. (2006). A systematic review of 
reasons for nonentry of eligible patients into surgical randomized controlled 
trials. Surgery, 139(4), 469-483. 
Afifi, W. A., & Weiner, J. L. (2004). Toward a Theory of Motivated Information 
Management. Communication Theory, 14(2), 167-190. 
Agrawal, M., Grady, C., Fairclough, D. L., Meropol, N. J., Maynard, K., & Emanuel, 
E. J. (2006). Patients' decision-making process regarding participation in phase 
I oncology research. Journal of Clinical Oncology, 24(27), 4479-4484. 
Ajzen, I. (1988). Attitudes, personality, and behavior. Milton Keynes, UK: Open 
University Press. 
Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and 
Human Decision Processes, 50, 179-211. 
Ajzen, I. (2004). The directive influence of attitudes on behavior. In A. S. R. 
Manstead, N. Frijda & A. Fischer (Eds.), Feelings and emtions: the Amsterdam 
symposium. New York: Cambridge University Press. 
Ajzen, I., & Albarracin, D. (2007). Predicting and changing behavior: A reasoned 
action approach. In I. Ajzen, D. Albarracin & R. Hornik (Eds.), Prediction and 
change of health behavior: Applying the reasoned action approach. Mahwah, 
NJ: Lawrence Erlbaum Associates. 
Albrecht, T. L., Blanchard, C., Ruckdeschel, J. C., Coovert, M., & Strongbow, R. 
(1999). Strategic physician communication and oncology clinical trials. 
Journal of Clinical Oncology, 17(10), 3324-3332. 
Albrecht, T. L., Eggly, S. E., Gleason, M. E. J., Harper, F. W. K., Foster, T. S., 
Peterson, A. M., et al. (2008). Influence of clinical communication on patients' 
decision making on participation in clinical trials. Journal of Clinical 
Oncology, 26(16), 2666-2673. 
 170 
 
Albrecht, T. L., Ruckdeschel, J. C., Riddle, D. L., Blanchard, C. G., Penner, L. A., 
Coovert, M. D., et al. (2003). Communication and consumer decision making 
about cancer clinical trials. Patient Education and Counseling, 50(1), 39-42. 
Almeida, L., Kashdan, T. B., Nunes, T., Coelho, R., Albino-Teixeira, A., & Soares-da-
Silva, P. (2008). Why volunteers for phase I clinical trials? Influences of 
anxiety, social anxiety and depressive symptoms on self-selection and the 
reporting of adverse events. European Journal of Clinical Pharmacology, 
64(6), 575-582. 
American Cancer Society. (2008). Cancer Statistics. Atlanta, GA. 
Angell, M., & Kassirer, J. P. (1994). Clinical research: What should the public believe. 
ew England Journal of Medicine, 331, 189-190. 
Aspinwall, L. G. (1998). Rethinking the role of positive affect in self-regulations. 
Motivation and Emotion, 22(1), 1-32. 
Aspinwall, L. G., & Brunhart, S. M. (1996). Distinguishing optimism from denial: 
Optimistic beliefs predict attention to health threats. Personality and Social 
Psychology Bulletin, 22, 993-1003. 
Atkinson, N. L., Saperstein, S. L., Massett, H. A., & et al. (2008). Using the Internet to 
search for cancer clinical trials: a comparative audit of clinical trial search 
tools. Contemporary Clinical Trials, 29(4), 555-564. 
Avis, N. E., Smith, K. W., Link, C. L., Hortobagyi, G. N., & Rivera, E. (2006). 
Factors associated with participation in breast cancer treatment clinical trials. 
Journal of Clinical Oncology, 24(12), 1860-1867. 
Bandura, A. (1977). Self-efficacy: Toward a Unifying Theory of Behavioral Change. 
Psychological Review, 84(2), 191-215. 
Baquet, C. R., Commiskey, P., Mullins, C. D., & Mishra, S. I. (2006). Recruitment 
and participation in clinical trials: Socio-demographic, rural/urban, and health 
care access predictors. Cancer Detection and Prevention, 30(1), 24-33. 
Barrett, R. (2002). A nurse’s primer on recruiting participants for clinical trials. 
Oncology ursing Forum, 29(7), 1091-1098. 
 171 
 
Barry, M. J., Fowler, F. J., Jr., Mulley, A. G., Jr., Henderson, J. V., Jr., & Wennberg, 
J. E. (1995). Patient Reactions to a Program Designed to Facilitate Patient 
Participation in Treatment Decisions for Benign Prostatic Hyperplasia. 
Medical Care, 33(8), 771-782. 
Battaglia, T. A., Ash, A., Prout, M. N., & Freund, K. M. (2006). Cancer prevention 
trials and primary care physicians: Factors associated with recommending trial 
enrollment. Cancer Detection and Prevention, 30(1), 34-37. 
Beauchamp, T. L., & Childress, J. F. (1994). The meaning and justification of 
informed consent. In T. L. Beauchamp & J. F. Childress (Eds.), Principles of 
Biomedical Ethics (Fourth ed., pp. 142-153). New York: Oxford. 
Bevan, E. G., Chee, L. C., Mcghee, S. M., & Mcinnes, G. T. (1993). Patients attitudes 
to particitpation in clinical trials. British Journal of Clinical Pharmacology, 
35(2), 204-207. 
Bless, H., & Schwarz, N. (1999). Sufficient and necessary conditions in dual-process 
models. In S. Chaiken & Y. Trope (Eds.), Dual-process theories in social 
psychology (pp. 423-440). New York: The Guilford Press. 
Bollen, K. A. (1989). Structural equations with latent variables. New York: John 
Wiley. 
Brashers, D. E. (2001). Communication and uncertainty management. Journal of 
Communication, 51, 477-497. 
Brashers, D. E., Goldsmith, D. J., & Hsieh, E. (2002). Information Seeking and 
Avoiding in Health Contexts. Human Communication Research, 28(2), 258-
271. 
Brody, J. (2008). Crisis of Care on the Front Line of Health. The ew York Times, p. 
F7. 
Cacioppo, J. T., & Berntson, G. G. (1994). Relationship between attitudes and 
evaluative space: A critical review, with emphasis on the separability of 
positive and negative substrates. Psychological Bulletin, 115, 401-423. 
 172 
 
Cameron, L., Leventhal, E. A., & Leventhal, H. P. (1995). Seeking Medical Care in 
Response to Symptoms and Life Stress. Psychosomatic Medicine, 57(1), 37-
47. 
Campbell, D. T., & Fiske, D. W. (1959). Convergent and discriminant validation by 
the multitrait-multimethod matrix. Psychological Bulletin, 56(2), 81-105. 
Carmines, E. G., & Zeller, R. A. (1979). Reliability and validity assessment. Beverly 
Hills, CA: Sage. 
Case, D. O. (2002). Looking for information: A survey of research on information 
seeking, needs, and behavior. San Diego, CA: Academic Press. 
Cassileth, B. R., Zupkis, R. V., Sutton-Smith, K., & March, V. (1980). Information 
and parcitipation preferences among cancer patients. Annals of Internal 
Medicine, 92, 832-836. 
Castel, P., Negrier, S., & Boissel, J. P. (2006). Why don't cancer patients enter clinical 
trials? A review. European Journal of Cancer, 42(12), 1744-1748. 
Catania, C., De Pas, T., Goldhirsch, A., Radice, D., Adamoli, L., Medici, M., et al. 
(2008). Participation in clinical trials as viewed by the patient: Understanding 
cultural and emotional aspects which influence choice. Oncology, 74(3-4), 
177-187. 
Chaffee, S. H. (1986). Mass media and interpersonal channels: Competitive, 
convergent, or complementary? In G. Gumpert & R. Cathcart (Eds.), 
InterMedia (3rd ed., pp. 62-80). New York: Oxford University Press. 
Chaiken, S. (1980). Heuristic versus systematic information processing and the use of 
source versus message cues in persuasion. Journal of Personality and Social 
Psychology, 39, 752-766. 
Chaiken, S., Liberman, A., & Eagly, A. H. (1989). Heuristic and systematic 
information processing within and beyond the persuasion context. In J. S. 
Uleman & J. A. Bargh (Eds.), Unintended thought (pp. 212-252). New York: 
Guilford Press. 
 173 
 
Chaiken, S., & Stangor, C. (1987). Attitude and attitude change. Annual Review of 
Psychology, 38, 575-630. 
Charles, C., Gafni, A., & Whelan, T. (1999). Decision-making in the physician-patient 
encounter: revisiting the shared treatment decision-making model. Social 
Science & Medicine, 49(5), 651-661. 
Chen, S., & Chaiken, S. (1999). The heuristic-systematic model in its broader context. 
In S. Chaiken & Y. Trope (Eds.), Dual-process theories in social psychology 
(pp. 73-96). New York: Guilford. 
Clarke, A., Shim, J. K., Mamo, L., Fosket, J. R., & Fishman, J. R. (2003). 
Biomedicalization: Technoscientific transformations of health, illness, and 
U.S. biomedicine. American Sociological Review, 68(2), 161-194. 
Clore, G. L., Schwarz, N., & Conway, M. (1994). Affective causes and consequences 
of social information processing. In J. Wyer, R. S. & T. K. Srull (Eds.), 
Handbook of social cognition (2nd ed., pp. 323-417). Hillsdale, NJ: Lawrence 
Ealbaum Associates. 
Cohen, J., Cohen, P., West, S. G., & Aiken, L. S. (2003). Applied Multiple 
Regression/Correlation Analysis for the Behavioral Sciences (3rd ed.). 
Mahwah, N.J.: Erlbaum Associates. 
Cohen, L., de Moor, C., & Amato, R. (2001). The association between treatment-
specific optimism and depressive symptomatology in patients enrolled in a 
phase I cancer clinical trial. Cancer, 91, 1949-1955. 
Comis, R. L., Miller, J. D., Aldige, C. R., Krebs, L., & Stoval, E. (2003). Public 
attitudes toward participation in cancer clinical trials. Journal of Clinical 
Oncology, 21(5), 830-835. 
Cox, K. (2002). Informed consent and decision-making: patients' experiences of the 
process of recruitment to phases I and II anti-cancer drug trials. Patient 
Education and Counseling, 46(1), 31-38. 
Crosson, K., Eisner, E., Brown, C., & Maat, J. T. (2001). Primary care physicians' 
attitudes, knowledge, and practices. Journal of Cancer Education, 16(4), 188-
192. 
 174 
 
Curbow, B., Fogarty, L. A., McDonnell, K. A., Chill, J., & Scott, L. B. (2006). The 
role of physician characteristics in clinical trial acceptance: Testing pathways 
of influence. Journal of Health Communication, 11, 199-218. 
Daugherty, C., Ratain, M. J., Grochowski, E., Stocking, C., Kodish, E., Mick, R., et al. 
(1995). Perceptions of cancer patients and their physicians involved in phase-I 
trials. Journal of Clinical Oncology, 13(5), 1062-1072. 
Davis, S. W., Nealon, E. O. D., & Stone, J. (1993). Evaluation of the National Cancer 
Institute's clinical trials booklet. Journal of the ational Cancer Institute 
Monographs, 14, 139-145. 
Degner, L. F., Kristjanson, L. J., Bowman, D., Sloan, J. A., Carriere, K. C., O'Neil, J., 
et al. (1997). Information needs and decisional preferences in women with 
breast cancer. JAMA, 277(18), 1485-1492. 
Dijksterhuis, A., Bos, M. W., Nordgren, L. F., & Van Baaren, R. B. (2006). On 
making the right choice: The deliberation-without-attention effect. Science, 
311, 1005-1007. 
Eagly, A., & Chaiken, S. (1993). The psychology of attitudes. Fort Worth, TX: 
Harcourt Brace and Jovanovich. 
Ellis, P. M. (2000). Attitudes towards and participation in randomised clinical trials in 
oncology: a review of the literature. Annals of Oncology, 11(8), 939-945. 
Ellis, P. M., Butow, P. N., Tattersall, M. H. N., Dunn, S. M., & Houssami, N. (2001). 
Randomized clinical trials in oncology: Understanding and attitudes predict 
willingness to participate. Journal of Clinical Oncology, 19(15), 3554-3561. 
Epstein, S. (2003). Inclusion, diversity, and biomedical knowledge making: the 
multiple politics of representation. In N. Oudschoorn & T. Pinch (Eds.), How 
Users Matter: The Co-Construction of Users and Technology (pp. 174-190). 
Cambridge, MA: MIT Press. 
Epstein, S. (2007). Inclusion: the politics of difference in medical research. Chicago: 
The University of Chicago Press. 
 175 
 
Fallowfield, L. J., Ford, S., & Lewis, S. (1995). No news is not good news: 
Information preferences of patients with cancer. Psycho-Oncology, 4, 197-202. 
Fallowfield, L. J., Ratcliffe, D., & Souhami, R. (1997). Clinicians' attitudes to clinical 
trials of cancer therapy. European Journal of Cancer, 33(13), 2221-2229. 
Fallowfield, L. J., Jenkins, V., Brennan, C., Sawtell, M., Moynihan, C., & Souhami, 
R. L. (1998). Attitudes of patients to randomised clinical trials of cancer 
therapy. European Journal of Cancer, 34(10), 1554-1559. 
Fazio, R. H. (1986). How do attitudes guide behavior? In R. M. H. Sorrentino & E. T. 
Higgins (Eds.), Handbook of motivation and cognition: Foundations of social 
behavior (pp. 204-243). New York: Guilford. 
Finucane, M. L., & Holup, J. (2006). Risk as value: Combining affect and analysis in 
risk judgments. Journal of Risk Research, 9(2), 141-164. 
Fishbein, M. (2007). A reasoned action approach: Some issues, questions, and 
clarifications. In I. Ajzen, D. Albarracin & R. Hornik (Eds.), Prediction and 
change of health behavior: Applying the reasoned action approach. Mahwah, 
NJ: Lawrence Erlbaum Associates. 
Fredrickson, B. L. (2001). The role of positive emotions in positive psychology: The 
broaden-and-build theory of positive emotions. American Psychologist, 56, 
218-226. 
Fredrickson, B. L. (2005). Positive emotions. In C. R. Snyder & S. J. Lopez (Eds.), 
Handbook of positive psychology (pp. 120-134). New York, NY: Oxford 
University Press. 
Frijda, N. H., Kuipers, P., & ter Schure, E. (1989). Relations among emotion, 
appraisal, and emotional action readiness. Journal of Personality and Social 
Psychology, 57(2), 212-228. 
Garrity, T. F., & Lawson, E. J. (1989). Patient-physician communication as a 
determinant of medication misuse in older, minority women. Journal of Drug 
Issues, 19, 245-259. 
 176 
 
Giuliano, A. R., Mokuau, N., Hughes, C., Tortolero-Luna, G., Risendal, B., Ho, R. C. 
S., et al. (2000). Participation of minorities in cancer research: The influence of 
structural, cultural, and linguistic factors. Annals of Epidemiology, 10(8), S22-
S34. 
Gordon, E. F., & Daugherty, C. K. (2001). Referral and decision making among 
advanced cancer patients participating in phase I trials at a single institution. 
Journal of Clinical Ethics, 12, 37-38. 
Grady, C., Hampson, L. A., Wallen, G. R., Rivera-Goba, M. V., Carrington, K. L., & 
Mittleman, B. B. (2006). Exploring the ethics of clinical research in an urban 
community. American Journal of Public Health, 96(11), 1996-2001. 
Grant, C. H., Cissna, K. N., & Rosenfeld, L. B. (2000). Patients' perceptions of 
physicians communication and outcomes of the accrual to trial process. Health 
Communication, 12(1), 23-39. 
Gregory, R., & Mendelsohn, R. (1993). Perceived risk, dread, and benefits. Risk 
Analysis, 13, 259-264. 
Griffin, R. J., Yang, Z. Boerner, F., Bourassa, S. Darrah, T., Knurek, S. Ortiz, S., & 
Dunwoody, S. (2005). Applying an information seeking and processing model 
to a study of communication about energy. Paper presented at the Association 
for Education in Journalism and Mass Communication annual convention, San 
Antonio, TX. 
Griffin, R. J., Dunwoody, S., & Neuwirth, K. (1999). Proposed model of the 
relationship of information seeking and processing to the development of 
preventive behaviors. Environmental Research, 80, S230-245. 
Griffin, R. J., Neuwirth, K., Dunwoody, S., & Giese, J. (2004). Information 
sufficiency and risk communication. Media Psychology, 6, 23-61. 
Griffin, R. J., Neuwirth, K., Giese, J., & Dunwoody, S. (2002). Linking the heuristic-
systematic model and depth of processing. Communication Research, 29, 705-
732. 
Griffin, R. J., Powell, M., Dunwoody, S., Neuwirth, K., Clark, D., & Novotny, V. 
(2004). Testing the robustness of a risk information processing model. Paper 
 177 
 
presented at the Association for Education in Journalism and Mass 
Communication annual convention, Toronto, Ontario, Canada 
Griffin, R. J., Yang, Z., Huurne, E., Boerner, F., Ortiz, S., & Dunwoody, S. (2008). 
After the Flood: Anger, Attribution, and the Seeking of Information. Science 
Communication, 29(3), 285-315. 
Guttman, N., & Ressler, W. H. (2001). On being responsible: Ethical issues in appeals 
to personal responsibility in health campaigns. Journal of Health 
Communication, 6, 117-136. 
Harris, K. A. (1998). The informational needs of patients with cancer and their 
families. Cancer Practice, 6(1), 39-46. 
Harris, Y., Gorelick, P. B., Samuels, P., & Bempong, I. (1996). Why African 
Americans may not be participating in clinical trials. Journal of the ational 
Medical Association, 88(10), 630-634. 
Hilgartner, S. (1992). The social construction of risk objects: Or, how to pry open 
networks of risk. In J. F. Short & L. Clarke (Eds.), Organizations, 
Uncertainties, and Risk (pp. 39-53). Boulder, CO: Westview Press. 
Howerton, M. W., Gibbons, M. C., Baffi, C. R., Gary, T. L., Lai, G. Y., Bolen, S., et 
al. (2007). Provider roles in the recruitment of underrepresented populations to 
cancer clinical trials. Cancer, 109(3), 465-476. 
Hutchison, C., & Campbell, S. (2002). Evaluation of an information booklet for 
patients considering participation in phase I clinical trials in cancer. European 
Journal of Cancer Care, 11(2), 131-138. 
Huurne, E. F. J., Griffin, R. J., & Gutteling, J. M. (2009). Risk information seeking 
among U.S. and Dutch residents. Science Communication. 
Isen, A. M. (1987). Positive affect, cognitive processes, and social behavior. In L. 
Berkowitz (Ed.), Advances in Experimental Social Psychology (Vol. 20, pp. 
203-253). San Diego, CA: Academic Press. 
 178 
 
Isen, A. M. (1999). Positive Affect. In T. P. Dalgleish, M. J. (Ed.), Handbook of 
cognition and emotion (pp. 521-538). Chichester, England: John Wiley & 
Sons. 
Isen, A. M. (2004). Some perspectives on positive feelings and emotions: Positive 
affect facilitates thinking and problem solving. In A. S. R. Manstead, N. Frijda 
& A. Fischer (Eds.), Feelings and Emotions: The Amsterdam Symposium (pp. 
263-281). New York: Cambridge. 
Ito, T. A., & Cacioppo, J. T. (2005). Variations on a human universal: Individual 
differences in positivity offset and negativity bias. Cognition and Emotion, 
19(1), 1-26. 
James, N., Daniels, H., Rahman, R., McConkey, C., Derry, J., & Young, A. (2007). A 
study of information seeking by cancer patients and their carers. Clinical 
Oncology, 19, 356-362. 
Jenkins, V. A,, & Fallowfield, L. J. (2000). Reasons for accepting or declining to 
participate in randomized clinical trials for cancer therapy. British Journal of 
Cancer, 82(11), 1783-1788. 
Jenkins, V. A., Fallowfield, L. J., Souhami, A., & Sawtell, M. (1999). How do doctors 
explain randomised clinical trials to their patients? European Journal of 
Cancer, 35(8), 1187-1193. 
Jensen, A. B., Madsen, B., Andersen, P., & Rose, C. (1993). Information for cancer 
patients entering a clinical trial--an evaluation of an information strategy. 
European Journal of Cancer, 29(16), 2235-2238. 
Johnson, J. D. (1997). Cancer-related information seeking. Cresskill, NJ: Hampton 
Press, Inc. 
Johnson, J. D., & Meishcke, H. (1992). Differences in evaluating of communication 
channels for cancer-related information. Journal of Behavioral Medicine, 
15(5), 429-445. 
Jones, J. M., Nyhof-Young, J., Moric, J., Friedman, A., Wells, W., & Catton, P. 
(2006). Identifying motivations and barriers to patient participation in clinical 
trials. Journal of Cancer Education, 21(4), 237-242. 
 179 
 
Jöreskog, K. G., & Sörbom, D. (1996a). PRELIS 2: User's reference guide. Chicago: 
Scientific Software International. 
Jöreskog, K. G., & Sörbom, D. (1996b). LISREL 8: User's reference guide. Chicago: 
Scientific Software International. 
Kahlor, L., Dunwoody, S., & Griffin, R. J. (2002). Attributions in explanations of risk 
estimates. Public Understanding of Science, 11, 243-257. 
Kahlor, L. (2007). An augmented risk information seeking model: The case of global 
warming. Media Psychology, 10, 414-435. 
Kahlor, L., Dunwoody, S., Griffin, R. J., & Neuwirth, K. (2006). Seeking and 
processing information about impersonal risk. Science Communication 28(2), 
163-194. 
Kahlor, L., Dunwoody, S., Griffin, R. J., Neuwirth, K., & Giese, J. (2003). Studying 
heuristic-systematic processing of risk communication. Risk Analysis, 23, 355-
368. 
Kahlor, L., & Rosenthal, S. (2009). If we seek, do we learn? Predicting knowledge of 
global warming. Science Communication, 30(3), 380-414. 
Kahneman, D., Slovic, P., & Tversky, A. (1982). Judgement under uncertainty: 
Heuristics and biases. New York: Cambridge University Press. 
Katz, E., Blumler, J. G., & Gurevitch, M. (1974). Utilization of mass communication 
by the individual. In J. G. Blumler & E. Katz (Eds.), The uses of mass 
communication: Current perspectives on gratifications research (pp. 19-32). 
Beverly Hills, CA: Sage. 
Kline, R. B. (2005). Principles and practice of structural equation modeling (2nd ed.). 
New York: Guilford Press. 
Kodish, E., Eder, M., Noll, R. B., Ruccione, K., Lange, B., Angiolillo, A., et al. 
(2004). Communication of randomization in childhood leukemia trials. JAMA, 
291(4), 470-475. 
 180 
 
Kodish, E., & Post, S. G. (1995). Oncology and hope. Journal of Clinical Oncology, 
13, 1817-1822. 
Kosicki, G. M. & McLeod, J. M. (1990). Learning from political news: Effects of 
media images and information processing strategies. In S. Kraus (Ed.), Mass 
Communication and Political Information Processing (pp. 69-83). Hillsdale, 
NJ: Erlbaum. 
Krupat, E., & Irish, J. T. (2007). Cancer patients as active participants in their care. In 
H. D. O'Hair, G. L. Kreps & L. Sparks (Eds.), Handbook of communication 
and cancer care. Cresskill, NJ: Hampton Press. 
Lara, P. N., Jr., Higdon, R., Lim, N., Kwan, K., Tanaka, M., Lau, D. H. M., et al. 
(2001). Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: 
Identifying Potential Barriers to Enrollment. Journal of Clinical Oncology, 
19(6), 1728-1733. 
Lara, P. N., Jr., Paterniti, D. A., Chiechi, C., Turrell, C., Morain, C., Horan, N., et al. 
(2005). Evaluation of Factors Affecting Awareness of and Willingness to 
Participate in Cancer Clinical Trials. Journal of Clinical Oncology, 23(36), 
9282-9289. 
Lazarus, R. S. (2006). Emotions and interpersonal relationships: Toward a person-
centered conceptualization of emotions and coping. Journal of Personality, 
74(1), 9-46. 
Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. New York, NY: 
Springer Publishing Company, Inc. 
Lemire, M., Paré, G., Sicotte, C., & Harvey, C. (2008). Determinants of Internet use as 
a preferred source of information on personal health. International Journal of 
Medical Informatics, 77, 723-734. 
Lerman, C., Daly, M., Walsh, W. P., Resch, N., Seay, J., Barsevick, A., et al. (1993). 
Communication between patients with breast cancer and health care providers: 
Determinants and implications. Cancer, 72(9), 2612-2620. 
Lerner, J. S., & Keltner, D. (2001). Fear, anger, and risk. Journal of Personality and 
Social Psychology 81, 146-159. 
 181 
 
Leventhal, H. (1970). Findings and theory in the study of fear communications. In L. 
Berkowitz (Ed.), Advances in Experimental Social Psychology (Vol. 5, pp. 
119-186). New York: Academic Press. 
Leydon, G. M., Boulton, M., Moynihan, C., Jones, A., Mossman, J., Boudioni, M., et 
al. (2008). Cancer patients' information needs and information seeking 
behaviour: in depth interview study. British Medical Journal, 320, 909-913. 
Linden, H. M., Reisch, L. M., Hart Jr., A., Harrington, M. A., Nakano, C., Jackson, J. 
C., et al. (2007). Attitudes toward participation in breast cancer randomized 
clinical trials in the African American community: a focus group study. 
Cancer ursing, 30(4), 261-269. 
Llewellyn-Thomas, H. A., McGreal, M. J., Thiel, E. C., & et al. (1991). Patients' 
willingness to enter clinical trials: measuring the association with perceived 
benefit and preference for decision participation. Social Science & Medicine, 
32(1), 35-42. 
Loewenstein, G. F., Weber, E. U., Hsee, C. K., & Welch, N. (2001). Risk as Feelings. 
Psychological Bulletin, 127(2), 267-286. 
MacKenzie, D. (1998). The certainty trough. In R. Williams, W. Faulkner & J. Fleck 
(Eds.), Exploring expertise (pp. 325-329). Houndmills, UK: Macmillan. 
Madsen, S. M., Holm, S., & Riis, P. (2007). Attitudes towards clinical research among 
cancer trial participants and non-participants: an interview study using a 
Grounded Theory approach. Journal of Medical Ethics, 33(4), 234-240. 
Madsen, S. M., Mirza, M. R., Holm, S., Hilsted, K. L., Kampmann, K., & Riis, P. 
(2002). Attitudes towards clinical research amongst participants and 
nonparticipants. Journal of Internal Medicine, 251(2), 156-168. 
Mancini, J., Geneve, J., Dalenc, F., Genre, D., Monnier, A., Kerbrat, P., et al. (2007). 
Decision-making and breast cancer clinical trials - How experience challenges 
attitudes. Contemporary Clinical Trials, 28(6), 684-694. 
Mannel, R. S., Walker, J. L., Gould, N., Scribner, D. R., Kamelle, S., Tillmanns, T., et 
al. (2003). Impact of individual physicians on enrollment of patients into 
clinical trials. American Journal of Clinical Oncology-Cancer Clinical Trials, 
26(2), 171-173. 
 182 
 
McComas, K. A., Yang, Z., Gay, G. K., Leonard, J. P., Dannenberg, A. J., & Dillon, 
H. (forthcoming). Individuals' willingness to talk to their doctors about clinical 
trial enrollment. Journal of Health Communication. 
McGuire, W. J. (1974). Psychological motives and communication gratification. In J. 
G. Blumler & E. Katz (Eds.), The uses of mass communications: Current 
perspectives on gratifications research (pp. 167-198). Beverly Hills, CA: 
Sage. 
Meropol, N. J., Buzaglo, J. S., Millard, J., Damjanov, N., Miller, S. M., Ridgway, C., 
et al. (2007). Barriers to clinical trial participation as perceived by oncologists 
and patients. Journal of the ational Comprehensive Cancer etwork, 5(8), 
655-664. 
Mettlin, C., Cummings, K. M., & Walsh, D. (1985). Risk factor and behavioral 
correlates of willingness to participate in cancer prevention trials. utrition in 
Cancer Care, 7(4), 189-198. 
Mieg, H. A. (2001). The social psychology of expertise: Case studies in research, 
professional domains, and expert roles. Mahwah, NJ: Lawrence Erlbaum 
Aoosciates. 
Miller, S. M. (1989). Cognitive informational styles in the process of coping with 
threat and frustration. Advances in Behavior Research and Therapy, 77, 223-
234. 
Miller, S. M., Shoda, Y., & Hurley, K. (1996). Applying cognitive-social theory to 
health-protective behavior: Breast self-examination in cancer screening. 
Psychological Bulletin 119(1), 70-94. 
Mills, E. J., Seely, D., Rachlis, B., Griffith, L., Wu, P., Wilson, K., et al. (2006). 
Barriers to participation in clinical trials of cancer: a meta-analysis and 
systematic review of patient-reported factors. Lancet Oncology, 7(2), 141-148. 
National Cancer Institute. (2001). Cancer clinical trials: the in-depth program. 
Bethesda, MD. 
National Cancer Institute. (1997). Boosting Cancer Trial Participation. Bethesda, 
MD. 
 183 
 
National Institutes of Health, National Cancer Institute. (1997). Results from Quarterly 
Omnibus Survey: Clinical Trials Questions. Bethesda, MD. 
National Institutes of Health, National Cancer Institute, Working Group on Enhancing 
Recruitment to Early Phase Cancer Clinical Trials. (2004). Enhancing 
Recruitment to Early Phase Cancer Clinical Trials: Literature Review. 
Bethesda, MD. 
Nelson, W. L., Han, P. K. J., Fagerlin, A., Stefanek, M., & Ubel, P. A. (2007). 
Rethinking the Objectives of Decision Aids: A Call for Conceptual Clarity. 
Medical Decision Making, 27(5), 609-618. 
Niederdeppe, J., Frosch, D. L., & Hornik, R. C. (2008). Cancer news coverage and 
information seeking. Journal of Health Communication, 13(2), 181-199. 
Niederdeppe, J., Hornik, R. C., Kelly, B. J., Frosch, D. L., Romantan, A., Stevens, R. 
S., et al. (2007). Examining the dimensions of cancer-related information 
seeking and scanning Behavior. Health Communication, 22(2), 153-167. 
Nisbett, R., Borgida, E., Crandall, R., & Reed, H. (1976). Popular induction: 
Information is not necessarily informative. In J. S. Carroll & J. Payne (Eds.), 
Cognition and social behavior. Hillsdale, NJ: Erlbaum. 
Nowotny, M. L. (1991). Every tomorrow, a vision of hope. Journal of Psychosocial 
Oncology, 9(3), 117-126. 
Nurgat, Z. A., Craig, W., Campbell, N. C., Bissett, J. D., Cassidy, J., & Nicolson, M. 
C. (2005). Patient motivations surrounding participation in phase I and phase II 
clinical trials of cancer chemotherapy. British Journal of Cancer, 92(6), 1001-
1005. 
Ortony, A., & Clore, G. L. (1981). Disentangling the affective lexicon. Paper 
presented at the Third Annual Conference of the Cognitive Science Society, 
Berkeley, CA. 
Parker-Pope, T. (2008). You’re Sick. Now What? Knowledge Is Power. The ew York 
Times, p. F1. 
 184 
 
Peel, E., Parry, O., Douglas, M., & Lawton, J. (2006). "It's no skin off my nose": Why 
people take part in qualitative research. Qualitative Health Research, 16(10), 
1335-1349. 
Pentz, R. D., Flamm, A. L., Sugarman, J., Cohen, M. Z., Ayers, G. D., Herbst, R. S., et 
al. (2002). Study of the media's potential influence on prospective research 
participants' understanding of and motivations for participation in a high-
profile phase I trial. Journal of Clinical Oncology, 20(18), 3785-3791. 
Petersen, S., Heesacker, M., & Marsh, R. D. (2001). Medical decision making among 
cancer patients. Journal of Counseling Psychology, 48(2), 239-244. 
Petty, R. E., & Cacioppo, J. T. (1986). Communication and persuasion: Central and 
peripheral routes to attitude change. New York: Springer-Verlag. 
Raghunathan, R., & Pham, M. T. (1999). All negative moods are not equal: 
Motivational influences of anxiety and sadness on decision making. 
Organizational Behavior and Human Decision Processes, 79(1), 56-77. 
Rimal, R. N., & Real, K. (2003). Understanding the influence of perceived norms on 
behaviors. Communication Theory, 13(2), 184-203. 
Roberson, N. L. (1994). Clinical trial participation - Viewpoints from racial/ethnic 
groups. Cancer, 74(9), 2687-2691. 
Rogers, E. M. (2002). Intermedia processes and powerful media effects. In J. Bryant & 
D. Zillmann (Eds.), Media effects: Advances in theory and research (pp. 199-
214). Mahwah, NJ: Lawrence Erlbaum Associates. 
Romantan, A., Hornik, R., Price, V., Cappella, J., & Viswanath, K. (2008). A 
comparative analysis of the performance of alternative measures of exposure. 
Communication Methods and Measures, 2(1-2), 80-99. 
Rotter, J. B. (1954). Social learning and clinical psychology. Englewood Cliffs, NJ: 
Prentice-Hall. 
Ryan, J., & Sysko, J. (2007). The contingency of patient preferences for involvement 
in health decision making. Health Care Management Review, 32(1), 30-36. 
 185 
 
Sardell, A. N., & Trierweiler, S. J. (1993). Disclosing the cancer diagnosis: Procedures 
that influence patient hopefulness. Cancer, 72(11), 3355-3365. 
Schain, W. S. (1994). Barriers to clinical trials. Part II: Knowledge and attitudes of 
potential participants. Cancer, 74(S9), 2666-2671. 
Scheier, M. F., & Carver, C. S. (1992). Effects of optimism on psychological and 
physical well-being: Theoretical overview and empirical update. Cognitive 
Therapy and Research, 16(2), 201-228. 
Schemer, C., Matthes, J., & Wirth, W. (2008). Toward improving the validity and 
reliability of media information processing measures in surveys. 
Communication Methods and Measures, 2(3), 193-225. 
Schwarz, N., & Bless, B. (1991). Happy and mindless, but sad and smart? The impact 
of affective states on analytic reasoning. In J. Forgas (Ed.), Emotion and social 
judgment (pp. 55-71). Oxford, UK: Pergamon Press. 
Schwarz, N., & Bohner, G. (1996). Feelings and their motivational implications. In P. 
M. Gollwitzer & J. A. Bargh (Eds.), The psychology of action: Linking 
cognition and motivation to behavior (pp. 119-145). New York: The Guilford 
Press. 
Schwarz, N., & Clore, G. L. (1988). How do I feel about it? Informative functions of 
affective states. In K. Fiedler & J. Forgas (Eds.), Affect, cognition and social 
behavior (pp. 44-62). Toronto: Hogrefe. 
Schwarzer, R. (1994). Optimism, vulnerability, and self-beliefs as health-related. 
Psychology & Health, 9, 161-180. 
Sharf, B. F. & Street, Jr., R. L. (1997). The Patient as a Central Construct: Shifting the 
Emphasis. Health Communication, 9, 1-11. 
Sharma, R. A., Symonds, R. P., O'Byrne, K. J., Cheater, F., Abrams, K. R., & 
Steward, W. P. (2001). Involving patients in treatment decisions: Can we learn 
from clinical trials? Clinical Oncology, 13(5), 328-332. 
Sharp, L., Cotton, S. C., Alexander, L., Williams, E., Gray, N. M., & Reid, J. M. 
(2006). Reasons for participation and non-participation in a randomized 
 186 
 
controlled trial: postal questionnaire surveys of women eligible for 
TOMBOLA (Trial of Management of Borderline and Other Low-grade 
Abnormal smears). Clinical Trials, 3(5), 431-442. 
Siegrist, M., Cvetkovich, G., & Roth, C. (2000). Salient value similarity, social trust, 
and risk/benefit perception. Risk Analysis, 17, 115-124. 
Siminoff, L. A., & Thomas, T. A. (2008). Why learning to communicate with our 
patients is so important: Using communication to enhance accrual to cancer 
clinical trials. Journal of Clinical Oncology, 26(16), 2614-2615. 
Slovic, P. (1992). Perception of risk: Reflections on the psychometric paradigm. In S. 
Krimsky & D. Golding (Eds.), Social Theories of Risk (pp. 117-152). 
Westport, CT: Praeger. 
Slovic, P., Peters, E., Finucane, M. L., & MacGregor, D. G. (2005). Affect, risk, and 
decision making. Health Psychology, 24(4), S35-40. 
Somkin, C. P., Altschuler, A., Ackerson, L., Geiger, A. M., Greene, S. M., 
Mouchawar, J., et al. (2005). Organizational barriers to physician participation 
in cancer clinical trials. American Journal of Managed Care, 11(7), 413-421. 
Stryker, J. E., Wray, R. J., Emmons, K. M., Winer, E., & Demetri, G. (2006). 
Understanding the decisions of cancer clinical trial participants to enter 
research studies: Factors associated with informed consent, patient satisfaction, 
and decisional regret. Patient Education and Counseling, 63(1-2), 104-109. 
Sutherland, H. J., Llewellyn-Thomas, H. A., Lockwood, G. A., Tritchler, D. L., & Till, 
J. E. (1989). Cancer patients: Their desire for information and participating in 
treatment decisions. Journal of the Royal Society of Medicine, 82(5), 260-263. 
Taylor, S. E. (1983). Adjustment to threatening events: A theory of cognitive 
adaptation. American Psychologist, 38(11), 1161-1173. 
Taylor, S. E., Kemeny, M. E., Reed, G. M., Bower, J. E., & Gruenewald, T. L. (2000). 
Psychological resources, positive illusions, and health. American Psychologist, 
55(1), 99-109. 
 187 
 
Taylor, S. E., Lichtman, R. R., & Wood, J. V. (1984). Attributions, beliefs about 
control, and adjustment to breast cancer. . Journal of Personality and Social 
Psychology, 46(3), 489-502. 
Thorne, S., Hislop, T. G., Kuo, M., & Armstrong, E.-A. (2006). Hope and Probability: 
Patient Perspectives of the Meaning of Numerical Information in Cancer 
Communication. Qualitative Health Research, 16(3), 318-336. 
Thorne, S. E., Hislop, T. G., Armstrong, E. A., & Oglov, V. (2008). Cancer care 
communication: The power to harm and the power to heal. Patient Education 
and Counseling, 71(1), 34-40. 
Tiedens, L. Z., & Linton, S. (2001). Judgment under emotional certainty and 
uncertainty: The effects of specific emotions on information processing. 
Journal of Personality and Social Psychology, 81(6), 973-988. 
Trauth, J. M., Musa, D., Siminoff, L., Jewell, I. K., & Ricci, E. (2000). Public attitudes 
regarding willingness to participate in medical research studies. Journal of 
Health & Social Policy, 12(2), 23-43. 
Trope, Y., & Neter, E. (1994). Reconciling competing motives in self-evaluation: The 
role of self-control in feedback seeking. Journal of Personality and Social 
Psychology, 66(4), 646-657. 
Trumbo, C. W. (2002). Information processing and risk perception: An adaptation of 
the heuristic-systematic model. Journal of Communication, 52(2), 367-382. 
Tversky, A., & Kahneman, D. (1974). Judgment under Uncertainty: Heuristics and 
Biases. Science, 185(4157), 1124-1131. 
Umutyan, A., Chiechi, C., Beckett, L. A., Paterniti, D. A., Turrell, C., Gandara, D. R., 
et al. (2008). Overcoming barriers to cancer clinical trial accrual: Impact of a 
mass media campaign. Cancer, 112(1), 212-219. 
van Luijn, H. E. M., Aaronson, N. K., Keus, R. B., & Musschenga, A. W. (2006). The 
evaluation of the risks and benefits of phase II cancer clinical trials by 
institutional review board (IRB) members: A case study. Journal of Medical 
Ethics, 32, 170-176. 
 188 
 
Verheggen, F. W. S. M., Jonkers, R., & Kok, G. (1996). Patients' perceptions on 
informed consent and the quality of information disclosure in clinical trials 
Patient Education and Counseling, 29, 137-153. 
Verheggen, F. W. S. M., Nieman, F., & Jonkers, R. (1998). Determinants of patient 
participation in clinical studies requiring informed consent: Why patients enter 
a clinical trial. Patient Education and Counseling, 35, 111-125. 
Viswanath, K., & Finnegan, R. (1995). The knowledge gap hypothesis: Twenty-five 
years later. In B. Burleson (Ed.), Communication yearbook (Vol. 19, pp. 187-
228). Thousand Oaks, CA: Sage. 
Weinstein, N. D. (1989). Optimistic biases about personal risks. Science, 246, 1232-
1233. 
Witte, K. (1994). Fear control and danger control: An empirical test of the extended 
parallel process model. Communication Monographs, 61, 113-134. 
Wright, J. R., Crooks, D., Ellis, P. M., Mings, D., & Whelan, T. J. (2002). Factors that 
influence the recruitment of patients to phase III studies in oncology - The 
perspective of the clinical research associate. Cancer, 95(7), 1584-1591. 
Wright, J. R., Whelan, T. J., Schiff, S., Dubois, S., Crooks, D., Haines, P. T., et al. 
(2004). Why cancer patients enter randomized clinical trials: Exploring the 
factors that influence their decision. Journal of Clinical Oncology, 22(21), 
4312-4318. 
Yeomanskinney, A., Vernon, S. W., Frankowski, R. F., Weber, D. M., Bitsura, J. M., 
& Vogel, V. G. (1995). Factors related to enrollment in the breast-cancer 
prevention trial at a comprehensive cancer center during the first year of 
recruitment. Cancer, 76(1), 46-56. 
 
